data_5x5s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5x5s _Structure_validation_residue.Date_analyzed 2017-03-31 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.537 0.208 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.91 -34.28 6.79 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.908 2.405 . . . . 0.0 112.826 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 p 58.75 178.53 0.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.976 0.417 . . . . 0.0 111.737 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.65 97.69 3.2 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.2 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.7 t -73.41 -68.38 0.5 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.879 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.92 45.9 0.4 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.719 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.1 tp -116.8 126.7 53.47 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.652 0.263 . . . . 0.0 111.084 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.2 p -136.95 -56.57 0.72 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.015 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.2 137.72 32.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.054 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 m -86.99 137.57 20.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.27 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.36 129.17 38.15 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.446 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.94 137.11 38.85 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.216 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 t -80.83 128.69 38.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.94 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.6 t 64.99 -81.91 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.177 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.17 132.34 0.17 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.622 0.248 . . . . 0.0 111.108 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.48 98.79 0.7 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.083 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.8 m -66.08 106.59 1.66 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.751 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.3 t -113.79 95.75 5.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.14 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mp -87.82 -26.71 22.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.025 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.71 139.17 50.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.938 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.63 144.46 15.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.897 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -100.84 148.12 25.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.859 0.361 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.74 69.58 0.97 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.756 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.11 -34.62 76.72 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.552 0.215 . . . . 0.0 111.093 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 45.2 mtm -59.73 -23.61 63.33 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.506 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.11 -9.4 55.42 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.2 11.52 11.82 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.7 m 64.69 49.14 2.35 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.929 0.395 . . . . 0.0 111.233 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.91 103.8 7.0 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.631 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -77.53 154.0 81.42 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.781 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.74 123.51 12.11 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.587 2.192 . . . . 0.0 112.07 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.407 ' CG2' ' HA ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -108.75 97.83 7.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.258 0.552 . . . . 0.0 111.374 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.418 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 2.5 tt -98.24 164.59 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.664 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -61.86 107.52 0.86 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.499 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.719 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -115.05 -143.56 8.12 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.272 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.18 41.9 1.4 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.907 0.384 . . . . 0.0 110.816 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.6 174.93 53.65 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.385 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.06 91.12 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.653 2.235 . . . . 0.0 112.212 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.431 ' HA ' ' OH ' ' A' ' 64' ' ' TYR . 38.1 mm -69.47 153.71 8.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.2 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.48 23.56 54.55 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.726 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 mmtm -128.14 132.01 48.95 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.605 0.24 . . . . 0.0 111.441 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.4 m -115.61 143.91 44.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.728 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.493 ' HB3' ' CE1' ' A' ' 85' ' ' TYR . 4.1 mm? -112.54 138.36 49.43 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.841 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.25 121.78 33.67 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.152 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.447 ' HB ' ' CZ ' ' A' ' 85' ' ' TYR . 7.2 p -111.93 136.46 48.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.098 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.449 ' HB ' ' CD1' ' A' ' 54' ' ' TRP . 35.8 m -128.2 120.73 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.321 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 52' ' ' ALA . . . -95.51 142.25 15.99 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.426 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -150.19 117.41 6.02 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.963 0.411 . . . . 0.0 111.503 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -175.96 -69.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.692 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.21 -28.0 9.26 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.544 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -110.05 -70.22 0.82 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.897 -0.138 . . . . 0.0 111.261 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 47' ' ' GLY . . . 80.55 31.51 0.18 Allowed 'General case' 0 C--N 1.343 0.297 0 CA-C-O 121.444 0.64 . . . . 0.0 109.826 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.7 m -62.63 -39.37 93.61 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.637 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.449 ' CD1' ' HB ' ' A' ' 46' ' ' VAL . 53.5 m0 58.13 48.13 13.42 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.918 0.39 . . . . 0.0 110.818 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -97.02 139.0 33.67 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.453 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.11 93.74 2.43 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.359 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -62.53 135.12 95.37 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.832 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.6 -37.93 20.45 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.742 2.295 . . . . 0.0 112.702 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.8 -26.13 65.51 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.371 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.408 ' HD3' ' CG2' ' A' ' 73' ' ' VAL . 27.4 mtt180 -125.42 17.23 8.26 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.083 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.73 -23.47 66.11 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.492 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -163.82 106.73 0.96 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.893 0.378 . . . . 0.0 111.427 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -105.55 131.11 53.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.295 179.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.431 ' OH ' ' HA ' ' A' ' 39' ' ' ILE . 62.3 m-85 -91.68 118.93 31.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.159 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.407 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 4.3 t -93.97 116.31 34.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.293 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.719 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -65.6 79.81 0.09 OUTLIER Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.618 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 169.68 32.57 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.867 0.392 . . . . 0.0 111.724 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.0 m120 61.98 22.69 13.25 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.847 0.356 . . . . 0.0 110.119 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.44 155.31 27.67 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.363 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.416 ' CZ ' HD22 ' A' ' 43' ' ' LEU . 24.5 t80 -120.71 139.46 53.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.439 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 130' ' ' TRP . 1.5 mt-30 -136.96 139.36 41.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.177 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.59 111.78 4.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.114 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.408 ' CG2' ' HD3' ' A' ' 60' ' ' ARG . 27.1 m -74.57 129.26 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.726 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.0 m -130.78 139.97 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -113.66 120.37 40.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.914 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -137.52 166.91 22.74 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.811 0.338 . . . . 0.0 111.831 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.17 172.92 1.27 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.642 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.414 ' HB1' ' CA ' ' A' ' 125' ' ' ALA . . . -110.31 143.23 40.82 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.344 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.51 91.17 1.02 Allowed Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.297 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 57.28 101.6 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.83 0.347 . . . . 0.0 111.928 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -142.05 135.66 29.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.936 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.6 mtm105 -109.57 145.21 36.75 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.426 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -149.14 161.63 41.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.866 0.365 . . . . 0.0 111.386 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -141.55 152.0 43.71 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.903 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -118.4 132.85 56.24 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.819 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -164.05 151.43 12.14 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.316 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.72 177.3 6.37 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.085 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.46 -34.82 19.97 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.474 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.1 38.19 1.26 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.658 0.266 . . . . 0.0 111.22 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 50.28 40.6 22.78 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.965 0.412 . . . . 0.0 111.193 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.06 176.99 3.11 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.514 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -43.57 116.14 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.877 2.384 . . . . 0.0 112.854 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -111.68 -175.69 2.76 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.252 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.459 ' HB3' ' CB ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -125.63 128.09 47.33 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.117 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.38 111.92 9.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.816 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.12 88.93 4.99 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.157 0.503 . . . . 0.0 111.02 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.55 108.46 10.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.959 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.04 31.8 65.78 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.323 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -85.28 -52.1 6.13 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.183 0.193 . . . . 0.0 111.158 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 57.38 86.02 0.08 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.384 0.611 . . . . 0.0 110.233 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.4 tt -76.76 146.77 37.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.594 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.72 152.93 80.63 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.02 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -46.77 110.66 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.598 2.198 . . . . 0.0 112.386 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.98 34.61 20.91 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.559 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.45 150.16 48.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.998 0.427 . . . . 0.0 111.127 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 35.9 p -84.8 144.91 28.16 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.315 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.82 149.08 42.64 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.417 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.33 131.15 36.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.958 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tp -92.72 99.38 12.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.709 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -107.65 -160.57 0.74 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.647 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.25 165.83 26.35 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.752 0.311 . . . . 0.0 111.262 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.72 123.43 5.17 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.112 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.97 50.08 3.38 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.835 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -172.29 38.67 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.705 0.288 . . . . 0.0 111.478 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.26 -138.59 10.35 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.532 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.2 140.34 36.61 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.688 0.28 . . . . 0.0 111.048 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.73 149.83 31.03 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.226 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.36 114.37 26.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.68 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.82 129.01 44.32 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.05 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.9 t -117.55 131.33 70.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.074 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.5 m -91.66 97.55 11.09 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.822 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 13.6 tp -130.89 105.62 15.28 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.776 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.32 8.37 1.49 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.918 2.412 . . . . 0.0 113.752 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -128.43 133.1 48.48 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.553 0.216 . . . . 0.0 111.031 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.414 ' CA ' ' HB1' ' A' ' 78' ' ' ALA . . . -85.07 142.34 29.62 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.427 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 160.41 -174.74 37.16 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.706 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.58 134.3 49.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.803 0.335 . . . . 0.0 111.007 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.06 161.29 16.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.281 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.2 m -108.3 125.08 65.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.533 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.462 ' O ' ' HA ' ' A' ' 71' ' ' GLN . 10.1 m95 -96.15 112.08 23.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.923 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.2 t -110.53 125.26 53.16 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.533 ' HB3' ' HA ' ' A' ' 143' ' ' ILE . 0.2 OUTLIER -148.75 143.98 26.75 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.607 -178.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -108.11 134.59 50.77 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.568 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -112.15 144.92 40.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.123 0.487 . . . . 0.0 110.953 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.474 ' HB ' ' HG2' ' A' ' 140' ' ' PRO . 5.0 t -68.84 164.01 22.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.752 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -94.03 -39.61 10.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.819 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.4 t -79.52 -27.27 41.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.322 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.431 ' CA ' HG22 ' A' ' 135' ' ' THR . . . 101.31 35.18 4.24 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.48 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.55 ' CB ' ' HD3' ' A' ' 140' ' ' PRO . 0.9 OUTLIER -112.87 -73.83 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 117.303 0.551 . . . . 0.0 111.418 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 97.0 Cg_endo -78.95 144.57 19.03 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.521 2.147 . . . . 0.0 113.077 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.2 120.7 4.14 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.963 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.01 147.65 51.78 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 111.338 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.533 ' HA ' ' HB3' ' A' ' 132' ' ' LEU . 38.6 mt -123.36 147.2 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.919 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.25 132.68 22.04 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.063 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.13 139.62 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.964 0.411 . . . . 0.0 111.614 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.34 158.77 43.63 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.809 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.45 134.92 44.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 13.5 t -117.76 117.37 35.83 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.874 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--O 1.251 1.15 0 C-N-CA 122.841 2.361 . . . . 0.0 112.791 179.891 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.569 0.223 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.4 128.36 12.72 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.8 2.333 . . . . 0.0 112.548 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 t -156.02 145.82 21.19 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.143 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -161.31 -67.51 0.06 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.252 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.52 -175.46 4.2 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.985 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.86 -121.17 5.68 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.356 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.5 tp 56.88 77.35 0.27 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 111.325 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.2 100.82 8.43 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.679 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.64 119.31 23.66 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.943 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.5 t -115.48 -58.63 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.151 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.91 123.57 22.31 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.251 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.78 137.96 33.48 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.821 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -96.89 99.37 8.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.301 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 t -98.98 35.89 1.8 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.057 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.73 128.09 16.86 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.491 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.39 105.23 0.59 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.877 0.37 . . . . 0.0 111.222 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.84 149.04 29.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.995 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.67 126.44 28.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.394 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 46.62 48.72 14.23 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.154 0.502 . . . . 0.0 111.18 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.4 tt -104.9 147.29 11.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.692 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.79 140.64 15.15 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.452 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -141.44 138.46 32.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.874 0.369 . . . . 0.0 111.161 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.19 75.9 1.99 Allowed Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.459 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -60.76 -38.18 84.35 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.647 0.26 . . . . 0.0 110.823 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -66.68 -30.2 70.39 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.978 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.75 -31.27 70.2 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.106 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.22 8.27 38.45 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.674 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.8 m 59.58 76.58 0.35 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.731 0.3 . . . . 0.0 111.085 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -141.21 111.89 7.04 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.554 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -72.29 115.01 34.6 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.832 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.99 121.2 9.31 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.446 2.097 . . . . 0.0 112.157 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.482 ' CG2' HG11 ' A' ' 65' ' ' VAL . 1.2 p -114.7 137.63 51.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.493 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.98 150.51 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.1 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 64' ' ' TYR . 4.4 pt-20 -53.8 107.33 0.25 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.029 0.442 . . . . 0.0 111.85 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.693 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -100.77 -88.82 2.03 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.781 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -126.56 30.03 5.62 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.663 0.268 . . . . 0.0 110.997 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.51 123.38 6.73 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.794 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -57.18 113.22 1.38 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.011 2.474 . . . . 0.0 112.434 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.6 mt -78.63 158.12 4.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.45 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.32 15.47 80.93 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.461 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -130.87 131.48 44.58 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 117.078 0.439 . . . . 0.0 110.845 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.6 m -116.17 139.27 50.5 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.081 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 pp -109.87 148.34 31.7 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.289 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.61 136.02 43.19 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.157 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.4 m -113.53 115.81 50.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.983 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.78 156.5 28.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.033 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . 172.89 134.12 1.76 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.336 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -84.42 86.83 7.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.117 0.484 . . . . 0.0 110.339 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -90.24 -171.29 3.05 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.079 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.3 -49.25 8.92 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.597 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.27 49.4 1.79 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.954 0.407 . . . . 0.0 111.361 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.62 -57.43 0.12 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.865 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 m 50.51 86.98 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.66 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 12.6 m0 62.1 60.87 1.42 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.044 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.6 120.14 35.33 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.22 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.42 101.15 6.07 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.657 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.62 121.83 80.05 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.63 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.97 -38.46 86.52 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.736 2.29 . . . . 0.0 112.484 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -67.4 -15.05 63.46 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.682 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -122.77 16.64 10.23 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.615 0.245 . . . . 0.0 110.953 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -50.88 -32.79 21.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.328 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -172.06 120.86 0.45 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.876 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.96 140.37 36.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.641 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 34' ' ' GLU . 58.8 m-85 -86.43 118.34 25.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.8 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.482 HG11 ' CG2' ' A' ' 32' ' ' THR . 4.3 t -101.71 123.17 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.693 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -67.23 78.99 0.16 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.84 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER 161.44 31.6 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.104 0.532 . . . . 0.0 112.406 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.3 t30 61.41 25.19 15.18 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.999 0.428 . . . . 0.0 110.525 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.529 ' CG2' ' HA ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -109.02 156.17 20.06 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.264 -178.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -118.15 136.56 53.54 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.602 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.438 ' CG ' ' HA ' ' A' ' 131' ' ' SER . 8.6 mt-30 -144.76 148.69 34.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.057 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.64 130.32 13.15 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.469 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.5 p -89.27 131.51 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.692 0.282 . . . . 0.0 110.76 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.38 145.56 35.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.542 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -114.27 122.31 46.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.515 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.6 163.95 24.91 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.899 0.38 . . . . 0.0 111.434 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -101.22 175.53 5.56 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.159 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.4 137.69 58.1 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.63 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.14 145.33 7.19 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.481 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.61 136.98 57.91 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.707 0.289 . . . . 0.0 111.126 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -140.94 148.68 40.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.059 0.457 . . . . 0.0 111.484 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.455 ' NH2' ' HB2' ' A' ' 117' ' ' ASP . 10.7 mtp-105 -117.96 140.66 49.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.081 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.427 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -147.99 177.83 9.03 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.085 0.469 . . . . 0.0 111.928 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.63 145.34 5.43 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.357 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.498 ' O ' ' HB2' ' A' ' 93' ' ' GLN . 3.3 m-85 -97.15 142.85 28.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.617 0.246 . . . . 0.0 111.139 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.456 ' HA ' ' CB ' ' A' ' 93' ' ' GLN . . . -162.91 122.41 2.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.76 148.92 44.13 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.74 0.305 . . . . 0.0 111.355 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -35.45 76.61 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.703 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -96.76 31.26 2.38 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.617 0.246 . . . . 0.0 111.388 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 51.97 40.81 28.97 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 111.244 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.477 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.6 OUTLIER -85.75 169.88 14.52 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.433 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 91' ' ' SER . 1.2 Cg_endo -43.89 105.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.008 2.472 . . . . 0.0 112.43 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 85' ' ' TYR . 5.0 pt20 -106.74 -174.68 2.59 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.175 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.09 122.82 39.41 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.108 0.48 . . . . 0.0 110.814 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.9 p -132.19 130.79 41.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.364 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.06 120.35 38.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.625 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 99' ' ' LEU . 3.0 p30 -64.88 -157.61 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.617 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.81 74.08 0.05 OUTLIER Glycine 0 C--N 1.342 0.91 0 C-N-CA 121.165 -0.541 . . . . 0.0 111.978 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 97' ' ' ASP . 1.4 tm? -109.41 -44.66 3.85 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.918 0.487 . . . . 0.0 110.938 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 62.21 81.99 0.19 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.313 0.578 . . . . 0.0 109.863 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 8.0 tt -73.8 146.05 44.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.681 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.38 153.23 69.0 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.463 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -44.6 110.92 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.817 2.345 . . . . 0.0 112.434 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.46 34.58 22.47 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.421 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.87 150.73 46.17 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.049 0.452 . . . . 0.0 111.34 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.11 140.9 43.75 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.225 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -111.47 149.04 31.89 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.035 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.7 m -93.58 139.47 30.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.307 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.464 ' HB2' ' CD1' ' A' ' 143' ' ' ILE . 51.5 tp -120.6 97.83 5.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.205 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.94 -73.02 0.47 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.504 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -169.07 125.5 0.92 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.666 0.27 . . . . 0.0 111.044 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.98 161.35 10.69 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 116.187 -0.461 . . . . 0.0 113.243 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.27 -90.31 0.17 Allowed Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.198 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -157.58 99.72 1.75 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.866 0.365 . . . . 0.0 111.146 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -134.23 -130.55 3.02 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.296 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.56 145.31 36.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.856 0.36 . . . . 0.0 110.792 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.455 ' HB2' ' NH2' ' A' ' 82' ' ' ARG . 1.1 m-20 -83.45 129.29 34.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.171 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.67 114.03 4.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.481 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.34 124.78 34.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.94 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 21.7 t -117.07 124.99 73.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.852 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.6 m -89.62 121.25 31.63 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.426 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.8 tp -127.28 110.64 21.34 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.977 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -85.21 8.94 4.34 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.864 2.376 . . . . 0.0 113.117 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -165.19 150.88 9.62 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.826 0.346 . . . . 0.0 110.965 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.75 141.43 56.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.326 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.17 142.53 3.88 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.46 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.82 125.93 33.02 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.847 0.356 . . . . 0.0 110.934 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.402 ' HE1' ' CD1' ' A' ' 130' ' ' TRP . 23.3 p90 -102.63 155.65 18.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.88 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.7 m -108.19 121.79 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.001 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.453 ' CE3' ' HB ' ' A' ' 145' ' ' VAL . 4.5 m95 -88.48 112.29 22.8 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.669 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.438 ' HA ' ' CG ' ' A' ' 71' ' ' GLN . 26.9 t -124.97 131.39 53.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.367 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.467 ' HG ' HG23 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -133.9 135.15 43.44 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.73 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.529 ' HA ' ' CG2' ' A' ' 69' ' ' THR . 1.9 tptm -122.03 131.19 53.86 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.051 0.453 . . . . 0.0 111.479 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -141.59 144.86 34.44 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.156 179.644 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.452 ' CG2' ' HD2' ' A' ' 140' ' ' PRO . 13.3 t -96.48 168.84 10.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.145 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -79.56 -5.97 56.04 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.812 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.9 m -65.4 -26.81 68.15 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.05 28.42 49.81 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.971 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.609 ' CB ' ' HD3' ' A' ' 140' ' ' PRO . 0.3 OUTLIER -139.69 -62.86 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 122.295 0.238 . . . . 0.0 111.188 179.763 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.609 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 22.0 Cg_exo -64.81 123.43 11.65 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.529 2.153 . . . . 0.0 111.883 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.77 117.36 5.76 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.23 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.55 149.63 45.51 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.23 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.467 HG23 ' HG ' ' A' ' 132' ' ' LEU . 2.4 mp -123.89 149.59 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.136 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -141.2 121.52 13.96 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.765 0.317 . . . . 0.0 111.307 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.453 ' HB ' ' CE3' ' A' ' 130' ' ' TRP . 14.9 p -130.6 135.82 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.95 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.0 p -141.09 154.36 45.89 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.251 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.5 122.39 43.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.778 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.09 122.39 40.81 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 C--O 1.251 1.14 0 C-N-CA 122.843 2.362 . . . . 0.0 112.412 -179.914 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.498 0.19 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.92 -31.44 63.01 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.687 2.258 . . . . 0.0 112.542 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 m -68.34 96.26 0.65 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.96 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.84 -46.62 2.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.018 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.5 m -142.48 79.42 1.66 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.738 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.14 -140.93 14.93 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.891 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.1 mt 57.65 44.27 20.99 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.864 0.364 . . . . 0.0 111.489 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -77.78 -40.96 39.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.306 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -115.79 118.15 32.22 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.744 0.307 . . . . 0.0 111.02 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 t -95.54 19.09 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.277 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.9 143.06 29.26 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.097 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.7 t -76.81 129.87 36.86 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.017 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.97 -52.52 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.045 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.99 151.29 28.53 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.069 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.84 138.27 48.15 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.242 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.24 130.14 56.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.324 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.3 m -68.7 147.15 52.26 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.96 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.93 123.03 7.38 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.384 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mp -96.33 86.17 4.13 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.53 137.32 40.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.84 144.92 12.77 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.701 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -127.29 138.61 53.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.661 0.267 . . . . 0.0 111.159 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.75 136.6 3.38 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.604 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -61.1 -34.21 74.58 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.697 0.284 . . . . 0.0 111.222 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -13.36 5.57 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.257 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.73 11.36 1.38 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.57 -19.3 45.93 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.58 88.27 2.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.74 0.305 . . . . 0.0 111.563 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -174.86 131.61 0.32 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.655 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -78.6 145.78 68.0 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.69 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -61.81 116.38 3.41 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.655 2.237 . . . . 0.0 112.049 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.449 HG23 HG13 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -102.82 97.54 7.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 111.06 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 tt -95.72 161.27 2.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.399 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.9 107.35 0.97 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.971 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.698 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -109.41 -130.89 6.1 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.979 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -105.92 42.45 1.25 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.74 0.305 . . . . 0.0 110.776 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.6 163.48 37.02 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.812 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.74 117.58 5.22 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.908 2.405 . . . . 0.0 112.978 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 39' ' ' ILE . 16.3 tt -69.82 153.12 8.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.612 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 50.81 14.25 1.04 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.117 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.22 131.84 47.01 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 117.35 0.575 . . . . 0.0 111.102 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.9 m -115.7 142.12 47.17 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.1 mt -112.24 122.67 48.38 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.406 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.51 118.74 37.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.766 0.317 . . . . 0.0 111.435 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.435 HG11 ' HG3' ' A' ' 56' ' ' GLN . 8.8 p -113.32 136.39 49.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.686 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' A' ' 54' ' ' TRP . 28.1 m -126.51 126.91 69.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.404 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.93 129.87 9.95 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.016 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 49' ' ' PHE . 6.3 t0 -120.02 94.46 4.4 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.555 ' CB ' ' HA ' ' A' ' 81' ' ' PHE . 0.3 OUTLIER 157.6 159.9 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.455 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 51.84 36.11 17.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.616 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.3 t70 57.05 65.01 1.48 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.199 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.48 -39.92 8.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.856 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 55.82 31.97 18.68 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.422 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.447 ' CD1' ' HB ' ' A' ' 46' ' ' VAL . 40.2 m0 53.96 62.54 2.55 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.921 0.391 . . . . 0.0 110.852 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -94.98 122.23 37.41 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.37 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.435 ' HG3' HG11 ' A' ' 45' ' ' VAL . 1.1 mm-40 -169.15 111.35 0.5 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.993 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.29 126.7 89.96 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.957 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.66 -32.96 77.75 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.79 2.327 . . . . 0.0 112.585 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -57.04 -24.29 52.69 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.778 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.402 ' HB3' ' CG2' ' A' ' 73' ' ' VAL . 77.5 mtt180 -118.8 12.92 13.09 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.555 0.217 . . . . 0.0 111.04 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.0 7.79 26.11 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -157.68 90.46 1.08 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.055 0.455 . . . . 0.0 111.033 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 71' ' ' GLN . 47.1 mtm180 -110.83 114.9 28.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.523 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -77.41 118.39 19.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.207 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.514 HG21 ' HG2' ' A' ' 71' ' ' GLN . 2.5 t -96.55 118.01 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.698 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -65.9 79.05 0.1 OUTLIER Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.545 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 171.55 28.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.959 0.446 . . . . 0.0 112.067 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.9 t30 62.02 22.39 13.05 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.889 0.376 . . . . 0.0 110.521 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.414 HG21 ' HA ' ' A' ' 133' ' ' LYS . 18.8 p -119.44 156.01 30.98 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.91 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -125.52 144.96 50.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.271 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.514 ' HG2' HG21 ' A' ' 65' ' ' VAL . 3.3 pt20 -149.63 158.84 44.54 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.57 122.58 8.22 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.362 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.402 ' CG2' ' HB3' ' A' ' 60' ' ' ARG . 5.0 m -75.24 129.23 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.7 0.286 . . . . 0.0 110.847 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.2 t -130.23 139.11 52.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.533 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.53 135.0 35.58 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.443 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -111.49 143.56 42.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.51 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.61 104.29 4.53 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.313 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 69.61 143.36 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.488 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.85 160.47 52.15 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.816 -0.629 . . . . 0.0 114.296 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 77.17 74.87 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.668 -0.766 . . . . 0.0 111.182 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.555 ' HA ' ' CB ' ' A' ' 49' ' ' PHE . 30.7 p90 -138.86 136.42 35.54 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.96 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -109.06 135.98 49.32 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.558 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.1 ptm -143.37 162.52 35.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.919 0.39 . . . . 0.0 111.813 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -149.91 141.89 23.88 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.784 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.452 ' HB2' ' HB3' ' A' ' 94' ' ' PHE . 14.4 m-85 -97.62 141.19 30.96 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.19 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.469 ' HA ' ' HB3' ' A' ' 93' ' ' GLN . . . -158.22 124.39 4.67 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.254 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.1 t -69.76 167.81 16.35 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -77.82 -40.83 39.19 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.635 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.62 35.48 1.36 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.739 0.304 . . . . 0.0 111.416 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 51.47 38.47 22.16 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.931 0.396 . . . . 0.0 111.305 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.49 177.86 2.67 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.5 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -43.1 119.32 1.57 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.845 2.363 . . . . 0.0 113.081 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.469 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 3.6 mt-30 -118.89 -175.3 2.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.933 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.452 ' HB3' ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -123.33 119.8 31.18 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.173 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.2 p -141.64 122.78 14.69 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.053 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -104.04 154.05 20.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.772 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.62 26.55 4.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.566 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.19 135.87 9.08 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.424 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.59 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 62.77 78.57 0.29 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.515 0.674 . . . . 0.0 109.727 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.5 tt -70.46 147.69 49.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.931 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.427 ' CG2' ' HD2' ' A' ' 103' ' ' PRO . 93.3 m -113.57 143.52 29.57 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.155 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.435 ' HB3' ' HG2' ' A' ' 147' ' ' LYS . 72.7 Cg_exo -41.16 116.36 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.885 2.39 . . . . 0.0 112.954 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.81 34.52 11.16 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.479 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HG2' ' N ' ' A' ' 106' ' ' THR . 16.8 tttt -131.38 152.55 50.52 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.077 0.465 . . . . 0.0 111.088 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.403 ' N ' ' HG2' ' A' ' 105' ' ' LYS . 2.2 p -81.28 140.2 34.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.91 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -104.09 148.93 25.69 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.111 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 m -86.06 133.31 33.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.855 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.409 ' HB2' ' CD1' ' A' ' 143' ' ' ILE . 69.4 tp -109.15 137.19 47.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.991 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -97.64 -67.89 0.83 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.924 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -178.15 -45.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.906 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 134.52 141.6 4.48 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.336 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.51 -108.31 0.39 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.117 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -145.04 99.52 3.34 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.831 0.348 . . . . 0.0 110.782 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.58 -137.22 5.05 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.589 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.95 129.56 55.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.632 0.253 . . . . 0.0 110.854 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -64.86 141.59 58.72 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.044 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 67.9 m -85.7 129.02 34.94 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.912 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -102.0 132.59 47.75 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.346 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.496 ' HB ' ' CZ ' ' A' ' 81' ' ' PHE . 15.8 t -119.92 129.96 74.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.6 m -95.44 93.02 6.97 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.911 0.386 . . . . 0.0 111.123 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.439 ' CD1' ' HD3' ' A' ' 147' ' ' LYS . 41.7 tp -131.91 100.3 16.04 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.192 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.66 -0.8 9.38 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.567 2.178 . . . . 0.0 113.891 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -110.33 122.43 47.66 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.7 0.286 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.99 120.76 19.07 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -165.18 168.11 39.12 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.79 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -68.05 131.8 46.11 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.934 0.397 . . . . 0.0 111.293 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.442 ' CE2' ' HB3' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -112.84 146.65 38.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.424 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 27.2 m -124.44 120.1 58.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.95 0.405 . . . . 0.0 110.988 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.434 ' CE3' ' CG2' ' A' ' 145' ' ' VAL . 4.5 t-105 -100.16 112.16 24.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.379 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 t -121.09 149.38 42.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.522 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.513 ' HG ' HG23 ' A' ' 143' ' ' ILE . 3.0 mp -133.68 135.41 44.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.527 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.414 ' HA ' HG21 ' A' ' 69' ' ' THR . 1.1 tptm -123.72 120.03 31.5 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.972 0.415 . . . . 0.0 111.203 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.405 ' HB3' ' CG ' ' A' ' 141' ' ' GLU . 0.1 OUTLIER -141.77 145.12 34.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.667 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.2 p -89.69 171.8 9.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.06 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -88.12 7.64 30.64 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.639 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.6 t -69.98 -26.73 64.23 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.454 0.169 . . . . 0.0 111.335 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.05 42.39 8.83 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.556 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.445 ' CB ' ' CD ' ' A' ' 140' ' ' PRO . 0.4 OUTLIER -158.93 -65.63 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 120.294 0.092 . . . . 0.0 111.018 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 139' ' ' ASP . 39.7 Cg_endo -66.55 122.55 10.0 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.5 2.134 . . . . 0.0 112.226 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.405 ' CG ' ' HB3' ' A' ' 134' ' ' PHE . 4.6 mt-10 -142.43 111.23 6.29 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.804 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -122.96 149.94 43.62 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.914 0.388 . . . . 0.0 110.959 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.513 HG23 ' HG ' ' A' ' 132' ' ' LEU . 12.1 mm -123.37 147.73 27.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.535 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.65 124.51 19.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.814 0.34 . . . . 0.0 111.068 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.434 ' CG2' ' CE3' ' A' ' 130' ' ' TRP . 14.8 p -132.92 137.56 53.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.5 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.1 p -139.93 155.64 47.06 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.795 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.442 ' HB3' ' CE2' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -117.61 125.38 50.67 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.892 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 84.0 m -123.63 116.4 27.94 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.936 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 C--O 1.25 1.1 0 C-N-CA 122.709 2.273 . . . . 0.0 112.729 179.968 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.396 0.141 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.62 91.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.834 2.356 . . . . 0.0 112.069 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.49 150.31 34.32 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.995 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.41 -27.94 56.48 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.744 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 t -58.99 -53.67 55.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.505 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.37 52.47 0.63 Allowed Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.412 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.76 142.67 31.9 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.758 0.313 . . . . 0.0 110.786 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 t -169.23 161.23 10.07 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.189 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -98.37 113.79 25.89 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.725 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.28 81.31 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.034 0.445 . . . . 0.0 111.148 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.74 138.52 37.33 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.538 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -97.74 130.7 44.69 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.035 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 m 40.14 82.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.337 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -127.83 136.94 52.13 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.336 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 65.58 111.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.841 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 70.85 131.46 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.532 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 m -162.18 117.05 1.89 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.323 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.4 135.6 54.25 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.775 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 tp -135.27 84.17 2.07 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.95 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 tt -88.22 135.73 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.822 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.05 141.74 5.5 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.67 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -151.76 138.65 18.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.668 0.271 . . . . 0.0 111.153 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.04 95.27 2.26 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.694 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -64.53 -34.98 79.49 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.564 0.221 . . . . 0.0 111.018 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.0 ptp -70.7 -25.9 63.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.126 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -101.19 11.45 39.38 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -80.24 -28.89 38.4 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 122.337 -0.227 . . . . 0.0 111.101 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.2 p -87.49 2.69 49.93 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.79 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -174.37 125.27 0.32 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.875 0.369 . . . . 0.0 111.303 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -95.88 152.9 39.32 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.588 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.41 127.67 26.19 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.821 2.347 . . . . 0.0 112.45 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.62 126.31 47.09 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.202 0.525 . . . . 0.0 111.997 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.419 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 12.4 tt -135.94 162.61 36.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.043 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -56.76 107.85 0.44 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.95 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.745 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -119.94 -130.59 4.02 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.239 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.76 33.63 5.56 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.566 0.222 . . . . 0.0 111.584 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.12 178.81 12.37 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.972 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.58 125.63 5.68 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.811 2.34 . . . . 0.0 113.173 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.428 ' CD1' ' CE2' ' A' ' 64' ' ' TYR . 21.0 mm -104.97 153.87 6.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.134 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.33 22.76 63.66 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.542 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -129.59 132.41 46.77 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.698 0.285 . . . . 0.0 111.029 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.5 m -115.09 128.43 56.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.706 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.4 ' HB2' ' OH ' ' A' ' 70' ' ' TYR . 4.0 mm? -100.84 122.69 43.86 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.441 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -103.95 119.05 38.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.883 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -97.14 119.07 44.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.972 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.4 m -122.41 -178.2 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.001 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 83' ' ' MET . . . 133.68 -91.04 0.25 Allowed Glycine 0 CA--C 1.518 0.281 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER 160.81 129.25 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.814 0.446 . . . . 0.0 110.129 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 6.8 m-85 -137.62 27.58 2.75 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 51' ' ' ASP . . . 51.95 92.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.838 0.351 . . . . 0.0 111.186 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 50' ' ' ALA . 17.8 t70 87.44 21.87 0.06 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.238 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.96 43.72 0.1 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.646 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 m -67.43 87.67 0.2 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.918 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.529 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 1.3 m0 73.07 61.13 0.1 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.684 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -107.46 116.1 31.34 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.472 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -153.15 94.78 1.88 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.578 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -74.02 135.93 76.68 Favored Pre-proline 0 C--O 1.233 0.187 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.727 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.09 -26.6 51.19 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.897 2.398 . . . . 0.0 112.95 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -28.26 69.35 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.495 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -130.97 22.53 4.92 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.79 0.329 . . . . 0.0 110.916 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.35 -16.89 61.8 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.119 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -162.69 128.18 3.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.711 0.291 . . . . 0.0 111.164 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 mtm105 -116.85 130.86 56.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.663 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.428 ' CE2' ' CD1' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -76.6 118.64 19.45 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.458 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.449 ' CG2' ' HB2' ' A' ' 71' ' ' GLN . 1.8 t -107.77 105.55 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.745 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -55.51 88.62 0.01 OUTLIER Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.595 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.441 ' CB ' ' O ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER 158.93 27.2 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.188 0.581 . . . . 0.0 112.485 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 61.83 21.47 12.27 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.884 0.373 . . . . 0.0 110.199 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -111.58 155.88 22.64 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.074 -179.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.4 ' OH ' ' HB2' ' A' ' 43' ' ' LEU . 47.9 t80 -114.62 134.97 54.65 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.772 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.449 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . 2.8 tp-100 -126.56 136.46 52.59 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.741 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.67 110.35 4.04 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.419 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.7 t -76.85 132.36 33.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.272 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.556 ' HB ' ' CE1' ' A' ' 128' ' ' TYR . 14.1 t -130.69 136.54 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.743 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -96.92 131.12 44.01 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.518 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -138.57 161.5 36.93 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.864 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.15 172.74 10.97 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.697 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.01 129.53 34.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.399 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.88 140.05 0.67 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.247 -0.501 . . . . 0.0 113.117 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.07 104.04 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.861 0.363 . . . . 0.0 111.499 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 122' ' ' LEU . 19.5 m-85 -132.21 138.69 48.05 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.733 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 -159.35 127.64 5.05 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.186 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -151.97 174.0 14.17 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.135 0.493 . . . . 0.0 112.074 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -168.29 142.75 3.4 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.26 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.524 ' O ' ' HB2' ' A' ' 93' ' ' GLN . 4.0 m-85 -99.09 142.94 29.93 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 111.35 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.97 125.1 3.48 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.75 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.13 169.49 14.94 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.261 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -78.91 -34.75 44.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.319 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.5 31.14 2.63 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.299 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 53.41 40.57 31.54 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.968 0.414 . . . . 0.0 111.249 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.58 178.55 2.21 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.567 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.62 121.72 2.85 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.726 2.284 . . . . 0.0 112.895 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 85' ' ' TYR . 11.8 pt20 -118.36 -175.22 2.82 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.616 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.43 ' HB3' ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -123.0 121.32 35.8 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.084 0.468 . . . . 0.0 110.428 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.82 112.81 3.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.191 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -107.86 130.02 55.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.464 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.67 118.93 24.19 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.904 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.11 42.27 80.97 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.196 -0.525 . . . . 0.0 112.367 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.7 tp -84.61 -56.65 3.5 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.547 0.202 . . . . 0.0 111.547 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 60.74 85.2 0.12 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.328 0.585 . . . . 0.0 110.02 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.1 tt -69.94 144.48 52.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.546 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.9 m -135.35 142.93 43.32 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.129 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -46.52 111.05 0.32 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.669 2.246 . . . . 0.0 112.479 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.39 34.43 16.92 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.553 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.38 150.83 49.94 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.995 0.426 . . . . 0.0 110.864 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 28.4 p -80.39 142.53 34.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.024 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.431 ' CB ' ' HB ' ' A' ' 143' ' ' ILE . . . -103.88 140.21 38.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.234 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.2 m -76.49 126.99 31.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.224 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.416 HD12 ' HG2' ' A' ' 141' ' ' GLU . 0.6 OUTLIER -116.28 96.59 5.62 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.644 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.93 -48.26 0.37 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.316 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.75 131.14 34.21 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.695 0.283 . . . . 0.0 110.798 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -133.75 61.73 0.64 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.571 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.84 90.49 0.08 OUTLIER Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.562 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 64.74 98.92 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 111.298 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -145.01 -134.84 2.8 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.281 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.82 131.36 55.06 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.621 0.248 . . . . 0.0 110.708 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.08 132.49 48.65 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.69 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.2 m -80.82 114.32 19.62 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.594 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.41 144.96 26.07 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.439 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 81' ' ' PHE . 2.5 t -127.43 138.76 53.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.995 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.3 m -106.7 100.72 10.21 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.414 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 81' ' ' PHE . 0.9 OUTLIER -130.87 117.5 17.31 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.051 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.32 8.24 4.5 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.796 2.331 . . . . 0.0 113.303 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -129.38 143.07 50.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.675 0.274 . . . . 0.0 110.942 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.72 140.08 30.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.041 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 166.92 177.11 38.46 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.776 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -101.75 135.73 42.8 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 111.085 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.556 ' CE1' ' HB ' ' A' ' 74' ' ' VAL . 14.1 p90 -108.73 163.24 13.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.811 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 12.1 m -111.76 130.7 64.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.433 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -92.37 112.44 24.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.536 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.32 125.94 52.85 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.979 0.418 . . . . 0.0 110.584 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.439 ' HG ' HG23 ' A' ' 143' ' ' ILE . 7.0 mp -134.33 135.76 42.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.493 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' A' ' 69' ' ' THR . 14.8 tttm -127.91 132.15 49.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.972 0.415 . . . . 0.0 111.688 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -128.92 145.3 51.26 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.62 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.46 ' CG2' ' HD2' ' A' ' 140' ' ' PRO . 10.3 t -78.45 178.91 7.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.287 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.22 -35.21 16.32 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.312 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 t -68.97 -26.82 65.23 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.503 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.83 26.49 26.7 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.248 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.582 ' CB ' ' CD ' ' A' ' 140' ' ' PRO . 0.9 OUTLIER -106.6 -76.49 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 117.122 0.461 . . . . 0.0 110.948 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 139' ' ' ASP . 37.1 Cg_endo -65.7 136.33 45.38 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.247 1.964 . . . . 0.0 112.264 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.416 ' HG2' HD12 ' A' ' 109' ' ' LEU . 5.8 tt0 -149.54 117.36 6.26 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.829 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.72 158.25 44.6 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.343 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.439 HG23 ' HG ' ' A' ' 132' ' ' LEU . 24.2 mt -124.99 154.8 33.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.254 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.21 134.27 25.67 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.964 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.73 140.29 46.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.849 0.357 . . . . 0.0 111.028 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 51.8 p -138.17 155.29 48.84 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.88 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.06 136.68 52.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 69.6 m -94.38 149.67 37.03 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.034 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 C--O 1.249 1.043 0 C-N-CA 122.741 2.294 . . . . 0.0 112.841 179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.442 ' HB ' ' HD3' ' A' ' 2' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.442 ' HD3' ' HB ' ' A' ' 1' ' ' THR . 73.0 Cg_endo -77.8 -44.72 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.187 1.925 . . . . 0.0 113.146 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.32 30.66 12.91 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.651 0.262 . . . . 0.0 111.278 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.91 36.21 4.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.037 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 m -67.52 -42.26 83.06 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.109 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.17 72.02 0.03 OUTLIER Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.407 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.6 mt -62.52 119.83 9.93 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.748 0.309 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.33 87.13 2.47 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.934 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.474 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 8.4 tttt -91.69 121.13 33.06 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.706 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 9' ' ' LYS . 9.9 p 56.75 153.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.882 0.739 . . . . 0.0 112.359 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.03 113.53 14.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.921 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.2 t -108.19 117.79 35.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.896 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 t 65.51 130.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.653 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.5 t -111.24 143.8 41.42 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.51 137.27 21.54 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.186 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.8 120.38 11.16 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.201 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 m -83.13 135.64 34.74 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.17 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.57 103.27 10.85 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.606 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 mp 57.37 26.29 12.3 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.397 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.9 tt -135.62 138.7 47.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.829 0.347 . . . . 0.0 110.987 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.66 143.24 15.63 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.466 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -128.67 138.35 52.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.641 0.258 . . . . 0.0 110.703 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.78 -18.1 41.07 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.779 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -53.15 -37.85 62.2 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.83 0.315 . . . . 0.0 111.457 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -60.49 -30.08 69.48 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.408 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -105.25 11.32 33.11 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.428 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -92.05 -30.67 15.91 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.406 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 p 178.97 -35.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.38 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.44 85.27 0.17 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.1 0.476 . . . . 0.0 110.494 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -75.49 113.91 30.86 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.105 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.03 100.55 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.491 2.127 . . . . 0.0 112.154 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.93 97.26 5.86 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.34 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.74 102.79 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.294 0.569 . . . . 0.0 111.982 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 67' ' ' GLU . 8.8 mm-40 -146.27 106.9 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.049 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.83 -130.05 6.58 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.371 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -157.94 93.13 1.23 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 111.242 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.82 158.68 32.68 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.848 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.73 104.18 1.44 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.664 2.243 . . . . 0.0 112.938 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.413 ' HA ' ' CE2' ' A' ' 64' ' ' TYR . 3.7 mt -77.11 154.06 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.84 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.65 25.69 69.3 Favored Glycine 0 C--N 1.337 0.583 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.822 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.54 131.85 45.28 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.969 0.414 . . . . 0.0 111.535 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.6 m -115.71 141.65 47.8 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.575 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -112.65 124.1 51.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.626 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.86 118.36 36.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.399 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.421 ' HB ' ' CZ ' ' A' ' 85' ' ' TYR . 13.8 p -111.78 136.06 49.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.18 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.9 m -122.39 120.35 60.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.247 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.71 110.27 1.45 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.372 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.21 82.74 0.35 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.097 0.475 . . . . 0.0 110.322 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -83.52 -171.81 3.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.086 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.23 -61.07 2.0 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.711 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -109.24 44.82 1.11 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.884 0.373 . . . . 0.0 111.35 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.61 -56.5 0.1 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.958 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.6 m 53.54 98.48 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.373 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 19.2 m0 66.55 62.57 0.53 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.689 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.69 125.17 39.17 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.29 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.43 143.36 28.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.761 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -123.98 147.58 54.51 Favored Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.919 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.12 -30.8 46.53 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.603 2.202 . . . . 0.0 112.349 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.16 2.4 35.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.561 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -128.6 19.82 6.17 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.37 0.128 . . . . 0.0 111.055 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -47.38 -50.97 21.15 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.926 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.422 ' CE1' ' CE1' ' A' ' 64' ' ' TYR . 0.0 OUTLIER 176.33 123.89 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.62 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 33.8 ttp180 -83.9 135.41 34.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.931 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.422 ' CE1' ' CE1' ' A' ' 62' ' ' TYR . 7.6 m-85 -81.57 118.92 23.16 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.121 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.9 103.99 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 67' ' ' GLU . . . -41.45 163.6 0.02 OUTLIER Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.794 -0.639 . . . . 0.0 114.513 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 34' ' ' GLU . 1.1 tm-20 84.49 28.98 0.07 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.148 0.579 . . . . 0.0 111.922 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 62.6 19.83 11.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.445 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.561 ' CG2' ' HG2' ' A' ' 133' ' ' LYS . 3.0 p -97.82 152.63 18.97 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -128.28 142.89 51.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.734 0.302 . . . . 0.0 110.888 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -143.77 136.62 27.38 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.844 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.17 130.76 13.96 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.696 0.284 . . . . 0.0 111.416 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.4 t -81.98 131.82 32.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.761 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.7 t -125.27 145.68 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.92 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -116.47 118.76 33.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.411 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -127.13 163.9 22.79 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.348 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.32 174.51 5.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.505 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.32 123.33 20.44 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.443 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 127.55 148.69 6.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.298 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.14 131.74 45.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.782 0.325 . . . . 0.0 111.391 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.03 147.53 37.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.004 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.0 mtp-105 -104.49 154.42 19.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.91 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -152.98 162.91 40.75 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.077 0.465 . . . . 0.0 111.955 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.52 156.73 32.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.674 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.51 ' HB2' ' HB3' ' A' ' 94' ' ' PHE . 2.9 m-85 -113.39 146.24 39.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.922 0.391 . . . . 0.0 111.175 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.73 123.38 1.5 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.073 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.01 147.39 45.16 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.943 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -60.73 -30.0 69.72 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.45 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.59 28.26 4.32 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.619 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 1.7 m95 54.4 38.82 30.29 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.988 0.423 . . . . 0.0 111.098 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.405 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -86.88 178.71 2.1 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.047 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 91' ' ' SER . 93.3 Cg_exo -43.28 118.53 1.38 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.857 2.371 . . . . 0.0 112.683 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 41.8 mt-30 -105.03 -175.01 2.67 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.203 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.51 ' HB3' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -127.09 133.17 50.47 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.755 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.12 111.71 1.97 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.543 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -92.08 100.18 12.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.854 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.07 107.65 0.57 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.038 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 54.45 77.67 0.14 Allowed Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.607 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.0 tp -138.72 -34.51 0.61 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 47.66 79.67 0.06 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.577 0.703 . . . . 0.0 110.782 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 tp -47.35 139.77 6.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.011 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.9 m -128.43 141.38 41.27 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.607 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -51.2 127.61 22.57 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.99 2.46 . . . . 0.0 112.857 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.17 34.76 85.57 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.535 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 145.9 50.95 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.049 0.452 . . . . 0.0 111.298 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.9 m -71.13 144.08 50.36 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.889 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -127.97 150.28 49.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.523 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.19 139.01 32.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.035 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.434 HD21 ' CE2' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -114.72 96.99 6.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.399 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -73.45 0.28 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.324 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.38 -177.72 5.78 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.719 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.18 141.02 12.32 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.598 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.59 -90.04 0.21 Allowed Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.485 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -126.51 90.88 3.25 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.879 0.371 . . . . 0.0 110.721 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -136.67 -139.59 3.97 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.047 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -111.05 124.16 51.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.696 0.284 . . . . 0.0 110.849 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.69 151.11 48.05 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 40.2 p -93.95 114.33 26.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.057 0.456 . . . . 0.0 110.89 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.13 126.35 40.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.646 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.21 124.96 73.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.958 0.408 . . . . 0.0 110.984 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.2 m -94.06 94.78 8.6 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.75 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 13.7 tp -130.8 100.69 17.38 Favored Pre-proline 0 N--CA 1.456 -0.169 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.254 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.44 8.91 1.04 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.371 2.714 . . . . 0.0 113.499 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -114.29 141.76 47.18 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.72 0.295 . . . . 0.0 110.923 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -100.41 140.04 35.23 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 170.38 -175.35 44.31 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.113 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -77.96 139.95 39.2 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 110.879 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.37 147.05 49.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.04 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.3 m -123.53 122.17 64.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.941 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -90.09 115.56 27.44 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.2 t -109.11 126.16 52.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.531 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 3.4 mp -140.84 136.32 32.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.561 ' HG2' ' CG2' ' A' ' 69' ' ' THR . 0.0 OUTLIER -133.0 120.12 20.96 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.906 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.434 ' CE2' HD21 ' A' ' 109' ' ' LEU . 3.2 m-85 -126.43 145.06 50.62 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.366 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 81.1 p -113.42 176.55 4.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.427 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -87.03 -18.91 29.48 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.747 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.8 m -65.87 -26.91 67.85 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.64 -17.47 54.48 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.385 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.463 ' CB ' ' HD3' ' A' ' 140' ' ' PRO . 0.5 OUTLIER -92.63 -54.52 0.25 Allowed Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 117.004 0.402 . . . . 0.0 110.976 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.463 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 13.5 Cg_exo -68.22 75.97 0.7 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.59 2.193 . . . . 0.0 112.122 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -130.67 103.46 6.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.631 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.18 152.91 41.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 5.2 pt -124.16 162.44 25.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.322 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -142.58 156.87 45.15 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.924 0.392 . . . . 0.0 111.013 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.4 p -135.9 134.25 50.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.2 m -145.01 153.02 41.05 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.97 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.71 155.76 22.96 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.368 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 14.1 m -87.33 109.19 23.71 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.334 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 C--O 1.249 1.072 0 C-N-CA 122.893 2.395 . . . . 0.0 112.825 -179.635 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.398 0.142 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -51.77 96.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.977 2.451 . . . . 0.0 112.663 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.48 -51.04 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.8 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.42 85.98 2.5 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.392 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.23 104.17 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.507 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.29 43.6 2.52 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.631 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.21 149.68 48.88 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.726 0.298 . . . . 0.0 110.73 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.6 m -110.31 86.71 2.36 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.006 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.66 120.36 27.02 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.837 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.47 152.06 21.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.411 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.32 118.48 20.55 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.207 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 t -91.76 123.98 35.56 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.104 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t 67.97 131.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.585 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.9 p -79.9 -28.36 39.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.206 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 65.82 91.31 0.08 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.012 0.434 . . . . 0.0 111.423 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -168.44 135.68 2.04 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.11 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.1 p -102.32 98.04 8.22 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.513 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.3 m -121.81 128.71 51.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.271 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.23 -30.1 16.08 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.104 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 tt -73.56 137.32 23.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.704 0.287 . . . . 0.0 111.299 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -128.98 142.69 13.78 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.527 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -143.81 138.61 28.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.752 0.31 . . . . 0.0 111.218 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.17 33.48 5.58 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.857 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -63.91 -34.97 79.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.702 0.287 . . . . 0.0 111.025 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 15.4 mtm -62.65 -26.15 68.49 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.237 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.88 -16.79 64.25 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -85.97 11.64 11.07 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.9 m 64.82 22.45 12.53 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.676 0.274 . . . . 0.0 111.367 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.44 91.56 5.87 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.88 0.371 . . . . 0.0 110.36 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -88.94 113.35 55.67 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.011 -179.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 30' ' ' ASN . 1.8 Cg_endo -82.78 99.41 0.92 Allowed 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.323 2.015 . . . . 0.0 111.508 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.98 97.19 5.81 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.467 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -135.88 102.16 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.32 0.581 . . . . 0.0 111.886 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 67' ' ' GLU . 20.7 mt-10 -146.77 106.65 3.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.683 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.77 -144.92 16.01 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.052 -1.07 . . . . 0.0 112.232 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -137.84 107.33 6.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.72 0.295 . . . . 0.0 111.016 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.71 -165.16 8.4 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.214 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.34 107.37 2.43 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.511 2.141 . . . . 0.0 112.315 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.483 HG12 ' CE2' ' A' ' 64' ' ' TYR . 18.6 mt -90.14 153.88 3.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.442 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.62 19.4 48.45 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.067 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -130.62 131.54 44.99 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.887 0.375 . . . . 0.0 111.465 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.407 ' OG1' ' HB1' ' A' ' 61' ' ' ALA . 4.5 t -116.01 141.06 48.62 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.95 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.41 ' HB3' ' CE1' ' A' ' 85' ' ' TYR . 63.2 mt -100.33 146.39 27.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.643 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -125.16 118.96 27.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.041 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.429 ' HB ' ' CE1' ' A' ' 85' ' ' TYR . 12.1 p -110.64 131.3 62.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.338 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.4 m -143.51 -179.2 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.362 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 83' ' ' MET . . . 150.32 -101.79 0.22 Allowed Glycine 0 N--CA 1.453 -0.205 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -171.54 117.17 0.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 111.06 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.541 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 1.1 m-85 -126.29 44.17 2.93 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.318 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 72.97 -68.34 0.23 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -178.28 50.56 0.01 OUTLIER 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.165 0.507 . . . . 0.0 110.269 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.22 30.86 0.54 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.779 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.8 p -142.15 -142.33 0.14 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.948 -0.115 . . . . 0.0 110.795 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 10.3 m0 53.12 34.15 16.68 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -136.47 125.44 24.29 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.005 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.76 75.58 1.48 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.973 0.416 . . . . 0.0 110.89 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -71.58 162.3 73.75 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.073 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.67 -33.15 93.66 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.725 2.283 . . . . 0.0 112.651 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -59.92 -27.38 66.71 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.384 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -129.77 21.94 5.45 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.798 0.332 . . . . 0.0 110.726 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.407 ' HB1' ' OG1' ' A' ' 42' ' ' THR . . . -58.42 -39.89 81.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.449 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -171.58 140.45 1.36 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.53 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -111.51 120.34 41.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.215 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.483 ' CE2' HG12 ' A' ' 39' ' ' ILE . 23.6 t80 -73.89 118.13 16.49 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.875 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.41 113.19 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.482 -0.781 . . . . 0.0 108.978 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -41.76 166.67 0.01 OUTLIER Glycine 0 C--N 1.338 0.65 0 N-CA-C 114.921 0.729 . . . . 0.0 114.921 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 76.88 26.93 0.75 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.836 0.454 . . . . 0.0 112.073 178.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 61.95 19.79 11.01 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.666 0.27 . . . . 0.0 111.384 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.7 p -92.02 150.91 20.72 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.515 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -128.17 134.09 49.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.518 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 130' ' ' TRP . 0.7 OUTLIER -132.85 137.46 46.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.786 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.44 132.04 14.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.419 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.84 131.0 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.6 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.85 142.23 44.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 111.855 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -95.74 124.39 39.74 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.598 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.525 ' HG3' ' CD2' ' A' ' 128' ' ' TYR . 1.7 mm-40 -116.94 163.32 16.39 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.964 0.411 . . . . 0.0 111.815 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -117.92 167.44 11.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.061 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.9 115.52 7.52 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.181 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 122' ' ' LEU . . . 129.43 147.79 6.39 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.321 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.93 137.34 58.23 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.767 0.318 . . . . 0.0 111.329 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.431 ' CE2' ' CG1' ' A' ' 120' ' ' VAL . 4.1 p90 -140.97 146.51 37.42 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.509 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.0 139.63 43.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.588 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -153.51 176.08 12.45 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.018 0.437 . . . . 0.0 111.948 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.46 142.09 13.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.46 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.492 ' O ' ' HB2' ' A' ' 93' ' ' GLN . 0.1 OUTLIER -97.68 143.14 28.64 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.717 0.294 . . . . 0.0 110.996 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 93' ' ' GLN . . . -162.35 124.54 2.78 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.356 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.86 179.15 3.3 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.963 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -84.54 -48.01 10.0 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.212 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -94.09 46.48 1.17 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.328 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 45.66 41.17 6.91 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.558 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.5 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.4 OUTLIER -86.41 170.21 13.15 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.83 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 91' ' ' SER . 2.3 Cg_endo -41.45 117.82 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.344 2.696 . . . . 0.0 112.598 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 85' ' ' TYR . 4.5 pt20 -124.74 -175.51 3.3 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.53 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.475 ' CE1' HD13 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -123.4 133.65 54.06 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.981 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -163.08 112.58 1.34 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.45 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.01 112.76 25.52 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.311 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -78.52 122.84 26.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.375 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.43 49.75 8.32 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.734 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -108.02 -53.86 2.57 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 61.76 82.03 0.18 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.388 0.613 . . . . 0.0 109.63 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.6 tt -69.12 147.34 51.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.134 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.438 ' CG2' ' HD2' ' A' ' 103' ' ' PRO . 95.1 m -117.32 144.54 34.1 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.847 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.438 ' HD2' ' CG2' ' A' ' 102' ' ' THR . 78.2 Cg_exo -40.76 110.7 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.727 2.284 . . . . 0.0 112.935 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.78 34.77 23.9 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.504 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.17 155.81 46.38 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.056 0.455 . . . . 0.0 111.202 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.5 m -91.31 145.07 24.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.454 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -124.1 146.68 48.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.492 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.2 m -68.86 145.14 53.96 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.095 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.415 ' HB2' HG22 ' A' ' 143' ' ' ILE . 2.4 tt -129.95 133.19 46.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.805 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.2 -65.7 0.85 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.261 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -172.01 142.89 1.5 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.762 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -72.01 -119.46 0.06 OUTLIER Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.126 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 58.7 45.5 94.69 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.207 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 62.09 87.03 0.1 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.85 0.357 . . . . 0.0 111.252 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -115.35 -139.79 6.92 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.264 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.85 122.88 33.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.585 0.231 . . . . 0.0 110.56 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.76 122.76 18.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.839 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.87 114.31 15.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.613 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.88 123.51 38.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.991 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.431 ' CG1' ' CE2' ' A' ' 81' ' ' PHE . 10.2 p -117.27 131.96 68.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.3 m -80.97 112.37 18.3 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.231 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 79' ' ' GLY . 0.5 OUTLIER -125.92 108.17 25.22 Favored Pre-proline 0 CA--C 1.529 0.164 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.301 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -84.72 8.35 4.68 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.641 2.227 . . . . 0.0 113.31 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -166.68 150.59 7.15 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.988 0.423 . . . . 0.0 111.504 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.87 142.25 40.26 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.998 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -178.13 163.8 32.18 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.871 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -65.3 137.57 57.62 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.748 0.309 . . . . 0.0 111.084 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.525 ' CD2' ' HG3' ' A' ' 76' ' ' GLU . 0.2 OUTLIER -125.33 149.9 47.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.005 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 26.4 m -124.61 127.76 73.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.34 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.438 ' CD2' HG11 ' A' ' 145' ' ' VAL . 0.9 OUTLIER -103.34 113.52 27.07 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.74 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 78.6 p -134.97 126.25 28.22 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.147 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.424 ' HB3' ' CG1' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -148.48 149.01 30.91 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.118 0.485 . . . . 0.0 111.244 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -109.81 134.7 51.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.817 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -114.72 144.83 42.84 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.379 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.502 ' HB ' ' HG2' ' A' ' 140' ' ' PRO . 9.9 t -82.38 163.8 21.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.8 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -91.48 -43.06 9.92 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.203 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 p -68.77 -26.85 65.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.765 0.317 . . . . 0.0 111.524 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.21 30.58 7.31 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.223 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.543 ' CB ' ' CD ' ' A' ' 140' ' ' PRO . 0.6 OUTLIER -111.31 -73.95 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 117.036 0.418 . . . . 0.0 111.654 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 139' ' ' ASP . 82.1 Cg_endo -78.19 124.6 6.69 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.424 2.083 . . . . 0.0 113.507 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -142.72 113.17 7.29 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.817 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.61 150.0 44.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.503 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.475 HD13 ' CE1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -146.86 136.64 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.874 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -145.27 150.98 37.63 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.86 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.438 HG11 ' CD2' ' A' ' 130' ' ' TRP . 35.1 m -136.61 146.0 29.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 120.756 0.312 . . . . 0.0 111.378 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 52.1 p -133.37 155.41 49.52 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.31 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.464 ' HB3' ' CE2' ' A' ' 128' ' ' TYR . 9.6 pttp -109.77 153.66 24.04 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.044 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 60.9 m -84.06 148.28 53.16 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.876 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 122.614 2.209 . . . . 0.0 112.415 -179.74 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.642 0.258 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.35 115.29 3.96 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.749 2.3 . . . . 0.0 112.576 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.51 167.81 11.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 60.11 74.92 0.43 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.437 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 t 63.88 95.35 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.381 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.79 -56.64 0.11 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.971 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 tt 69.58 -73.52 0.09 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.353 0.261 . . . . 0.0 110.769 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.9 t 47.27 -173.06 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.85 119.15 35.6 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-O 120.798 0.333 . . . . 0.0 111.476 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 m -142.35 38.05 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.6 137.01 57.07 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.328 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.0 m -95.46 132.98 39.96 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.8 t 63.85 90.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.198 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.3 p -109.47 149.59 29.36 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.173 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.37 124.25 47.61 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.144 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.55 114.17 10.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.004 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 p -116.52 137.16 52.39 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.04 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.2 m -164.94 91.15 0.54 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.995 0.426 . . . . 0.0 111.18 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mp -110.82 -19.48 12.81 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.662 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.23 141.33 41.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.726 0.298 . . . . 0.0 111.089 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.7 143.69 14.85 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.786 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.35 148.41 45.09 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.008 0.432 . . . . 0.0 111.084 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.26 34.05 3.71 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.707 -0.679 . . . . 0.0 113.111 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -68.07 -41.35 82.07 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.732 0.266 . . . . 0.0 110.832 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -63.09 -29.91 71.18 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.004 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.96 9.46 27.72 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.768 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.04 14.45 26.36 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.427 0.156 . . . . 0.0 111.417 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.8 m 59.3 55.92 4.05 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.565 0.222 . . . . 0.0 111.137 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -158.56 31.1 0.23 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -78.85 113.13 32.72 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.894 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -90.84 99.99 0.25 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.926 2.417 . . . . 0.0 113.03 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.64 96.72 5.51 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.872 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.91 102.38 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.423 0.63 . . . . 0.0 112.322 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -147.1 106.42 3.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.292 177.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.39 -140.99 15.55 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.013 -1.089 . . . . 0.0 112.785 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.503 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 0.6 OUTLIER 59.04 -86.44 0.02 OUTLIER 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.224 0.61 . . . . 0.0 110.977 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.14 -69.54 0.21 Allowed Glycine 0 CA--C 1.521 0.428 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.894 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.85 89.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.122 2.548 . . . . 0.0 113.486 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -69.7 153.33 8.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.781 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.16 39.34 27.41 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.704 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.83 132.28 35.17 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.67 0.272 . . . . 0.0 110.75 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.0 m -114.91 147.92 39.33 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.606 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 mt -136.21 170.6 15.76 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.696 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -125.19 118.81 26.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.906 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 85' ' ' TYR . 13.7 p -111.36 134.77 52.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.0 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.456 ' HB ' ' CD1' ' A' ' 54' ' ' TRP . 32.5 m -131.82 128.03 59.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.292 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 54' ' ' TRP . . . -101.49 173.37 23.87 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.243 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -160.86 89.17 0.79 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.235 0.54 . . . . 0.0 111.09 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 165.14 -82.15 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.043 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.467 ' CB ' ' HG2' ' A' ' 77' ' ' LYS . . . -89.11 -43.25 11.19 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -118.8 68.47 0.79 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.719 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.82 -7.52 59.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.886 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.1 m -50.81 -24.91 3.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.037 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.456 ' CD1' ' HB ' ' A' ' 46' ' ' VAL . 16.2 m0 65.83 62.35 0.63 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.899 0.381 . . . . 0.0 110.97 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -95.62 123.67 39.28 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.078 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -117.59 63.37 0.74 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.699 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 142.89 94.08 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.882 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.42 -51.69 1.85 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.419 2.079 . . . . 0.0 112.118 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -10.33 33.74 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 73' ' ' VAL . 5.2 mmt85 -94.21 -23.12 18.02 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.383 0.135 . . . . 0.0 110.955 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.51 64.73 1.45 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.75 0.31 . . . . 0.0 111.531 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -138.53 21.33 2.73 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.913 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 mmm-85 -106.05 114.44 28.59 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.821 0.343 . . . . 0.0 111.295 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.44 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 0.6 OUTLIER -101.28 120.04 39.66 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.041 179.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.55 122.29 65.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.0 0.429 . . . . 0.0 110.349 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 36' ' ' ASP . . . -51.77 169.58 0.48 Allowed Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.901 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER 78.69 30.89 0.35 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.644 0.377 . . . . 0.0 111.234 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 62.27 21.06 12.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.461 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.2 p -95.91 155.06 16.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.752 0.311 . . . . 0.0 110.75 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -127.74 133.6 49.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.392 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.46 129.5 43.04 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.084 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.5 131.4 14.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.473 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.443 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 29.4 t -82.55 125.3 39.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.403 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.2 t -125.97 140.21 49.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.772 0.32 . . . . 0.0 111.082 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -115.83 124.26 50.25 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.37 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -137.67 166.29 24.3 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.092 0.472 . . . . 0.0 111.673 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.467 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -85.96 173.42 9.95 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.412 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.52 133.41 52.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.813 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.82 147.22 7.54 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.52 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.0 136.68 57.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.679 0.276 . . . . 0.0 110.738 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.544 ' CZ ' HD11 ' A' ' 122' ' ' LEU . 7.3 p90 -142.19 147.07 35.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.587 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 -103.29 131.62 50.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.498 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.405 ' CE ' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -136.21 164.96 26.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.029 0.442 . . . . 0.0 111.748 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -142.12 152.67 43.47 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.806 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.464 ' CZ ' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -117.8 142.01 47.78 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.345 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -161.54 134.35 6.13 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.115 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.4 153.78 25.54 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.126 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -66.71 -30.15 70.31 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.504 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -95.72 30.09 2.45 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.352 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 10.9 m0 53.39 41.24 32.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 111.382 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.467 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.4 OUTLIER -86.05 169.58 15.12 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.388 179.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 91' ' ' SER . 3.3 Cg_exo -40.11 126.6 1.95 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.185 2.59 . . . . 0.0 112.56 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -104.77 -178.03 3.54 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.504 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -128.53 122.94 32.27 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.656 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.78 129.3 11.43 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.86 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.04 108.17 19.16 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.6 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.11 95.03 0.08 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.624 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 53.88 82.45 0.05 OUTLIER Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.148 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.406 HD12 HD11 ' A' ' 101' ' ' LEU . 3.2 tm? -129.4 -77.94 0.55 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.806 0.303 . . . . 0.0 111.451 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 119' ' ' ALA . 34.9 mt-10 64.41 113.17 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.116 0.26 . . . . 0.0 110.969 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -144.35 149.71 36.61 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.484 ' CG2' ' HD2' ' A' ' 103' ' ' PRO . 97.6 m -77.5 145.95 72.68 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.806 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.484 ' HD2' ' CG2' ' A' ' 102' ' ' THR . 97.5 Cg_exo -43.56 130.39 7.08 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.678 2.252 . . . . 0.0 112.443 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.39 26.2 33.98 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.043 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.439 ' HB3' HD23 ' A' ' 101' ' ' LEU . 12.0 tttm -132.06 151.96 51.46 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.026 0.441 . . . . 0.0 111.119 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.7 m -77.98 145.58 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.49 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.82 132.99 46.68 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.246 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 m -69.19 127.92 34.8 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.1 tp -107.74 138.65 43.59 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.644 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.9 -61.18 1.77 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -167.8 -175.85 2.88 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.995 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -123.82 113.75 2.15 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.464 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -174.67 -108.49 0.22 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.515 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -127.38 48.46 2.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.923 0.392 . . . . 0.0 110.998 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.22 -135.2 5.47 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.466 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -100.4 136.78 39.76 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.667 0.27 . . . . 0.0 110.907 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.36 131.05 41.43 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.9 m -76.1 141.37 41.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.707 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 81' ' ' PHE . . . -125.04 143.69 50.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.053 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 15.7 t -116.74 124.77 73.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.404 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.4 m -74.95 93.21 2.66 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.686 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.544 HD11 ' CZ ' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -105.74 113.16 64.25 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.94 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.64 8.28 4.71 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.695 2.263 . . . . 0.0 112.609 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -166.99 151.03 6.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.779 0.324 . . . . 0.0 110.948 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.29 136.02 49.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.854 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -178.69 169.76 41.4 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.161 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -85.31 132.24 34.28 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 111.199 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -134.75 148.68 50.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.66 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.5 m -114.8 130.92 68.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.89 0.376 . . . . 0.0 111.459 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.401 ' CZ3' ' HB ' ' A' ' 145' ' ' VAL . 0.7 OUTLIER -88.92 115.54 26.55 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.559 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 28.1 t -114.58 134.85 54.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.152 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.09 135.1 43.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.807 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.8 tttm -148.8 121.83 8.83 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.909 0.385 . . . . 0.0 111.973 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -141.32 145.79 35.89 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.891 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.0 p -75.71 169.25 18.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.083 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.25 -1.82 50.55 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.801 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.65 -27.1 68.13 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.383 0.142 . . . . 0.0 111.383 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.57 -16.89 58.35 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.049 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.499 ' CB ' ' HD3' ' A' ' 140' ' ' PRO . 0.2 OUTLIER -102.01 -58.64 0.1 Allowed Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 117.005 0.403 . . . . 0.0 111.567 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.499 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 47.5 Cg_exo -57.81 94.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.562 2.175 . . . . 0.0 112.598 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -130.76 104.69 7.32 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.575 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.49 138.39 47.54 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.749 0.309 . . . . 0.0 111.268 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.86 141.83 37.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.126 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -139.82 156.26 46.83 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.03 0.443 . . . . 0.0 111.47 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.401 ' HB ' ' CZ3' ' A' ' 130' ' ' TRP . 10.8 p -122.73 139.79 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.666 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 67.7 m -129.03 135.48 49.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.129 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -112.88 135.76 53.28 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.771 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 2.1 p -117.73 109.35 41.63 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.787 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--O 1.251 1.143 0 C-N-CA 122.539 2.159 . . . . 0.0 112.55 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.548 0.213 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.04 165.02 33.04 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.808 2.338 . . . . 0.0 112.416 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 t -116.15 123.34 47.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.62 135.59 51.67 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 p -127.21 37.61 4.23 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.972 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.51 28.62 69.92 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.841 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.16 82.23 1.13 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.927 0.394 . . . . 0.0 110.588 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.6 p -129.06 -65.55 0.86 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.783 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -115.78 109.78 18.16 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.614 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.7 t -148.63 -65.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.4 115.37 20.71 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.117 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.7 m -92.62 122.12 34.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.713 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.9 m -124.86 122.53 63.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.172 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -152.65 118.65 5.46 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.963 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.19 96.38 5.77 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.003 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.46 97.56 1.62 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.216 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.7 p -146.99 131.62 17.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.154 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.75 123.58 37.77 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.985 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.6 tp 61.47 89.87 0.07 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.956 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.22 139.81 46.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.367 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.36 144.22 15.97 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.6 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.41 138.96 44.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.639 0.257 . . . . 0.0 110.905 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.91 152.68 20.61 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.061 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -65.42 -39.25 91.91 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.486 0.184 . . . . 0.0 111.247 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -26.41 68.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.121 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.88 -11.82 59.43 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.13 -30.42 39.04 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.529 0.204 . . . . 0.0 110.725 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.2 t -63.03 -37.46 87.29 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.691 0.282 . . . . 0.0 110.306 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -145.11 103.18 3.84 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.541 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -71.0 137.56 84.9 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.556 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -53.48 117.03 3.38 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.683 2.255 . . . . 0.0 112.126 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.449 ' CG2' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -108.12 97.6 7.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.342 0.592 . . . . 0.0 111.119 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 tt -92.83 160.51 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.271 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -64.11 107.26 1.23 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.772 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.66 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -107.46 -119.49 4.43 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.894 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -113.44 29.53 7.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.648 0.261 . . . . 0.0 110.805 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.11 117.39 10.7 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.312 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.4 112.65 1.11 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.742 2.295 . . . . 0.0 112.246 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 mp -70.24 153.63 8.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.98 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.95 22.82 76.2 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.485 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.479 ' HA ' ' HG2' ' A' ' 88' ' ' LYS . 1.7 mttp -127.94 132.23 49.27 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.855 0.359 . . . . 0.0 111.296 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.9 m -115.32 140.18 49.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.718 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.6 123.19 47.5 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.416 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.464 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -93.99 130.82 39.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.908 0.385 . . . . 0.0 111.162 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 m -112.34 132.83 59.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.307 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 84' ' ' GLN . 8.1 t -137.76 161.06 33.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.869 0.366 . . . . 0.0 110.76 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' A' ' 53' ' ' SER . . . -125.34 -159.07 10.2 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.916 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER 172.19 135.66 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.05 0.453 . . . . 0.0 111.259 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 48' ' ' ASP . 1.8 m-85 72.16 130.24 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.549 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 63.53 10.2 4.75 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.535 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 t0 40.25 64.85 0.84 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.935 0.398 . . . . 0.0 111.192 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' ' CD1' ' A' ' 81' ' ' PHE . . . -91.88 -37.73 12.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.658 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.412 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 13.4 t -122.99 -101.42 0.4 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.224 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 15.8 m95 49.35 30.99 3.52 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.873 0.368 . . . . 0.0 110.949 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -132.81 117.07 17.32 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.367 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.464 ' HG3' ' CE1' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -114.29 103.79 11.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.887 -179.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -98.28 116.23 65.58 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.923 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.95 -33.48 72.53 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.846 2.364 . . . . 0.0 112.871 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -59.35 -27.68 66.16 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.444 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.62 20.65 5.12 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.151 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.45 -30.62 71.71 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.366 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.462 ' HB2' ' CE2' ' A' ' 70' ' ' TYR . 2.3 p90 -151.76 120.91 6.72 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.833 0.349 . . . . 0.0 111.311 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.45 120.41 38.05 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.187 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -62.44 118.36 7.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.317 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.449 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 3.4 t -105.09 122.7 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.66 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -66.4 76.11 0.13 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.411 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' CG ' ' O ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER 167.83 29.24 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 O-C-N 123.849 0.382 . . . . 0.0 111.965 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 t30 61.91 24.95 14.93 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.891 0.376 . . . . 0.0 110.529 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.418 HG23 ' HA ' ' A' ' 133' ' ' LYS . 0.7 OUTLIER -113.75 156.02 24.57 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.398 -179.18 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -127.43 133.91 49.92 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.088 179.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.413 ' HG2' HG21 ' A' ' 65' ' ' VAL . 3.1 pt20 -143.25 157.7 44.27 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 111.828 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.5 132.13 14.88 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.209 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.0 t -74.63 127.08 36.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.555 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.9 t -130.52 143.88 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.083 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -101.88 136.83 41.04 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.174 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -131.22 166.6 20.8 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.036 0.446 . . . . 0.0 112.05 -179.339 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -99.8 171.39 7.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.357 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.09 120.57 21.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.406 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 122' ' ' LEU . . . 129.61 152.79 7.67 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.505 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.36 126.14 27.28 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.754 0.311 . . . . 0.0 111.494 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 9.5 p90 -141.27 152.8 44.82 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.068 0.461 . . . . 0.0 111.497 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.478 ' HB3' ' HB3' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -103.59 149.55 24.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.794 178.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.7 137.86 37.19 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.504 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.479 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 1.2 tt0 -111.97 148.33 34.0 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.415 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.633 ' HB2' ' CG ' ' A' ' 94' ' ' PHE . 6.2 m-85 -128.07 159.77 34.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.394 0.616 . . . . 0.0 112.3 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 92' ' ' PRO . . . -121.27 153.62 37.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.069 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.52 173.6 6.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.051 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.479 ' HG2' ' HA ' ' A' ' 41' ' ' LYS . 39.1 tptt -76.92 -9.58 58.79 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.79 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.04 31.91 0.77 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.724 0.297 . . . . 0.0 111.051 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 10.6 m0 60.32 17.35 7.01 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.1 t -97.6 117.56 65.22 Favored Pre-proline 0 C--O 1.231 0.086 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.51 ' HA ' ' CB ' ' A' ' 86' ' ' ALA . 57.3 Cg_endo -97.75 61.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.158 2.572 . . . . 0.0 113.429 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -157.78 124.44 4.91 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.633 ' CG ' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -141.71 126.15 17.71 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.544 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 p -157.2 164.13 38.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.921 0.391 . . . . 0.0 111.666 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 99' ' ' LEU . . . -133.24 97.54 4.01 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.679 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.02 110.4 0.39 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.379 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.01 78.06 0.14 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.215 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.472 HD21 ' CB ' ' A' ' 107' ' ' ALA . 19.1 tp -135.62 -66.96 0.55 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 69.94 83.44 0.15 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.324 0.583 . . . . 0.0 110.003 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.41 144.96 49.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.421 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.5 151.2 74.18 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.979 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -52.07 118.63 4.73 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.799 2.333 . . . . 0.0 112.451 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.84 34.47 65.93 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.415 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.82 144.58 51.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.841 0.353 . . . . 0.0 111.111 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 71.8 p -72.63 143.04 48.32 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.112 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.472 ' CB ' HD21 ' A' ' 99' ' ' LEU . . . -119.65 137.18 54.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.3 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.95 138.12 45.93 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.859 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.466 ' HG ' ' CD1' ' A' ' 143' ' ' ILE . 0.5 OUTLIER -116.69 101.71 8.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.661 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.78 -70.62 0.54 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -179.55 -64.82 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.979 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 149.62 -131.67 3.74 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.303 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.89 48.4 66.6 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.516 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 59.74 65.82 1.08 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.89 0.376 . . . . 0.0 111.091 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.2 -137.12 9.12 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.216 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -102.92 113.41 26.83 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.822 0.311 . . . . 0.0 111.079 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -64.64 145.27 56.42 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.154 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.405 ' CG2' HD22 ' A' ' 99' ' ' LEU . 0.7 OUTLIER -86.65 119.55 27.02 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.351 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 81' ' ' PHE . . . -110.34 138.32 46.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.66 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.7 p -116.54 126.07 73.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 120.898 0.38 . . . . 0.0 110.998 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.5 m -80.47 95.42 6.45 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.032 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 79' ' ' GLY . 10.0 mt -124.91 114.04 26.66 Favored Pre-proline 0 C--O 1.225 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.437 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.92 8.9 4.19 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.87 2.38 . . . . 0.0 113.292 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -155.02 151.81 28.88 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.016 0.436 . . . . 0.0 111.376 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.11 143.38 28.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.419 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -178.11 172.26 44.77 Favored Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.611 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -66.67 139.24 57.84 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.784 0.326 . . . . 0.0 111.076 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.88 142.39 50.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.055 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 12.5 m -116.2 121.18 66.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 120.957 0.408 . . . . 0.0 110.639 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -98.51 117.04 32.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.536 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.1 t -126.41 142.55 51.49 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.186 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.425 ' HG ' HG12 ' A' ' 143' ' ' ILE . 10.3 mp -133.86 142.76 47.94 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.758 0.313 . . . . 0.0 111.021 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.418 ' HA ' HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -111.82 120.23 41.25 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.11 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -114.12 144.96 42.29 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.795 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.4 t -86.86 -178.57 6.35 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.123 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -92.41 -41.05 10.54 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.333 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 p -66.41 -22.84 66.24 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.685 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.4 17.0 61.28 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.039 -0.6 . . . . 0.0 113.01 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.535 ' CB ' ' CD ' ' A' ' 140' ' ' PRO . 0.5 OUTLIER -102.97 -73.32 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.999 0.4 . . . . 0.0 111.033 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.535 ' CD ' ' CB ' ' A' ' 139' ' ' ASP . 54.3 Cg_endo -69.12 127.47 15.15 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.304 2.003 . . . . 0.0 112.509 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 109' ' ' LEU . 6.7 mm-40 -138.99 116.97 11.64 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.139 0.495 . . . . 0.0 110.618 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.88 158.01 31.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.988 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.466 ' CD1' ' HG ' ' A' ' 109' ' ' LEU . 2.7 mt -123.47 153.42 29.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.171 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.81 116.84 12.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.611 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.88 148.68 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.818 0.342 . . . . 0.0 111.406 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 60.1 p -154.11 157.79 39.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.906 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.24 147.24 41.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.76 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 49.1 m -70.34 138.52 86.68 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.886 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.658 2.239 . . . . 0.0 112.814 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 120.475 0.178 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.82 -33.9 42.79 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.523 2.149 . . . . 0.0 112.395 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.3 m -141.66 131.55 24.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.942 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.4 149.34 20.6 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.637 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 m -143.35 110.93 5.87 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.084 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.26 -145.05 11.11 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.73 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.63 34.27 22.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.751 0.31 . . . . 0.0 111.211 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.9 p -128.68 107.37 9.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.03 112.27 4.92 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.276 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.79 161.51 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.496 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.48 115.35 4.16 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.321 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.9 m -101.05 131.03 47.14 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.3 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.3 m -145.85 132.71 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.179 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.8 78.13 1.52 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.296 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 68.2 115.13 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.69 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -116.32 122.3 44.49 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.319 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.59 137.31 42.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.577 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.4 m -128.12 118.17 22.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.818 0.342 . . . . 0.0 111.182 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.08 32.39 5.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.229 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -138.48 140.71 39.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.215 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.12 146.55 13.87 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.572 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -128.8 145.18 51.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.794 0.331 . . . . 0.0 111.028 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -120.3 -156.94 10.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.174 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -54.47 -34.32 61.34 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.3 mtm -55.89 -30.48 61.64 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -109.55 10.02 25.17 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.96 -30.56 14.68 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.7 t -171.0 64.16 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.874 0.368 . . . . 0.0 110.833 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -155.23 23.38 0.42 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.818 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -97.46 114.41 64.81 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.805 -0.18 . . . . 0.0 111.385 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -70.24 142.33 45.56 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.025 2.484 . . . . 0.0 112.441 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.38 117.02 33.08 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.398 0.618 . . . . 0.0 111.874 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.407 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 5.7 tt -131.56 164.15 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.177 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.08 107.45 0.64 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.547 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.727 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -116.95 -134.96 5.41 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.314 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -105.71 36.72 2.44 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.632 0.253 . . . . 0.0 111.173 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.1 129.32 23.51 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.599 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HB2' ' HG2' ' A' ' 41' ' ' LYS . 48.9 Cg_exo -56.23 116.85 3.48 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.943 2.429 . . . . 0.0 112.523 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 mp -80.36 154.82 4.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.552 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.18 14.71 81.96 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.706 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.451 ' HE3' ' CE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -131.0 132.31 44.92 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.018 0.409 . . . . 0.0 111.169 179.539 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.64 144.05 44.47 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.08 122.81 31.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.322 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -105.0 118.7 37.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.617 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.46 135.24 56.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.28 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.406 ' CG2' ' HB3' ' A' ' 84' ' ' GLN . 33.2 m -131.77 120.89 46.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.79 115.67 4.3 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.759 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.73 88.35 7.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.079 0.466 . . . . 0.0 111.149 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 73.2 -176.85 0.17 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.552 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' CB ' ' HB3' ' A' ' 81' ' ' PHE . . . 72.55 49.9 0.19 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.322 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 56.97 31.98 20.79 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.572 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.93 -40.78 8.31 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.966 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.2 t 57.28 25.28 10.93 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.731 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 49.35 62.64 2.52 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.927 0.394 . . . . 0.0 111.151 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.3 mtmm -94.75 137.86 33.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.137 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.99 90.59 2.27 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.132 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -77.78 130.21 74.08 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.134 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.64 -26.5 46.69 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.972 2.448 . . . . 0.0 112.852 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -70.67 -7.51 45.1 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.906 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.422 ' HG2' ' HB ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -127.8 20.64 6.51 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.51 0.195 . . . . 0.0 111.032 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.8 -86.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.04 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.451 ' CE1' ' HE3' ' A' ' 41' ' ' LYS . 8.9 t80 -129.36 137.12 50.78 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.833 0.349 . . . . 0.0 111.046 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.68 121.68 41.52 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.136 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -62.61 118.35 7.5 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.832 0.349 . . . . 0.0 111.623 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.474 ' CG2' ' HB2' ' A' ' 71' ' ' GLN . 1.8 t -107.28 107.12 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.727 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -54.32 87.72 0.01 OUTLIER Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.558 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 66' ' ' GLY . 0.4 OUTLIER 160.12 25.84 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 t30 61.74 23.21 13.58 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.935 0.398 . . . . 0.0 110.358 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.418 ' CG2' ' HA ' ' A' ' 133' ' ' LYS . 19.7 p -116.68 155.82 28.17 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.23 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.439 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -112.37 148.82 33.47 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.986 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.474 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -146.7 140.2 25.76 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.091 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.4 130.64 13.65 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.182 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.422 ' HB ' ' HG2' ' A' ' 60' ' ' ARG . 23.2 t -81.15 136.31 23.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.856 0.36 . . . . 0.0 110.691 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.1 t -129.94 146.05 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.25 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.64 131.63 54.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.124 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.26 165.72 23.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.841 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.55 168.22 9.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.39 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.43 124.74 22.07 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.718 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.67 149.19 8.6 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.133 -0.555 . . . . 0.0 112.605 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.66 128.55 20.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.742 0.306 . . . . 0.0 111.516 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.465 ' CE2' HG13 ' A' ' 120' ' ' VAL . 22.3 p90 -142.87 148.33 36.83 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.825 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.408 ' HG3' ' CB ' ' A' ' 119' ' ' ALA . 0.4 OUTLIER -110.99 156.36 21.36 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.58 179.154 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -144.22 150.44 37.98 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.406 ' HB3' ' CG2' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -118.7 144.72 46.04 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.573 178.179 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.467 ' HB2' ' CG ' ' A' ' 94' ' ' PHE . 16.0 m-85 -128.22 160.09 33.18 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.589 0.709 . . . . 0.0 112.574 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.582 ' CB ' ' HA ' ' A' ' 92' ' ' PRO . . . -111.2 123.81 50.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.489 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.03 -178.03 0.72 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.101 0.476 . . . . 0.0 111.904 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.416 ' CB ' ' HD3' ' A' ' 41' ' ' LYS . 15.4 pttp -80.98 -14.95 57.48 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.012 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -87.94 42.21 1.04 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.486 0.184 . . . . 0.0 111.363 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 51.95 23.28 2.09 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.651 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 t -101.42 118.11 60.63 Favored Pre-proline 0 CA--C 1.522 -0.098 0 CA-C-O 120.499 0.19 . . . . 0.0 110.67 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.582 ' HA ' ' CB ' ' A' ' 86' ' ' ALA . 70.4 Cg_endo -89.13 53.47 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.739 2.293 . . . . 0.0 112.582 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 13.2 mt-30 -152.43 124.59 8.1 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.467 ' CG ' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -141.92 120.63 12.62 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.442 ' HB ' ' N ' ' A' ' 116' ' ' GLN . 69.2 p -152.36 125.97 8.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.676 0.274 . . . . 0.0 111.248 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.62 99.59 11.2 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.766 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.79 114.31 2.02 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.665 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.06 85.54 0.04 OUTLIER Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.494 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.8 tp -152.5 -57.1 0.14 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 64.45 79.85 0.25 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.44 0.638 . . . . 0.0 109.426 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.43 ' CD2' HG12 ' A' ' 145' ' ' VAL . 0.5 OUTLIER -53.03 143.85 16.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.149 -178.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.6 151.47 78.73 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.452 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.425 ' HD3' ' CG2' ' A' ' 120' ' ' VAL . 50.3 Cg_exo -56.15 118.75 5.6 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.875 2.383 . . . . 0.0 112.267 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.0 34.77 89.39 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.025 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.89 147.57 48.75 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.91 0.386 . . . . 0.0 111.542 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.5 t -71.56 145.48 49.04 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.305 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -128.9 144.23 51.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.671 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.8 m -82.09 129.38 34.79 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.915 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.53 95.72 8.58 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.601 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -73.89 -65.37 0.84 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -176.54 -66.25 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.563 0.22 . . . . 0.0 111.45 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.68 114.73 2.8 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.467 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.86 75.97 0.03 OUTLIER Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.237 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 58.92 34.76 23.83 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.739 0.304 . . . . 0.0 111.169 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.58 -128.89 4.78 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.303 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.442 ' N ' ' HB ' ' A' ' 95' ' ' THR . 14.7 tt0 -109.38 111.71 23.42 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.731 0.3 . . . . 0.0 110.993 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.67 150.37 47.29 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.586 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.44 113.96 21.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.765 0.317 . . . . 0.0 110.756 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.408 ' CB ' ' HG3' ' A' ' 82' ' ' ARG . . . -102.12 126.46 49.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.061 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.465 HG13 ' CE2' ' A' ' 81' ' ' PHE . 11.3 p -116.68 124.99 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.452 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 m -85.65 92.74 8.65 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.272 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.9 tp -131.5 101.15 16.04 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.341 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.91 8.62 0.56 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.467 2.778 . . . . 0.0 113.816 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -123.08 142.97 50.29 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.659 0.266 . . . . 0.0 111.038 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -98.57 142.33 30.3 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.34 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.03 175.27 40.73 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.248 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -67.26 140.35 57.36 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.761 0.315 . . . . 0.0 111.012 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.529 ' CE1' HG22 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -130.33 148.48 52.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.268 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.42 129.44 73.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.848 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.407 ' CD1' HG21 ' A' ' 145' ' ' VAL . 4.9 m95 -106.48 112.3 25.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.039 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.3 p -109.33 134.38 51.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.294 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -132.84 135.66 45.77 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.679 0.276 . . . . 0.0 110.643 -179.38 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.418 ' HA ' ' CG2' ' A' ' 69' ' ' THR . 11.2 tptm -106.63 130.57 54.35 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.644 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 132' ' ' LEU . 21.8 m-85 -139.84 145.05 37.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.918 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.4 p -110.65 -179.63 3.81 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.365 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -89.57 -20.84 23.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.582 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.2 m -65.61 -27.14 68.19 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.78 -17.26 55.71 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.256 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.51 ' CB ' ' HD3' ' A' ' 140' ' ' PRO . 0.3 OUTLIER -86.1 -56.85 0.36 Allowed Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 117.154 0.477 . . . . 0.0 110.897 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.51 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 22.6 Cg_exo -63.77 98.59 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.613 2.209 . . . . 0.0 112.0 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -134.2 106.78 7.33 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.63 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.95 144.97 51.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.256 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 21.3 pt -134.91 139.18 47.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.006 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -147.93 161.23 41.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.973 0.416 . . . . 0.0 111.487 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.529 HG22 ' CE1' ' A' ' 128' ' ' TYR . 8.3 p -125.29 145.77 32.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.6 m -144.43 151.52 39.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -105.67 141.18 37.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.063 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 62.0 m -121.32 131.35 24.48 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.696 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--O 1.252 1.18 0 C-N-CA 122.697 2.265 . . . . 0.0 112.313 -179.823 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.488 0.185 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -56.73 154.37 31.88 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.109 2.539 . . . . 0.0 113.127 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.2 m -150.61 144.01 24.98 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.218 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.14 128.54 33.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.854 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.4 101.38 14.06 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.116 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.67 -56.87 5.24 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.536 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.12 90.01 2.22 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.88 0.371 . . . . 0.0 111.076 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.21 -49.4 0.08 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.075 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -62.9 136.85 58.07 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.368 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.2 p -93.77 150.21 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.207 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.97 115.83 4.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.134 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -107.72 126.3 52.44 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.335 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 t 67.43 109.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.688 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 m 66.78 95.53 0.06 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.513 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.92 98.07 1.18 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.654 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -172.24 122.75 0.47 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.317 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.04 90.89 1.08 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.34 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 m 64.5 104.74 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.825 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.2 -44.1 69.36 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.154 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.55 141.33 16.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.877 0.37 . . . . 0.0 111.251 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.81 141.28 3.16 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.683 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -121.16 138.44 54.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.642 0.258 . . . . 0.0 110.9 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.04 -26.66 58.7 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.881 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.58 -50.0 74.39 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.71 0.255 . . . . 0.0 111.11 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.19 -19.42 39.87 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.085 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.29 11.51 12.01 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.01 -30.34 16.86 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 122.283 -0.261 . . . . 0.0 111.018 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.3 p -116.35 -32.83 5.15 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -117.06 99.04 6.79 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.942 0.401 . . . . 0.0 111.5 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -97.24 152.76 38.45 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.644 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.24 119.93 7.26 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.311 2.007 . . . . 0.0 112.456 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.19 141.44 31.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.123 0.487 . . . . 0.0 110.623 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.424 ' CG2' ' HA3' ' A' ' 66' ' ' GLY . 15.5 tt -148.75 164.65 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.714 -178.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -61.55 108.05 0.9 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.804 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.76 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -147.65 -159.57 8.45 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.978 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 61.12 -73.92 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.235 0.214 . . . . 0.0 111.558 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 35' ' ' GLY . . . 96.8 -114.51 4.98 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.37 -19.19 33.54 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.471 2.114 . . . . 0.0 112.998 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.404 HD13 HG23 ' A' ' 39' ' ' ILE . 3.8 mt -89.02 167.68 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.11 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.54 51.15 5.71 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.614 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.29 157.92 21.38 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.035 0.445 . . . . 0.0 111.155 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.506 ' HB ' ' CD1' ' A' ' 62' ' ' TYR . 1.5 t -54.47 120.79 7.13 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.432 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.416 ' CD2' ' HB2' ' A' ' 87' ' ' SER . 1.0 OUTLIER -119.31 177.02 5.06 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.982 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -130.77 118.89 21.5 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.094 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.419 ' HB ' ' CE1' ' A' ' 85' ' ' TYR . 12.1 p -97.4 130.87 45.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.509 ' HB ' ' CG ' ' A' ' 54' ' ' TRP . 1.3 m -141.5 -179.1 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.29 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.08 -18.25 12.42 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.912 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -43.0 -80.64 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 68.41 4.49 4.27 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.44 60.77 0.6 Allowed 'General case' 0 C--O 1.231 0.091 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.6 t70 71.7 20.66 4.57 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.009 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.99 -44.21 5.8 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.52 0.2 . . . . 0.0 110.875 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.9 m 71.56 25.42 3.36 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.576 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.509 ' CG ' ' HB ' ' A' ' 46' ' ' VAL . 23.1 m0 48.88 62.19 2.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 111.558 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -95.26 136.88 35.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.283 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -136.15 96.01 3.31 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.725 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.8 116.32 17.93 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.714 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.66 -32.52 75.77 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.765 2.31 . . . . 0.0 112.538 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -58.34 -24.58 60.18 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.581 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -130.62 22.86 5.06 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.748 0.309 . . . . 0.0 110.917 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -53.06 -30.11 34.03 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.759 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.506 ' CD1' ' HB ' ' A' ' 42' ' ' THR . 1.9 p90 -163.95 131.71 3.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.777 0.322 . . . . 0.0 111.241 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.74 115.4 23.83 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.992 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -60.96 118.18 6.4 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.915 0.388 . . . . 0.0 111.367 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 71' ' ' GLN . 2.4 t -101.46 96.42 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.76 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -45.23 87.9 0.01 OUTLIER Glycine 0 C--N 1.337 0.618 0 O-C-N 123.89 0.744 . . . . 0.0 112.726 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER 156.52 26.05 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.377 0.692 . . . . 0.0 112.451 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t30 62.27 25.18 15.04 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 122.071 -0.393 . . . . 0.0 111.052 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.8 154.75 25.75 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.497 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -117.35 133.56 55.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.833 0.349 . . . . 0.0 111.115 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.51 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -141.49 133.71 27.9 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.972 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.7 120.24 7.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.7 t -76.71 130.43 36.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.495 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.6 m -127.26 134.02 66.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -104.72 99.86 9.52 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.343 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -126.37 166.76 16.57 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.427 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 169.57 3.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.243 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.39 143.92 47.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.158 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.52 97.28 1.95 Allowed Glycine 0 C--N 1.335 0.485 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.387 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.97 72.33 0.49 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.679 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -134.34 139.04 45.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.706 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -120.55 155.84 32.83 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.929 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.5 ptm -154.58 155.06 34.07 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.939 0.4 . . . . 0.0 111.992 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.13 140.7 17.91 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.302 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.419 ' CE1' ' HB ' ' A' ' 45' ' ' VAL . 7.5 m-85 -97.09 142.37 29.1 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 111.725 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.501 ' HA ' ' CB ' ' A' ' 93' ' ' GLN . . . -163.76 122.98 2.02 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.123 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.416 ' HB2' ' CD2' ' A' ' 43' ' ' LEU . 8.8 t -74.6 165.08 25.8 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.842 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.2 mtmm -69.97 -50.2 44.14 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.332 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.93 35.66 0.85 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.924 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 1.3 t90 52.31 40.84 29.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.004 0.43 . . . . 0.0 111.452 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.402 ' HB3' ' HD2' ' A' ' 92' ' ' PRO . 0.5 OUTLIER -86.67 177.14 2.98 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.895 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 91' ' ' SER . 81.4 Cg_exo -45.62 111.49 0.33 Allowed 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.905 2.403 . . . . 0.0 112.849 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.501 ' CB ' ' HA ' ' A' ' 86' ' ' ALA . 10.3 pt20 -128.09 -174.76 3.3 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.948 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.425 ' CE1' HD12 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -122.87 120.0 32.18 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.956 0.408 . . . . 0.0 110.3 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.9 p -129.07 134.48 48.11 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.019 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -125.75 140.65 52.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.129 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.15 104.79 7.96 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.879 0.371 . . . . 0.0 111.854 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.57 102.55 0.01 OUTLIER Glycine 0 C--N 1.337 0.585 0 CA-C-N 116.019 -0.537 . . . . 0.0 113.213 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -169.74 -38.86 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 60.1 76.36 0.37 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.757 0.789 . . . . 0.0 109.534 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.415 HD21 HG11 ' A' ' 145' ' ' VAL . 9.6 tt -55.65 143.67 29.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.078 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.402 ' CG2' ' HD2' ' A' ' 103' ' ' PRO . 1.9 m -130.02 143.1 47.74 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.13 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.402 ' HD2' ' CG2' ' A' ' 102' ' ' THR . 82.9 Cg_exo -46.55 118.36 2.54 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.899 2.399 . . . . 0.0 112.448 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.07 34.52 29.87 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.537 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.29 144.65 51.5 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.798 0.333 . . . . 0.0 111.15 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.2 t -78.65 137.27 37.74 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -108.83 145.57 35.05 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.18 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.6 m -81.62 134.25 35.47 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.888 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.415 ' CD1' ' HA ' ' A' ' 94' ' ' PHE . 49.5 tp -104.05 142.59 34.19 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.812 0.339 . . . . 0.0 110.798 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -102.74 -70.91 0.74 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.178 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 179.99 -66.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.723 0.297 . . . . 0.0 111.035 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 155.58 146.79 4.53 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.502 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.79 -33.23 6.02 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.442 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -147.16 97.11 2.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.718 0.294 . . . . 0.0 110.369 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -127.49 102.12 0.59 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.206 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.93 143.77 9.67 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.82 0.343 . . . . 0.0 110.772 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 82' ' ' ARG . 13.5 m-20 -64.09 122.44 16.57 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.082 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 82' ' ' ARG . 94.3 m -93.82 113.98 26.13 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.918 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.55 137.77 32.02 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.017 0.437 . . . . 0.0 111.78 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.0 t -125.23 133.76 68.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.581 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.1 m -92.5 93.23 8.45 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.747 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.409 HD11 ' CD ' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -131.5 107.31 14.46 Favored Pre-proline 0 C--O 1.226 -0.184 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.611 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -76.76 8.55 3.03 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.723 2.282 . . . . 0.0 113.785 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -122.43 117.02 24.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.741 0.305 . . . . 0.0 111.181 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.94 140.9 36.47 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.286 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 171.11 -165.34 38.47 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.84 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -95.8 121.61 37.71 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 110.822 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.437 ' CD1' ' HG3' ' A' ' 147' ' ' LYS . 0.9 OUTLIER -105.91 154.53 20.43 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.544 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 32.4 m -110.56 120.54 61.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.048 0.452 . . . . 0.0 111.623 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -101.31 112.09 24.5 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.336 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 79.7 p -123.24 133.55 54.19 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.218 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.42 HD12 HG23 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -135.82 136.66 40.83 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.729 0.3 . . . . 0.0 110.853 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -124.23 119.75 30.25 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.066 0.46 . . . . 0.0 110.735 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 141' ' ' GLU . 1.9 p90 -142.85 152.52 42.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.395 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.2 p -72.12 157.2 38.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.057 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -93.96 -12.01 29.67 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.782 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.1 t -93.07 15.35 15.33 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.1 -8.38 79.91 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.674 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.637 ' HB3' ' HD2' ' A' ' 140' ' ' PRO . 1.2 m-20 -61.68 -178.07 0.17 Allowed Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 117.012 0.406 . . . . 0.0 111.441 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 139' ' ' ASP . 68.3 Cg_exo -41.16 154.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.397 2.731 . . . . 0.0 113.851 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -140.2 115.27 9.74 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.085 -178.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.42 154.03 38.29 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.012 0.434 . . . . 0.0 111.77 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.425 HD12 ' CE1' ' A' ' 94' ' ' PHE . 10.4 mt -123.63 155.95 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.97 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.72 132.81 39.27 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.793 0.33 . . . . 0.0 111.146 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.415 HG11 HD21 ' A' ' 101' ' ' LEU . 13.0 p -125.42 129.21 72.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.817 0.341 . . . . 0.0 111.105 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 95.1 p -143.8 144.99 32.04 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.967 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.437 ' HG3' ' CD1' ' A' ' 128' ' ' TYR . 8.8 ttpp -117.06 104.01 10.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -114.97 141.52 27.05 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.753 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.251 1.149 0 C-N-CA 122.438 2.092 . . . . 0.0 112.494 -179.775 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.537 0.208 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.91 -34.28 6.79 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.908 2.405 . . . . 0.0 112.826 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 p 58.75 178.53 0.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.976 0.417 . . . . 0.0 111.737 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.65 97.69 3.2 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.2 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.7 t -73.41 -68.38 0.5 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.879 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.92 45.9 0.4 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.719 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.1 tp -116.8 126.7 53.47 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.652 0.263 . . . . 0.0 111.084 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.2 p -136.95 -56.57 0.72 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.015 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.2 137.72 32.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.054 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 m -86.99 137.57 20.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.27 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.36 129.17 38.15 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.446 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.94 137.11 38.85 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.216 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 t -80.83 128.69 38.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.94 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.6 t 64.99 -81.91 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.177 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.17 132.34 0.17 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.622 0.248 . . . . 0.0 111.108 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.48 98.79 0.7 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.083 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.8 m -66.08 106.59 1.66 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.751 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.3 t -113.79 95.75 5.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.14 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mp -87.82 -26.71 22.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.025 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.641 ' H ' HD13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -132.71 139.17 50.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.938 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.63 144.46 15.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.897 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -100.84 148.12 25.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.859 0.361 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.74 69.58 0.97 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.756 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.11 -34.62 76.72 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.552 0.215 . . . . 0.0 111.093 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 45.2 mtm -59.73 -23.61 63.33 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.506 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.11 -9.4 55.42 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.2 11.52 11.82 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.7 m 64.69 49.14 2.35 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.929 0.395 . . . . 0.0 111.233 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.91 103.8 7.0 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.631 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -77.53 154.0 81.42 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.781 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.74 123.51 12.11 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.587 2.192 . . . . 0.0 112.07 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.898 HG22 ' HA ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -108.75 97.83 7.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.258 0.552 . . . . 0.0 111.374 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.418 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 2.5 tt -98.24 164.59 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.664 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -61.86 107.52 0.86 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.499 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.728 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -115.05 -143.56 8.12 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.272 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.18 41.9 1.4 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.907 0.384 . . . . 0.0 110.816 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.6 174.93 53.65 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.385 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.06 91.12 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.653 2.235 . . . . 0.0 112.212 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.726 HD13 ' CE2' ' A' ' 64' ' ' TYR . 38.1 mm -69.47 153.71 8.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.2 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 58.48 23.56 54.55 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.726 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 mmtm -128.14 132.01 48.95 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.605 0.24 . . . . 0.0 111.441 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.4 m -115.61 143.91 44.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.728 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.503 ' HB3' ' CE1' ' A' ' 85' ' ' TYR . 4.1 mm? -112.54 138.36 49.43 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.841 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.25 121.78 33.67 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.152 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.786 HG11 HG11 ' A' ' 74' ' ' VAL . 7.2 p -111.93 136.46 48.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.098 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.456 ' HB ' ' CD1' ' A' ' 54' ' ' TRP . 35.8 m -128.2 120.73 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.321 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 52' ' ' ALA . . . -95.51 142.25 15.99 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.426 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -150.19 117.41 6.02 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.963 0.411 . . . . 0.0 111.503 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -175.96 -69.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.692 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.21 -28.0 9.26 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.544 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.562 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 5.9 p-10 -110.05 -70.22 0.82 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.897 -0.138 . . . . 0.0 111.261 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 51' ' ' ASP . . . 80.55 31.51 0.18 Allowed 'General case' 0 C--N 1.343 0.297 0 CA-C-O 121.444 0.64 . . . . 0.0 109.826 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.7 m -62.63 -39.37 93.61 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.637 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.456 ' CD1' ' HB ' ' A' ' 46' ' ' VAL . 53.5 m0 58.13 48.13 13.42 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.918 0.39 . . . . 0.0 110.818 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -97.02 139.0 33.67 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.453 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.11 93.74 2.43 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.359 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -62.53 135.12 95.37 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.832 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.6 -37.93 20.45 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.742 2.295 . . . . 0.0 112.702 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.8 -26.13 65.51 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.371 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.437 ' HD3' HG21 ' A' ' 73' ' ' VAL . 27.4 mtt180 -125.42 17.23 8.26 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.083 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.73 -23.47 66.11 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.492 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -163.82 106.73 0.96 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.893 0.378 . . . . 0.0 111.427 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -105.55 131.11 53.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.295 179.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.726 ' CE2' HD13 ' A' ' 39' ' ' ILE . 62.3 m-85 -91.68 118.93 31.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.159 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.898 ' HA ' HG22 ' A' ' 32' ' ' THR . 4.3 t -93.97 116.31 34.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.293 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.728 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -65.6 79.81 0.09 OUTLIER Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.618 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 169.68 32.57 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.867 0.392 . . . . 0.0 111.724 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.0 m120 61.98 22.69 13.25 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.847 0.356 . . . . 0.0 110.119 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -115.44 155.31 27.67 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.363 -179.029 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.44 ' CZ ' HD23 ' A' ' 43' ' ' LEU . 24.5 t80 -120.71 139.46 53.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.439 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 130' ' ' TRP . 2.6 mt-30 -136.96 139.36 41.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.177 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.59 111.78 4.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.114 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 1.013 HG12 HG12 ' A' ' 129' ' ' VAL . 27.1 m -74.57 129.26 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.726 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.786 HG11 HG11 ' A' ' 45' ' ' VAL . 15.0 m -130.78 139.97 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -113.66 120.37 40.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.914 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -137.52 166.91 22.74 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.811 0.338 . . . . 0.0 111.831 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.17 172.92 1.27 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.642 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.547 ' HB2' ' CA ' ' A' ' 125' ' ' ALA . . . -110.31 143.23 40.82 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.344 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 122' ' ' LEU . . . 87.51 91.17 1.02 Allowed Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.297 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 57.28 101.6 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.83 0.347 . . . . 0.0 111.928 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.407 ' CE2' ' HB ' ' A' ' 120' ' ' VAL . 3.1 p90 -142.05 135.66 29.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.936 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.6 mtm105 -109.57 145.21 36.75 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.426 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -149.14 161.63 41.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.866 0.365 . . . . 0.0 111.386 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -141.55 152.0 43.71 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.903 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.503 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -118.4 132.85 56.24 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.819 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -164.05 151.43 12.14 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.316 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.72 177.3 6.37 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.085 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.46 -34.82 19.97 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.474 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.1 38.19 1.26 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.658 0.266 . . . . 0.0 111.22 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 50.28 40.6 22.78 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.965 0.412 . . . . 0.0 111.193 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.429 ' HB3' ' HD2' ' A' ' 92' ' ' PRO . 0.8 OUTLIER -86.06 176.99 3.11 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.514 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 91' ' ' SER . 96.2 Cg_exo -43.57 116.14 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.877 2.384 . . . . 0.0 112.854 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -111.68 -175.69 2.76 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.252 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.463 ' HB3' ' CB ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -125.63 128.09 47.33 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.117 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.38 111.92 9.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.816 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.842 ' HB1' ' HB3' ' A' ' 99' ' ' LEU . . . -96.12 88.93 4.99 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.157 0.503 . . . . 0.0 111.02 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.55 108.46 10.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.959 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.04 31.8 65.78 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.323 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.842 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 2.6 tm? -85.28 -52.1 6.13 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.183 0.193 . . . . 0.0 111.158 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.437 ' C ' HD13 ' A' ' 99' ' ' LEU . 0.2 OUTLIER 57.38 86.02 0.08 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.384 0.611 . . . . 0.0 110.233 -179.228 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.873 HD12 ' HB2' ' A' ' 107' ' ' ALA . 9.4 tt -76.76 146.77 37.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.594 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.86 HG22 ' HD2' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -129.72 152.93 80.63 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.02 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.86 ' HD2' HG22 ' A' ' 102' ' ' THR . 81.9 Cg_exo -46.77 110.66 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.598 2.198 . . . . 0.0 112.386 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.98 34.61 20.91 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.559 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.45 150.16 48.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.998 0.427 . . . . 0.0 111.127 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 35.9 p -84.8 144.91 28.16 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.315 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.873 ' HB2' HD12 ' A' ' 101' ' ' LEU . . . -119.82 149.08 42.64 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.417 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.33 131.15 36.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.958 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.585 ' CD1' HD11 ' A' ' 143' ' ' ILE . 7.1 tp -92.72 99.38 12.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.709 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -107.65 -160.57 0.74 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.647 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.25 165.83 26.35 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.752 0.311 . . . . 0.0 111.262 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.72 123.43 5.17 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.112 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.97 50.08 3.38 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.835 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -172.29 38.67 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.705 0.288 . . . . 0.0 111.478 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.26 -138.59 10.35 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.532 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.2 140.34 36.61 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.688 0.28 . . . . 0.0 111.048 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.73 149.83 31.03 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.226 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.622 HG22 ' H ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -97.36 114.37 26.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.68 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.82 129.01 44.32 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.05 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.418 HG22 ' HB3' ' A' ' 101' ' ' LEU . 22.9 t -117.55 131.33 70.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.074 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.5 m -91.66 97.55 11.09 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.822 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.729 HD11 ' CD ' ' A' ' 147' ' ' LYS . 13.6 tp -130.89 105.62 15.28 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.776 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.32 8.37 1.49 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.918 2.412 . . . . 0.0 113.752 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -128.43 133.1 48.48 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.553 0.216 . . . . 0.0 111.031 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.547 ' CA ' ' HB2' ' A' ' 78' ' ' ALA . . . -85.07 142.34 29.62 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.427 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 160.41 -174.74 37.16 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.706 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.58 134.3 49.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.803 0.335 . . . . 0.0 111.007 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.06 161.29 16.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.281 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.013 HG12 HG12 ' A' ' 73' ' ' VAL . 13.2 m -108.3 125.08 65.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.533 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.593 ' CZ3' HG21 ' A' ' 143' ' ' ILE . 10.1 m95 -96.15 112.08 23.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.923 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.529 ' C ' HD23 ' A' ' 132' ' ' LEU . 34.2 t -110.53 125.26 53.16 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.693 HD12 ' CZ ' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -148.75 143.98 26.75 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.607 -178.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -108.11 134.59 50.77 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.568 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.693 ' CZ ' HD12 ' A' ' 132' ' ' LEU . 23.5 m-85 -112.15 144.92 40.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.123 0.487 . . . . 0.0 110.953 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.637 HG21 ' N ' ' A' ' 139' ' ' ASP . 5.0 t -68.84 164.01 22.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.752 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -94.03 -39.61 10.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.819 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.4 t -79.52 -27.27 41.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.322 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.31 35.18 4.24 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.48 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.637 ' N ' HG21 ' A' ' 135' ' ' THR . 0.9 OUTLIER -112.87 -73.83 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 117.303 0.551 . . . . 0.0 111.418 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.569 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 97.0 Cg_endo -78.95 144.57 19.03 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.521 2.147 . . . . 0.0 113.077 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.2 120.7 4.14 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.963 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.01 147.65 51.78 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 111.338 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.593 HG21 ' CZ3' ' A' ' 130' ' ' TRP . 38.6 mt -123.36 147.2 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.919 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.25 132.68 22.04 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.063 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.793 HG12 HD11 ' A' ' 101' ' ' LEU . 12.0 p -141.13 139.62 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.964 0.411 . . . . 0.0 111.614 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.34 158.77 43.63 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.809 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.729 ' CD ' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -102.45 134.92 44.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 13.5 t -117.76 117.37 35.83 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.874 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--O 1.251 1.15 0 C-N-CA 122.841 2.361 . . . . 0.0 112.791 179.891 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.569 0.223 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.4 128.36 12.72 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.8 2.333 . . . . 0.0 112.548 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 t -156.02 145.82 21.19 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.143 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -161.31 -67.51 0.06 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.252 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.52 -175.46 4.2 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.985 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.86 -121.17 5.68 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.356 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.5 tp 56.88 77.35 0.27 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 111.325 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.2 100.82 8.43 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.679 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.64 119.31 23.66 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.943 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.5 t -115.48 -58.63 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.151 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.91 123.57 22.31 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.251 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.78 137.96 33.48 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.821 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -96.89 99.37 8.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.301 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 t -98.98 35.89 1.8 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.057 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.73 128.09 16.86 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.491 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.39 105.23 0.59 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.877 0.37 . . . . 0.0 111.222 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.479 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -80.84 149.04 29.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.995 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.67 126.44 28.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.394 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 46.62 48.72 14.23 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.154 0.502 . . . . 0.0 111.18 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 17' ' ' SER . 10.4 tt -104.9 147.29 11.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.692 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.79 140.64 15.15 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.452 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -141.44 138.46 32.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.874 0.369 . . . . 0.0 111.161 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.19 75.9 1.99 Allowed Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.459 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -60.76 -38.18 84.35 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.647 0.26 . . . . 0.0 110.823 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -66.68 -30.2 70.39 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.978 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.75 -31.27 70.2 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.106 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.22 8.27 38.45 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.674 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.8 m 59.58 76.58 0.35 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.731 0.3 . . . . 0.0 111.085 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -141.21 111.89 7.04 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.554 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -72.29 115.01 34.6 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.832 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.99 121.2 9.31 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.446 2.097 . . . . 0.0 112.157 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.645 ' CG2' HG13 ' A' ' 65' ' ' VAL . 1.2 p -114.7 137.63 51.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.493 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.441 ' H ' HD12 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -118.98 150.51 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.1 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.439 ' HA ' ' HB3' ' A' ' 64' ' ' TYR . 4.4 pt-20 -53.8 107.33 0.25 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.029 0.442 . . . . 0.0 111.85 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.7 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -100.77 -88.82 2.03 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.781 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -126.56 30.03 5.62 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.663 0.268 . . . . 0.0 110.997 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.51 123.38 6.73 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.794 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -57.18 113.22 1.38 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.011 2.474 . . . . 0.0 112.434 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 40' ' ' GLY . 3.6 mt -78.63 158.12 4.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.45 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.442 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 78.32 15.47 80.93 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.461 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -130.87 131.48 44.58 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 117.078 0.439 . . . . 0.0 110.845 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.451 HG23 ' HB1' ' A' ' 61' ' ' ALA . 41.6 m -116.17 139.27 50.5 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.081 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.454 HD12 ' C ' ' A' ' 43' ' ' LEU . 4.6 pp -109.87 148.34 31.7 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.289 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.61 136.02 43.19 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.157 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.618 HG22 ' HG2' ' A' ' 56' ' ' GLN . 8.4 m -113.53 115.81 50.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.983 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.78 156.5 28.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.033 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . 172.89 134.12 1.76 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.336 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -84.42 86.83 7.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.117 0.484 . . . . 0.0 110.339 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 52' ' ' ALA . 16.4 m-85 -90.24 -171.29 3.05 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.079 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.3 -49.25 8.92 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.597 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.27 49.4 1.79 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.954 0.407 . . . . 0.0 111.361 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.56 ' HB1' ' HG3' ' A' ' 55' ' ' LYS . . . -153.62 -57.43 0.12 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.865 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 m 50.51 86.98 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.66 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 12.6 m0 62.1 60.87 1.42 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.044 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.56 ' HG3' ' HB1' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -95.6 120.14 35.33 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.22 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.618 ' HG2' HG22 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -128.42 101.15 6.07 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.657 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.62 121.83 80.05 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.63 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.97 -38.46 86.52 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.736 2.29 . . . . 0.0 112.484 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -67.4 -15.05 63.46 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.682 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.722 ' HD3' HG12 ' A' ' 73' ' ' VAL . 1.7 mmp_? -122.77 16.64 10.23 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.615 0.245 . . . . 0.0 110.953 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.451 ' HB1' HG23 ' A' ' 42' ' ' THR . . . -50.88 -32.79 21.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.328 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -172.06 120.86 0.45 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.876 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.96 140.37 36.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.641 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.439 ' HB3' ' HA ' ' A' ' 34' ' ' GLU . 58.8 m-85 -86.43 118.34 25.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.8 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.645 HG13 ' CG2' ' A' ' 32' ' ' THR . 4.3 t -101.71 123.17 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.7 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -67.23 78.99 0.16 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.84 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER 161.44 31.6 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.104 0.532 . . . . 0.0 112.406 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.3 t30 61.41 25.19 15.18 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.999 0.428 . . . . 0.0 110.525 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.838 HG22 ' HA ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -109.02 156.17 20.06 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.264 -178.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.463 ' O ' HD12 ' A' ' 132' ' ' LEU . 7.6 m-85 -118.15 136.56 53.54 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.602 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.455 ' CG ' ' HA ' ' A' ' 131' ' ' SER . 8.6 mt-30 -144.76 148.69 34.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.057 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.64 130.32 13.15 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.469 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.722 HG12 ' HD3' ' A' ' 60' ' ' ARG . 14.5 p -89.27 131.51 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.692 0.282 . . . . 0.0 110.76 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.38 145.56 35.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.542 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -114.27 122.31 46.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.515 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.6 163.95 24.91 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.899 0.38 . . . . 0.0 111.434 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -101.22 175.53 5.56 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.159 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.534 ' HB2' ' N ' ' A' ' 125' ' ' ALA . . . -60.4 137.69 58.1 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.63 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.14 145.33 7.19 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.481 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.61 136.98 57.91 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.707 0.289 . . . . 0.0 111.126 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.571 ' CE1' HD22 ' A' ' 122' ' ' LEU . 2.8 p90 -140.94 148.68 40.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.059 0.457 . . . . 0.0 111.484 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.461 ' NH2' ' HB2' ' A' ' 117' ' ' ASP . 10.7 mtp-105 -117.96 140.66 49.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.081 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.45 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -147.99 177.83 9.03 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.085 0.469 . . . . 0.0 111.928 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.63 145.34 5.43 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.357 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.542 ' CE1' HG12 ' A' ' 45' ' ' VAL . 3.3 m-85 -97.15 142.85 28.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.617 0.246 . . . . 0.0 111.139 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.468 ' HA ' ' CB ' ' A' ' 93' ' ' GLN . . . -162.91 122.41 2.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.76 148.92 44.13 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.74 0.305 . . . . 0.0 111.355 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -35.45 76.61 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.703 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -96.76 31.26 2.38 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.617 0.246 . . . . 0.0 111.388 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 51.97 40.81 28.97 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 111.244 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.472 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.6 OUTLIER -85.75 169.88 14.52 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.433 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 91' ' ' SER . 1.2 Cg_endo -43.89 105.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.008 2.472 . . . . 0.0 112.43 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 85' ' ' TYR . 5.0 pt20 -106.74 -174.68 2.59 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.175 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.09 122.82 39.41 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.108 0.48 . . . . 0.0 110.814 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.9 p -132.19 130.79 41.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.364 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.06 120.35 38.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.625 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 99' ' ' LEU . 3.0 p30 -64.88 -157.61 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.617 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.81 74.08 0.05 OUTLIER Glycine 0 C--N 1.342 0.91 0 C-N-CA 121.165 -0.541 . . . . 0.0 111.978 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.615 HD13 ' C ' ' A' ' 99' ' ' LEU . 1.4 tm? -109.41 -44.66 3.85 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.918 0.487 . . . . 0.0 110.938 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.48 ' C ' HD13 ' A' ' 99' ' ' LEU . 19.3 mt-10 62.21 81.99 0.19 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.313 0.578 . . . . 0.0 109.863 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.837 HD12 ' HB2' ' A' ' 107' ' ' ALA . 8.0 tt -73.8 146.05 44.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.681 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.811 HG22 ' HD2' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -124.38 153.23 69.0 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.463 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.811 ' HD2' HG22 ' A' ' 102' ' ' THR . 91.5 Cg_exo -44.6 110.92 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.817 2.345 . . . . 0.0 112.434 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.46 34.58 22.47 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.421 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.87 150.73 46.17 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.049 0.452 . . . . 0.0 111.34 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.11 140.9 43.75 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.225 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.877 ' HB3' ' HB ' ' A' ' 143' ' ' ILE . . . -111.47 149.04 31.89 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.035 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.7 m -93.58 139.47 30.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.307 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.96 ' HB2' HD11 ' A' ' 143' ' ' ILE . 51.5 tp -120.6 97.83 5.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.205 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.94 -73.02 0.47 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.504 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -169.07 125.5 0.92 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.666 0.27 . . . . 0.0 111.044 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.98 161.35 10.69 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 116.187 -0.461 . . . . 0.0 113.243 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.27 -90.31 0.17 Allowed Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.198 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -157.58 99.72 1.75 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.866 0.365 . . . . 0.0 111.146 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -134.23 -130.55 3.02 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.296 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.56 145.31 36.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.856 0.36 . . . . 0.0 110.792 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.461 ' HB2' ' NH2' ' A' ' 82' ' ' ARG . 1.1 m-20 -83.45 129.29 34.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.171 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.67 114.03 4.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.481 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.34 124.78 34.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.94 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 21.7 t -117.07 124.99 73.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.852 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.6 m -89.62 121.25 31.63 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.426 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.571 HD22 ' CE1' ' A' ' 81' ' ' PHE . 4.8 tp -127.28 110.64 21.34 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.977 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -85.21 8.94 4.34 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.864 2.376 . . . . 0.0 113.117 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -165.19 150.88 9.62 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.826 0.346 . . . . 0.0 110.965 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.534 ' N ' ' HB2' ' A' ' 78' ' ' ALA . . . -67.75 141.43 56.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.326 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.17 142.53 3.88 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.46 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.82 125.93 33.02 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.847 0.356 . . . . 0.0 110.934 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.405 ' HE1' ' CD1' ' A' ' 130' ' ' TRP . 23.3 p90 -102.63 155.65 18.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.88 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 145' ' ' VAL . 23.7 m -108.19 121.79 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.001 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.464 ' CE3' ' HB ' ' A' ' 145' ' ' VAL . 4.5 m95 -88.48 112.29 22.8 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.669 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.455 ' HA ' ' CG ' ' A' ' 71' ' ' GLN . 26.9 t -124.97 131.39 53.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.367 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.815 HD23 HG12 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -133.9 135.15 43.44 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.73 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.838 ' HA ' HG22 ' A' ' 69' ' ' THR . 1.9 tptm -122.03 131.19 53.86 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.051 0.453 . . . . 0.0 111.479 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -141.59 144.86 34.44 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.156 179.644 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.481 HG21 ' HG2' ' A' ' 140' ' ' PRO . 13.3 t -96.48 168.84 10.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.145 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -79.56 -5.97 56.04 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.812 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.9 m -65.4 -26.81 68.15 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.05 28.42 49.81 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.971 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.619 ' CB ' ' HD3' ' A' ' 140' ' ' PRO . 0.3 OUTLIER -139.69 -62.86 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 122.295 0.238 . . . . 0.0 111.188 179.763 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.619 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 22.0 Cg_exo -64.81 123.43 11.65 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.529 2.153 . . . . 0.0 111.883 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.731 ' HG2' HD23 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -150.77 117.36 5.76 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.23 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.55 149.63 45.51 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.23 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.96 HD11 ' HB2' ' A' ' 109' ' ' LEU . 2.4 mp -123.89 149.59 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.136 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -141.2 121.52 13.96 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.765 0.317 . . . . 0.0 111.307 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.649 HG12 HD11 ' A' ' 101' ' ' LEU . 14.9 p -130.6 135.82 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.95 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.0 p -141.09 154.36 45.89 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.251 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.412 ' HG2' ' HB3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -117.5 122.39 43.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.778 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.09 122.39 40.81 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 C--O 1.251 1.14 0 C-N-CA 122.843 2.362 . . . . 0.0 112.412 -179.914 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.498 0.19 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.92 -31.44 63.01 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.687 2.258 . . . . 0.0 112.542 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 m -68.34 96.26 0.65 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.96 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.84 -46.62 2.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.018 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.5 m -142.48 79.42 1.66 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.738 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.14 -140.93 14.93 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.891 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.1 mt 57.65 44.27 20.99 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.864 0.364 . . . . 0.0 111.489 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -77.78 -40.96 39.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.306 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -115.79 118.15 32.22 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.744 0.307 . . . . 0.0 111.02 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 10' ' ' VAL . 9.0 t -95.54 19.09 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.277 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.9 143.06 29.26 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.097 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.7 t -76.81 129.87 36.86 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.017 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.97 -52.52 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.045 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.99 151.29 28.53 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.069 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.84 138.27 48.15 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.242 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.24 130.14 56.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.324 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.3 m -68.7 147.15 52.26 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.96 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.93 123.03 7.38 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.384 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mp -96.33 86.17 4.13 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.58 ' H ' HD13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -139.53 137.32 40.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.84 144.92 12.77 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.701 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -127.29 138.61 53.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.661 0.267 . . . . 0.0 111.159 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.75 136.6 3.38 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.604 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -61.1 -34.21 74.58 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.697 0.284 . . . . 0.0 111.222 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -13.36 5.57 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.257 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.73 11.36 1.38 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.57 -19.3 45.93 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.58 88.27 2.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.74 0.305 . . . . 0.0 111.563 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -174.86 131.61 0.32 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.655 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -78.6 145.78 68.0 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.69 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -61.81 116.38 3.41 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.655 2.237 . . . . 0.0 112.049 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.915 HG22 ' HA ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -102.82 97.54 7.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 111.06 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 tt -95.72 161.27 2.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.399 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.9 107.35 0.97 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.971 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.704 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -109.41 -130.89 6.1 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.979 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -105.92 42.45 1.25 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.74 0.305 . . . . 0.0 110.776 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.6 163.48 37.02 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.812 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.74 117.58 5.22 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.908 2.405 . . . . 0.0 112.978 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.3 tt -69.82 153.12 8.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.612 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 50.81 14.25 1.04 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.117 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.22 131.84 47.01 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 117.35 0.575 . . . . 0.0 111.102 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.9 m -115.7 142.12 47.17 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.542 HD12 ' CD1' ' A' ' 70' ' ' TYR . 6.1 mt -112.24 122.67 48.38 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.406 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.51 118.74 37.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.766 0.317 . . . . 0.0 111.435 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.719 HG13 ' HG3' ' A' ' 56' ' ' GLN . 8.8 p -113.32 136.39 49.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.686 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.458 ' HB ' ' CD1' ' A' ' 54' ' ' TRP . 28.1 m -126.51 126.91 69.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.404 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.93 129.87 9.95 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.016 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 49' ' ' PHE . 6.3 t0 -120.02 94.46 4.4 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.568 ' CB ' ' HA ' ' A' ' 81' ' ' PHE . 0.3 OUTLIER 157.6 159.9 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.455 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.672 ' HB1' ' HB3' ' A' ' 78' ' ' ALA . . . 51.84 36.11 17.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.616 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.3 t70 57.05 65.01 1.48 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.199 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.48 -39.92 8.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.856 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 55.82 31.97 18.68 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.422 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.458 ' CD1' ' HB ' ' A' ' 46' ' ' VAL . 40.2 m0 53.96 62.54 2.55 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.921 0.391 . . . . 0.0 110.852 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -94.98 122.23 37.41 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.37 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.719 ' HG3' HG13 ' A' ' 45' ' ' VAL . 1.1 mm-40 -169.15 111.35 0.5 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.993 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.29 126.7 89.96 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.957 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.66 -32.96 77.75 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.79 2.327 . . . . 0.0 112.585 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -57.04 -24.29 52.69 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.778 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.414 ' HB3' ' CG2' ' A' ' 73' ' ' VAL . 77.5 mtt180 -118.8 12.92 13.09 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.555 0.217 . . . . 0.0 111.04 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 43' ' ' LEU . . . -87.0 7.79 26.11 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -157.68 90.46 1.08 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.055 0.455 . . . . 0.0 111.033 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.742 ' CZ ' HG13 ' A' ' 73' ' ' VAL . 47.1 mtm180 -110.83 114.9 28.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.523 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -77.41 118.39 19.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.207 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.915 ' HA ' HG22 ' A' ' 32' ' ' THR . 2.5 t -96.55 118.01 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.704 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -65.9 79.05 0.1 OUTLIER Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.545 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 171.55 28.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.959 0.446 . . . . 0.0 112.067 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.9 t30 62.02 22.39 13.05 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.889 0.376 . . . . 0.0 110.521 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.65 HG22 ' HA ' ' A' ' 133' ' ' LYS . 18.8 p -119.44 156.01 30.98 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.91 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.542 ' CD1' HD12 ' A' ' 43' ' ' LEU . 0.8 OUTLIER -125.52 144.96 50.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.271 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.504 ' HG2' HG22 ' A' ' 65' ' ' VAL . 3.3 pt20 -149.63 158.84 44.54 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.538 ' HB3' ' OH ' ' A' ' 85' ' ' TYR . . . -150.57 122.58 8.22 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.362 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.932 HG12 HG12 ' A' ' 129' ' ' VAL . 5.0 m -75.24 129.23 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.7 0.286 . . . . 0.0 110.847 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.2 t -130.23 139.11 52.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.533 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.53 135.0 35.58 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.443 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -111.49 143.56 42.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.51 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.464 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -141.61 104.29 4.53 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.313 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.672 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . 69.61 143.36 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.488 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 80' ' ' ALA . . . -68.85 160.47 52.15 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.816 -0.629 . . . . 0.0 114.296 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 79' ' ' GLY . . . 77.17 74.87 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.668 -0.766 . . . . 0.0 111.182 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.568 ' HA ' ' CB ' ' A' ' 49' ' ' PHE . 30.7 p90 -138.86 136.42 35.54 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.96 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -109.06 135.98 49.32 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.558 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.1 ptm -143.37 162.52 35.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.919 0.39 . . . . 0.0 111.813 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -149.91 141.89 23.88 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.784 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.538 ' OH ' ' HB3' ' A' ' 72' ' ' ALA . 14.4 m-85 -97.62 141.19 30.96 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.19 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.468 ' HA ' ' HB3' ' A' ' 93' ' ' GLN . . . -158.22 124.39 4.67 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.254 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.1 t -69.76 167.81 16.35 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -77.82 -40.83 39.19 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.635 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.62 35.48 1.36 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.739 0.304 . . . . 0.0 111.416 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 51.47 38.47 22.16 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.931 0.396 . . . . 0.0 111.305 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.49 177.86 2.67 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.5 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -43.1 119.32 1.57 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.845 2.363 . . . . 0.0 113.081 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 3.6 mt-30 -118.89 -175.3 2.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.933 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.468 ' HB3' ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -123.33 119.8 31.18 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.173 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.2 p -141.64 122.78 14.69 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.053 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.434 ' HB1' ' CD2' ' A' ' 99' ' ' LEU . . . -104.04 154.05 20.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.772 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.62 26.55 4.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.566 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.19 135.87 9.08 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.424 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.434 ' CD2' ' HB1' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -174.59 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 62.77 78.57 0.29 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.515 0.674 . . . . 0.0 109.727 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.653 ' CD1' ' HB2' ' A' ' 107' ' ' ALA . 7.5 tt -70.46 147.69 49.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.931 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.523 HG23 ' HD2' ' A' ' 103' ' ' PRO . 93.3 m -113.57 143.52 29.57 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.155 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.523 ' HD2' HG23 ' A' ' 102' ' ' THR . 72.7 Cg_exo -41.16 116.36 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.885 2.39 . . . . 0.0 112.954 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.81 34.52 11.16 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.479 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.564 ' O ' HD11 ' A' ' 101' ' ' LEU . 16.8 tttt -131.38 152.55 50.52 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.077 0.465 . . . . 0.0 111.088 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.41 ' N ' ' HG2' ' A' ' 105' ' ' LYS . 2.2 p -81.28 140.2 34.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.91 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.653 ' HB2' ' CD1' ' A' ' 101' ' ' LEU . . . -104.09 148.93 25.69 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.111 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 m -86.06 133.31 33.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.855 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.683 HD23 ' HG2' ' A' ' 141' ' ' GLU . 69.4 tp -109.15 137.19 47.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.991 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -97.64 -67.89 0.83 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.924 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -178.15 -45.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.906 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 134.52 141.6 4.48 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.336 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.51 -108.31 0.39 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.117 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -145.04 99.52 3.34 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.831 0.348 . . . . 0.0 110.782 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.58 -137.22 5.05 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.589 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.95 129.56 55.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.632 0.253 . . . . 0.0 110.854 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -64.86 141.59 58.72 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.044 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 67.9 m -85.7 129.02 34.94 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.912 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -102.0 132.59 47.75 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.346 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.505 ' HB ' ' CZ ' ' A' ' 81' ' ' PHE . 15.8 t -119.92 129.96 74.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 121' ' ' THR . 5.6 m -95.44 93.02 6.97 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.911 0.386 . . . . 0.0 111.123 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.647 HD13 ' HD3' ' A' ' 147' ' ' LYS . 41.7 tp -131.91 100.3 16.04 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.192 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.66 -0.8 9.38 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.567 2.178 . . . . 0.0 113.891 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -110.33 122.43 47.66 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.7 0.286 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.428 ' HB2' ' HE2' ' A' ' 77' ' ' LYS . . . -72.99 120.76 19.07 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -165.18 168.11 39.12 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.79 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -68.05 131.8 46.11 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.934 0.397 . . . . 0.0 111.293 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.609 ' CE1' HG22 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -112.84 146.65 38.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.424 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.932 HG12 HG12 ' A' ' 73' ' ' VAL . 27.2 m -124.44 120.1 58.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.95 0.405 . . . . 0.0 110.988 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.81 ' CE3' HG21 ' A' ' 145' ' ' VAL . 4.5 t-105 -100.16 112.16 24.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.379 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 t -121.09 149.38 42.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.522 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.811 HD23 HD12 ' A' ' 143' ' ' ILE . 3.0 mp -133.68 135.41 44.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.527 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.65 ' HA ' HG22 ' A' ' 69' ' ' THR . 1.1 tptm -123.72 120.03 31.5 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.972 0.415 . . . . 0.0 111.203 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.417 ' HB3' ' CG ' ' A' ' 141' ' ' GLU . 0.1 OUTLIER -141.77 145.12 34.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.667 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.2 p -89.69 171.8 9.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.06 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -88.12 7.64 30.64 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.639 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.6 t -69.98 -26.73 64.23 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.454 0.169 . . . . 0.0 111.335 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.05 42.39 8.83 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.556 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.445 ' CB ' ' CD ' ' A' ' 140' ' ' PRO . 0.4 OUTLIER -158.93 -65.63 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 120.294 0.092 . . . . 0.0 111.018 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 139' ' ' ASP . 39.7 Cg_endo -66.55 122.55 10.0 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.5 2.134 . . . . 0.0 112.226 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.683 ' HG2' HD23 ' A' ' 109' ' ' LEU . 4.6 mt-10 -142.43 111.23 6.29 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.804 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.534 ' O ' HD13 ' A' ' 143' ' ' ILE . 1.2 tp60 -122.96 149.94 43.62 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.914 0.388 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.811 HD12 HD23 ' A' ' 132' ' ' LEU . 12.1 mm -123.37 147.73 27.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.535 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.65 124.51 19.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.814 0.34 . . . . 0.0 111.068 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.81 HG21 ' CE3' ' A' ' 130' ' ' TRP . 14.8 p -132.92 137.56 53.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.5 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.1 p -139.93 155.64 47.06 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.795 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.647 ' HD3' HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -117.61 125.38 50.67 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.892 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 84.0 m -123.63 116.4 27.94 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.936 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 C--O 1.25 1.1 0 C-N-CA 122.709 2.273 . . . . 0.0 112.729 179.968 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.396 0.141 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.62 91.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.834 2.356 . . . . 0.0 112.069 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.49 150.31 34.32 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.995 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.41 -27.94 56.48 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.744 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 t -58.99 -53.67 55.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.505 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.37 52.47 0.63 Allowed Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.412 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.76 142.67 31.9 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.758 0.313 . . . . 0.0 110.786 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 t -169.23 161.23 10.07 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.189 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -98.37 113.79 25.89 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.725 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.28 81.31 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.034 0.445 . . . . 0.0 111.148 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.74 138.52 37.33 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.538 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -97.74 130.7 44.69 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.035 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 m 40.14 82.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.337 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -127.83 136.94 52.13 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.336 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 65.58 111.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.841 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 70.85 131.46 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.532 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 m -162.18 117.05 1.89 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.323 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.4 135.6 54.25 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.775 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 tp -135.27 84.17 2.07 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.95 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 tt -88.22 135.73 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.822 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.05 141.74 5.5 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.67 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -151.76 138.65 18.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.668 0.271 . . . . 0.0 111.153 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.04 95.27 2.26 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.694 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -64.53 -34.98 79.49 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.564 0.221 . . . . 0.0 111.018 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.0 ptp -70.7 -25.9 63.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.126 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -101.19 11.45 39.38 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -80.24 -28.89 38.4 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 122.337 -0.227 . . . . 0.0 111.101 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.65 ' O ' HG21 ' A' ' 129' ' ' VAL . 31.2 p -87.49 2.69 49.93 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.79 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -174.37 125.27 0.32 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.875 0.369 . . . . 0.0 111.303 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -95.88 152.9 39.32 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.588 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.41 127.67 26.19 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.821 2.347 . . . . 0.0 112.45 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.925 HG22 ' HA ' ' A' ' 65' ' ' VAL . 0.5 OUTLIER -100.62 126.31 47.09 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.202 0.525 . . . . 0.0 111.997 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.419 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 12.4 tt -135.94 162.61 36.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.043 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -56.76 107.85 0.44 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.95 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.758 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -119.94 -130.59 4.02 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.239 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.76 33.63 5.56 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.566 0.222 . . . . 0.0 111.584 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.12 178.81 12.37 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.972 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.58 125.63 5.68 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.811 2.34 . . . . 0.0 113.173 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.479 HD11 ' CZ ' ' A' ' 64' ' ' TYR . 21.0 mm -104.97 153.87 6.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.134 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 62.33 22.76 63.66 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.542 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -129.59 132.41 46.77 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.698 0.285 . . . . 0.0 111.029 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.457 HG23 ' HB1' ' A' ' 61' ' ' ALA . 72.5 m -115.09 128.43 56.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.706 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.413 ' HB2' ' OH ' ' A' ' 70' ' ' TYR . 4.0 mm? -100.84 122.69 43.86 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.441 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -103.95 119.05 38.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.883 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 45' ' ' VAL . 12.1 p -97.14 119.07 44.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.972 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.4 m -122.41 -178.2 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.001 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' A' ' 83' ' ' MET . . . 133.68 -91.04 0.25 Allowed Glycine 0 CA--C 1.518 0.281 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER 160.81 129.25 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.814 0.446 . . . . 0.0 110.129 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 6.8 m-85 -137.62 27.58 2.75 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 51' ' ' ASP . . . 51.95 92.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.838 0.351 . . . . 0.0 111.186 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 50' ' ' ALA . 17.8 t70 87.44 21.87 0.06 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.238 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.96 43.72 0.1 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.646 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 m -67.43 87.67 0.2 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.918 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.529 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 1.3 m0 73.07 61.13 0.1 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.684 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -107.46 116.1 31.34 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.472 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -153.15 94.78 1.88 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.578 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.409 ' CG ' ' HG2' ' A' ' 60' ' ' ARG . 5.5 ptmt -74.02 135.93 76.68 Favored Pre-proline 0 C--O 1.233 0.187 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.727 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 52.3 Cg_exo -55.09 -26.6 51.19 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.897 2.398 . . . . 0.0 112.95 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -28.26 69.35 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.495 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.409 ' HG2' ' CG ' ' A' ' 57' ' ' LYS . 0.6 OUTLIER -130.97 22.53 4.92 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.79 0.329 . . . . 0.0 110.916 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . . . -63.35 -16.89 61.8 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.119 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -162.69 128.18 3.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.711 0.291 . . . . 0.0 111.164 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 mtm105 -116.85 130.86 56.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.663 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.479 ' CZ ' HD11 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -76.6 118.64 19.45 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.458 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.925 ' HA ' HG22 ' A' ' 32' ' ' THR . 1.8 t -107.77 105.55 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.758 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -55.51 88.62 0.01 OUTLIER Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.595 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.441 ' CB ' ' O ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER 158.93 27.2 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.188 0.581 . . . . 0.0 112.485 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 61.83 21.47 12.27 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.884 0.373 . . . . 0.0 110.199 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.748 HG23 ' HG3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -111.58 155.88 22.64 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.074 -179.2 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.413 ' OH ' ' HB2' ' A' ' 43' ' ' LEU . 47.9 t80 -114.62 134.97 54.65 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.772 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.47 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . 2.8 tp-100 -126.56 136.46 52.59 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.741 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.67 110.35 4.04 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.419 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.568 HG22 HG12 ' A' ' 129' ' ' VAL . 39.7 t -76.85 132.36 33.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.272 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.566 ' HB ' ' CE1' ' A' ' 128' ' ' TYR . 14.1 t -130.69 136.54 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.743 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -96.92 131.12 44.01 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.518 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -138.57 161.5 36.93 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.864 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.15 172.74 10.97 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.697 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.798 ' HB2' ' HB2' ' A' ' 125' ' ' ALA . . . -82.01 129.53 34.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.399 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.88 140.05 0.67 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.247 -0.501 . . . . 0.0 113.117 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.07 104.04 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.861 0.363 . . . . 0.0 111.499 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 122' ' ' LEU . 19.5 m-85 -132.21 138.69 48.05 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.733 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 -159.35 127.64 5.05 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.186 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -151.97 174.0 14.17 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.135 0.493 . . . . 0.0 112.074 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -168.29 142.75 3.4 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.26 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.548 ' O ' ' HB2' ' A' ' 93' ' ' GLN . 4.0 m-85 -99.09 142.94 29.93 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 111.35 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.97 125.1 3.48 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.75 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.13 169.49 14.94 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.261 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -78.91 -34.75 44.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.319 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.5 31.14 2.63 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.299 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 53.41 40.57 31.54 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.968 0.414 . . . . 0.0 111.249 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.404 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 1.0 OUTLIER -86.58 178.55 2.21 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.567 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 91' ' ' SER . 99.1 Cg_exo -43.62 121.72 2.85 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.726 2.284 . . . . 0.0 112.895 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.548 ' HB2' ' O ' ' A' ' 85' ' ' TYR . 11.8 pt20 -118.36 -175.22 2.82 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.616 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.446 ' HB3' ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -123.0 121.32 35.8 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.084 0.468 . . . . 0.0 110.428 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.82 112.81 3.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.191 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 99' ' ' LEU . . . -107.86 130.02 55.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.464 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.67 118.93 24.19 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.904 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.11 42.27 80.97 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.196 -0.525 . . . . 0.0 112.367 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.529 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 4.7 tp -84.61 -56.65 3.5 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.547 0.202 . . . . 0.0 111.547 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 60.74 85.2 0.12 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.328 0.585 . . . . 0.0 110.02 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.727 ' CG ' HG11 ' A' ' 145' ' ' VAL . 7.1 tt -69.94 144.48 52.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.546 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.453 HG23 ' HD2' ' A' ' 103' ' ' PRO . 87.9 m -135.35 142.93 43.32 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.129 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.454 ' HG3' HD11 ' A' ' 122' ' ' LEU . 85.2 Cg_exo -46.52 111.05 0.32 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.669 2.246 . . . . 0.0 112.479 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.39 34.43 16.92 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.553 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.743 ' O ' HG12 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -128.38 150.83 49.94 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.995 0.426 . . . . 0.0 110.864 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.526 HG22 ' HG2' ' A' ' 144' ' ' MET . 28.4 p -80.39 142.53 34.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.024 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.831 ' HB3' ' HB ' ' A' ' 143' ' ' ILE . . . -103.88 140.21 38.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.234 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.2 m -76.49 126.99 31.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.224 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.836 ' HG ' HD11 ' A' ' 143' ' ' ILE . 0.6 OUTLIER -116.28 96.59 5.62 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.644 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.93 -48.26 0.37 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.316 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.75 131.14 34.21 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.695 0.283 . . . . 0.0 110.798 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -133.75 61.73 0.64 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.571 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.84 90.49 0.08 OUTLIER Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.562 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 64.74 98.92 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 111.298 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -145.01 -134.84 2.8 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.281 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.82 131.36 55.06 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.621 0.248 . . . . 0.0 110.708 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.08 132.49 48.65 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.69 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 101' ' ' LEU . 4.2 m -80.82 114.32 19.62 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.594 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.41 144.96 26.07 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.439 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 81' ' ' PHE . 2.5 t -127.43 138.76 53.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.995 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.3 m -106.7 100.72 10.21 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.414 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.583 ' HB2' ' CE1' ' A' ' 81' ' ' PHE . 0.9 OUTLIER -130.87 117.5 17.31 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.051 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.32 8.24 4.5 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.796 2.331 . . . . 0.0 113.303 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -129.38 143.07 50.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.675 0.274 . . . . 0.0 110.942 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.798 ' HB2' ' HB2' ' A' ' 78' ' ' ALA . . . -86.72 140.08 30.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.041 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 166.92 177.11 38.46 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.776 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -101.75 135.73 42.8 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 111.085 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.566 ' CE1' ' HB ' ' A' ' 74' ' ' VAL . 14.1 p90 -108.73 163.24 13.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.811 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.65 HG21 ' O ' ' A' ' 28' ' ' CYS . 12.1 m -111.76 130.7 64.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.433 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.474 ' HE1' ' HH ' ' A' ' 128' ' ' TYR . 1.7 m95 -92.37 112.44 24.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.536 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.477 ' C ' HD12 ' A' ' 132' ' ' LEU . 0.9 OUTLIER -109.32 125.94 52.85 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.979 0.418 . . . . 0.0 110.584 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.622 ' HG ' HG23 ' A' ' 143' ' ' ILE . 7.0 mp -134.33 135.76 42.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.493 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.748 ' HG3' HG23 ' A' ' 69' ' ' THR . 14.8 tttm -127.91 132.15 49.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.972 0.415 . . . . 0.0 111.688 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -128.92 145.3 51.26 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.62 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.94 HG21 ' HD2' ' A' ' 140' ' ' PRO . 10.3 t -78.45 178.91 7.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.287 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.22 -35.21 16.32 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.312 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 t -68.97 -26.82 65.23 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.503 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.727 ' H ' HG23 ' A' ' 135' ' ' THR . . . 88.83 26.49 26.7 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.248 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.582 ' CB ' ' CD ' ' A' ' 140' ' ' PRO . 0.9 OUTLIER -106.6 -76.49 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 117.122 0.461 . . . . 0.0 110.948 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.94 ' HD2' HG21 ' A' ' 135' ' ' THR . 37.1 Cg_endo -65.7 136.33 45.38 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.247 1.964 . . . . 0.0 112.264 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.783 ' HG2' HD13 ' A' ' 109' ' ' LEU . 5.8 tt0 -149.54 117.36 6.26 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.829 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.72 158.25 44.6 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.343 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.836 HD11 ' HG ' ' A' ' 109' ' ' LEU . 24.2 mt -124.99 154.8 33.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.254 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.526 ' HG2' HG22 ' A' ' 106' ' ' THR . 0.0 OUTLIER -143.21 134.27 25.67 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.964 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 105' ' ' LYS . 14.0 p -122.73 140.29 46.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.849 0.357 . . . . 0.0 111.028 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 51.8 p -138.17 155.29 48.84 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.88 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.06 136.68 52.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 69.6 m -94.38 149.67 37.03 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.034 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 C--O 1.249 1.043 0 C-N-CA 122.741 2.294 . . . . 0.0 112.841 179.989 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.47 ' HB ' ' HD3' ' A' ' 2' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.47 ' HD3' ' HB ' ' A' ' 1' ' ' THR . 73.0 Cg_endo -77.8 -44.72 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.187 1.925 . . . . 0.0 113.146 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.32 30.66 12.91 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.651 0.262 . . . . 0.0 111.278 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.91 36.21 4.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.037 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 m -67.52 -42.26 83.06 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.109 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.17 72.02 0.03 OUTLIER Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.407 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.6 mt -62.52 119.83 9.93 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.748 0.309 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.33 87.13 2.47 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.934 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.75 ' O ' HG12 ' A' ' 10' ' ' VAL . 8.4 tttt -91.69 121.13 33.06 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.706 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 9' ' ' LYS . 9.9 p 56.75 153.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.882 0.739 . . . . 0.0 112.359 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.03 113.53 14.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.921 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.2 t -108.19 117.79 35.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.896 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 t 65.51 130.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.653 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.5 t -111.24 143.8 41.42 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.51 137.27 21.54 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.186 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.8 120.38 11.16 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.201 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 m -83.13 135.64 34.74 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.17 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.57 103.27 10.85 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.606 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 mp 57.37 26.29 12.3 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.397 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.9 tt -135.62 138.7 47.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.829 0.347 . . . . 0.0 110.987 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.66 143.24 15.63 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.466 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -128.67 138.35 52.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.641 0.258 . . . . 0.0 110.703 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.78 -18.1 41.07 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.779 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -53.15 -37.85 62.2 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.83 0.315 . . . . 0.0 111.457 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -60.49 -30.08 69.48 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.408 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -105.25 11.32 33.11 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.428 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -92.05 -30.67 15.91 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.406 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 p 178.97 -35.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.38 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.44 85.27 0.17 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.1 0.476 . . . . 0.0 110.494 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 3.4 m-80 -75.49 113.91 30.86 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.105 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 30' ' ' ASN . 1.2 Cg_endo -82.03 100.55 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.491 2.127 . . . . 0.0 112.154 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -116.93 97.26 5.86 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.34 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.591 ' N ' HD13 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -129.74 102.79 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.294 0.569 . . . . 0.0 111.982 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 67' ' ' GLU . 8.8 mm-40 -146.27 106.9 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.049 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.83 -130.05 6.58 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.371 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -157.94 93.13 1.23 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 111.242 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.82 158.68 32.68 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.848 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.73 104.18 1.44 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.664 2.243 . . . . 0.0 112.938 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.436 ' HA ' ' CE2' ' A' ' 64' ' ' TYR . 3.7 mt -77.11 154.06 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.84 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 74.65 25.69 69.3 Favored Glycine 0 C--N 1.337 0.583 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.822 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.54 131.85 45.28 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.969 0.414 . . . . 0.0 111.535 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.934 HG23 ' HB1' ' A' ' 61' ' ' ALA . 61.6 m -115.71 141.65 47.8 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.575 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 43' ' ' LEU . 9.9 mt -112.65 124.1 51.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.626 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.602 ' HE2' HE21 ' A' ' 56' ' ' GLN . 0.2 OUTLIER -101.86 118.36 36.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.399 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 85' ' ' TYR . 13.8 p -111.78 136.06 49.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.18 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.9 m -122.39 120.35 60.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.247 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.71 110.27 1.45 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.372 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.21 82.74 0.35 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.097 0.475 . . . . 0.0 110.322 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.449 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 13.6 m-85 -83.52 -171.81 3.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.086 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.23 -61.07 2.0 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.711 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -109.24 44.82 1.11 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.884 0.373 . . . . 0.0 111.35 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -154.61 -56.5 0.1 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.958 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.6 m 53.54 98.48 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.373 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 19.2 m0 66.55 62.57 0.53 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.689 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HG3' ' HB1' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -94.69 125.17 39.17 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.29 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.602 HE21 ' HE2' ' A' ' 44' ' ' TYR . 1.3 pt20 -146.43 143.36 28.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.761 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -123.98 147.58 54.51 Favored Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.919 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.12 -30.8 46.53 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.603 2.202 . . . . 0.0 112.349 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.16 2.4 35.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.561 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -128.6 19.82 6.17 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.37 0.128 . . . . 0.0 111.055 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.934 ' HB1' HG23 ' A' ' 42' ' ' THR . . . -47.38 -50.97 21.15 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.926 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.422 ' CE1' ' CE1' ' A' ' 64' ' ' TYR . 0.0 OUTLIER 176.33 123.89 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.62 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 33.8 ttp180 -83.9 135.41 34.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.931 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.436 ' CE2' ' HA ' ' A' ' 39' ' ' ILE . 7.6 m-85 -81.57 118.92 23.16 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.121 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -128.9 103.99 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.602 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 67' ' ' GLU . . . -41.45 163.6 0.02 OUTLIER Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.794 -0.639 . . . . 0.0 114.513 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.446 ' HB3' HG23 ' A' ' 69' ' ' THR . 1.1 tm-20 84.49 28.98 0.07 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.148 0.579 . . . . 0.0 111.922 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 62.6 19.83 11.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.445 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.81 HG22 ' HG2' ' A' ' 133' ' ' LYS . 3.0 p -97.82 152.63 18.97 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -128.28 142.89 51.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.734 0.302 . . . . 0.0 110.888 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -143.77 136.62 27.38 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.844 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.17 130.76 13.96 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.696 0.284 . . . . 0.0 111.416 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.4 t -81.98 131.82 32.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.761 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.7 t -125.27 145.68 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.92 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -116.47 118.76 33.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.411 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -127.13 163.9 22.79 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.348 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.32 174.51 5.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.505 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.67 ' HB1' ' O ' ' A' ' 123' ' ' PRO . . . -68.32 123.33 20.44 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.443 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 127.55 148.69 6.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.298 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.14 131.74 45.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.782 0.325 . . . . 0.0 111.391 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.03 147.53 37.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.004 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.0 mtp-105 -104.49 154.42 19.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.91 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -152.98 162.91 40.75 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.077 0.465 . . . . 0.0 111.955 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.52 156.73 32.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.674 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.524 ' HB2' ' HB3' ' A' ' 94' ' ' PHE . 2.9 m-85 -113.39 146.24 39.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.922 0.391 . . . . 0.0 111.175 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.73 123.38 1.5 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.073 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.01 147.39 45.16 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.943 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -60.73 -30.0 69.72 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.45 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.59 28.26 4.32 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.619 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 1.7 m95 54.4 38.82 30.29 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.988 0.423 . . . . 0.0 111.098 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.423 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -86.88 178.71 2.1 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.047 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 91' ' ' SER . 93.3 Cg_exo -43.28 118.53 1.38 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.857 2.371 . . . . 0.0 112.683 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.478 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 41.8 mt-30 -105.03 -175.01 2.67 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.203 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.524 ' HB3' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -127.09 133.17 50.47 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.755 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.12 111.71 1.97 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.543 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.688 ' HB3' ' CG2' ' A' ' 118' ' ' THR . . . -92.08 100.18 12.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.854 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.07 107.65 0.57 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.038 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 54.45 77.67 0.14 Allowed Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.607 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.739 HD21 ' CB ' ' A' ' 107' ' ' ALA . 6.0 tp -138.72 -34.51 0.61 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 47.66 79.67 0.06 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.577 0.703 . . . . 0.0 110.782 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.812 HD21 HG21 ' A' ' 145' ' ' VAL . 1.2 tp -47.35 139.77 6.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.011 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.9 m -128.43 141.38 41.27 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.607 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.651 ' CG ' HD13 ' A' ' 122' ' ' LEU . 75.6 Cg_exo -51.2 127.61 22.57 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.99 2.46 . . . . 0.0 112.857 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.17 34.76 85.57 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.535 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 145.9 50.95 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.049 0.452 . . . . 0.0 111.298 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.9 m -71.13 144.08 50.36 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.889 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.739 ' CB ' HD21 ' A' ' 99' ' ' LEU . . . -127.97 150.28 49.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.523 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.19 139.01 32.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.035 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.632 HD22 ' CE2' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -114.72 96.99 6.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.399 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -73.45 0.28 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.324 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.38 -177.72 5.78 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.719 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.18 141.02 12.32 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.598 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.59 -90.04 0.21 Allowed Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.485 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -126.51 90.88 3.25 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.879 0.371 . . . . 0.0 110.721 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -136.67 -139.59 3.97 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.047 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -111.05 124.16 51.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.696 0.284 . . . . 0.0 110.849 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.69 151.11 48.05 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.688 ' CG2' ' HB3' ' A' ' 96' ' ' ALA . 40.2 p -93.95 114.33 26.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.057 0.456 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.13 126.35 40.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.646 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.449 HG23 ' HD3' ' A' ' 103' ' ' PRO . 9.9 p -117.21 124.96 73.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.958 0.408 . . . . 0.0 110.984 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.2 m -94.06 94.78 8.6 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.75 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.651 HD13 ' CG ' ' A' ' 103' ' ' PRO . 13.7 tp -130.8 100.69 17.38 Favored Pre-proline 0 N--CA 1.456 -0.169 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.254 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.67 ' O ' ' HB1' ' A' ' 78' ' ' ALA . 10.6 Cg_exo -71.44 8.91 1.04 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.371 2.714 . . . . 0.0 113.499 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -114.29 141.76 47.18 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.72 0.295 . . . . 0.0 110.923 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -100.41 140.04 35.23 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 170.38 -175.35 44.31 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.113 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -77.96 139.95 39.2 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 110.879 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.64 ' HE1' HG22 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -126.37 147.05 49.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.04 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.3 m -123.53 122.17 64.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.941 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -90.09 115.56 27.44 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.42 ' C ' HD12 ' A' ' 132' ' ' LEU . 5.2 t -109.11 126.16 52.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.531 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 132' ' ' LEU . 3.4 mp -140.84 136.32 32.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.81 ' HG2' HG22 ' A' ' 69' ' ' THR . 0.0 OUTLIER -133.0 120.12 20.96 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.906 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.632 ' CE2' HD22 ' A' ' 109' ' ' LEU . 3.2 m-85 -126.43 145.06 50.62 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.366 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 81.1 p -113.42 176.55 4.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.427 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -87.03 -18.91 29.48 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.747 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.8 m -65.87 -26.91 67.85 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.64 -17.47 54.48 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.385 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.465 ' CB ' ' HD3' ' A' ' 140' ' ' PRO . 0.5 OUTLIER -92.63 -54.52 0.25 Allowed Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 117.004 0.402 . . . . 0.0 110.976 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.465 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 13.5 Cg_exo -68.22 75.97 0.7 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.59 2.193 . . . . 0.0 112.122 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -130.67 103.46 6.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.631 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.18 152.91 41.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.65 HG13 ' HB3' ' A' ' 107' ' ' ALA . 5.2 pt -124.16 162.44 25.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.322 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -142.58 156.87 45.15 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.924 0.392 . . . . 0.0 111.013 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.812 HG21 HD21 ' A' ' 101' ' ' LEU . 13.4 p -135.9 134.25 50.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.2 m -145.01 153.02 41.05 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.97 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.557 ' HE3' HD11 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -111.71 155.76 22.96 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.368 -179.773 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 14.1 m -87.33 109.19 23.71 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.334 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 C--O 1.249 1.072 0 C-N-CA 122.893 2.395 . . . . 0.0 112.825 -179.635 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.398 0.142 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -51.77 96.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.977 2.451 . . . . 0.0 112.663 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.48 -51.04 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.8 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.42 85.98 2.5 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.392 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.23 104.17 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.507 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.29 43.6 2.52 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.631 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.21 149.68 48.88 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.726 0.298 . . . . 0.0 110.73 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.6 m -110.31 86.71 2.36 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.006 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.66 120.36 27.02 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.837 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.47 152.06 21.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.411 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.32 118.48 20.55 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.207 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 t -91.76 123.98 35.56 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.104 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 15' ' ' ALA . 21.6 t 67.97 131.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.585 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.9 p -79.9 -28.36 39.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.206 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' H ' HG12 ' A' ' 13' ' ' VAL . . . 65.82 91.31 0.08 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.012 0.434 . . . . 0.0 111.423 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -168.44 135.68 2.04 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.11 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.1 p -102.32 98.04 8.22 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.513 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.3 m -121.81 128.71 51.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.271 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 19' ' ' LEU . 3.4 mm? -92.23 -30.1 16.08 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.104 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 tt -73.56 137.32 23.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.704 0.287 . . . . 0.0 111.299 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -128.98 142.69 13.78 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.527 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -143.81 138.61 28.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.752 0.31 . . . . 0.0 111.218 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.17 33.48 5.58 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.857 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -63.91 -34.97 79.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.702 0.287 . . . . 0.0 111.025 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 15.4 mtm -62.65 -26.15 68.49 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.237 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.88 -16.79 64.25 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -85.97 11.64 11.07 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.564 ' O ' HG11 ' A' ' 129' ' ' VAL . 31.9 m 64.82 22.45 12.53 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.676 0.274 . . . . 0.0 111.367 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.44 91.56 5.87 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.88 0.371 . . . . 0.0 110.36 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -88.94 113.35 55.67 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.011 -179.526 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 30' ' ' ASN . 1.8 Cg_endo -82.78 99.41 0.92 Allowed 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.323 2.015 . . . . 0.0 111.508 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.474 ' O ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -116.98 97.19 5.81 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.467 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -135.88 102.16 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.32 0.581 . . . . 0.0 111.886 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 67' ' ' GLU . 20.7 mt-10 -146.77 106.65 3.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.683 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.77 -144.92 16.01 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.052 -1.07 . . . . 0.0 112.232 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -137.84 107.33 6.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.72 0.295 . . . . 0.0 111.016 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.71 -165.16 8.4 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.214 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.34 107.37 2.43 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.511 2.141 . . . . 0.0 112.315 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.508 HG12 ' CE2' ' A' ' 64' ' ' TYR . 18.6 mt -90.14 153.88 3.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.442 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.474 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 59.62 19.4 48.45 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.067 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -130.62 131.54 44.99 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.887 0.375 . . . . 0.0 111.465 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.4 ' HB ' ' CD2' ' A' ' 62' ' ' TYR . 4.5 t -116.01 141.06 48.62 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.95 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.45 HD12 ' CD1' ' A' ' 70' ' ' TYR . 63.2 mt -100.33 146.39 27.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.643 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -125.16 118.96 27.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.041 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.443 ' HB ' ' CE1' ' A' ' 85' ' ' TYR . 12.1 p -110.64 131.3 62.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.338 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.4 m -143.51 -179.2 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.362 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 83' ' ' MET . . . 150.32 -101.79 0.22 Allowed Glycine 0 N--CA 1.453 -0.205 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 6.4 p-10 -171.54 117.17 0.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 111.06 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 83' ' ' MET . 1.1 m-85 -126.29 44.17 2.93 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.318 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 49' ' ' PHE . . . 72.97 -68.34 0.23 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -178.28 50.56 0.01 OUTLIER 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.165 0.507 . . . . 0.0 110.269 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.22 30.86 0.54 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.779 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.514 ' HG ' ' HD1' ' A' ' 49' ' ' PHE . 82.8 p -142.15 -142.33 0.14 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.948 -0.115 . . . . 0.0 110.795 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 10.3 m0 53.12 34.15 16.68 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -136.47 125.44 24.29 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.005 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.76 75.58 1.48 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.973 0.416 . . . . 0.0 110.89 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -71.58 162.3 73.75 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.073 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.52 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 21.0 Cg_endo -60.67 -33.15 93.66 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.725 2.283 . . . . 0.0 112.651 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -59.92 -27.38 66.71 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.384 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -129.77 21.94 5.45 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.798 0.332 . . . . 0.0 110.726 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . . . -58.42 -39.89 81.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.449 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.401 ' HB2' ' HE2' ' A' ' 70' ' ' TYR . 13.0 p90 -171.58 140.45 1.36 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.53 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -111.51 120.34 41.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.215 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.508 ' CE2' HG12 ' A' ' 39' ' ' ILE . 23.6 t80 -73.89 118.13 16.49 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.875 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -134.41 113.19 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.482 -0.781 . . . . 0.0 108.978 178.081 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -41.76 166.67 0.01 OUTLIER Glycine 0 C--N 1.338 0.65 0 N-CA-C 114.921 0.729 . . . . 0.0 114.921 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 76.88 26.93 0.75 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.836 0.454 . . . . 0.0 112.073 178.713 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 61.95 19.79 11.01 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.666 0.27 . . . . 0.0 111.384 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.687 ' O ' HG23 ' A' ' 65' ' ' VAL . 21.7 p -92.02 150.91 20.72 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.515 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.45 ' CD1' HD12 ' A' ' 43' ' ' LEU . 9.9 t80 -128.17 134.09 49.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.518 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 130' ' ' TRP . 0.7 OUTLIER -132.85 137.46 46.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.786 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.44 132.04 14.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.419 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.84 131.0 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.6 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.85 142.23 44.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 111.855 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -95.74 124.39 39.74 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.598 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.543 ' HG3' ' CD2' ' A' ' 128' ' ' TYR . 1.7 mm-40 -116.94 163.32 16.39 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.964 0.411 . . . . 0.0 111.815 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -117.92 167.44 11.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.061 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.9 115.52 7.52 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.181 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 122' ' ' LEU . . . 129.43 147.79 6.39 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.321 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.93 137.34 58.23 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.767 0.318 . . . . 0.0 111.329 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.431 ' CE2' ' CG1' ' A' ' 120' ' ' VAL . 4.1 p90 -140.97 146.51 37.42 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.509 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.0 139.63 43.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.588 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.554 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -153.51 176.08 12.45 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.018 0.437 . . . . 0.0 111.948 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.46 142.09 13.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.46 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.508 ' O ' ' HB2' ' A' ' 93' ' ' GLN . 0.1 OUTLIER -97.68 143.14 28.64 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.717 0.294 . . . . 0.0 110.996 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.481 ' HA ' ' HB3' ' A' ' 93' ' ' GLN . . . -162.35 124.54 2.78 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.356 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.449 ' HB3' ' H ' ' A' ' 91' ' ' SER . 0.2 OUTLIER -71.86 179.15 3.3 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.963 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -84.54 -48.01 10.0 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.212 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -94.09 46.48 1.17 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.328 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 45.66 41.17 6.91 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.558 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.501 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.4 OUTLIER -86.41 170.21 13.15 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.83 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' A' ' 91' ' ' SER . 2.3 Cg_endo -41.45 117.82 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.344 2.696 . . . . 0.0 112.598 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.508 ' HB2' ' O ' ' A' ' 85' ' ' TYR . 3.2 pt20 -124.74 -175.51 3.3 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.53 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.604 ' HA ' HD11 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -123.4 133.65 54.06 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.981 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.447 HG21 ' HA2' ' A' ' 112' ' ' GLY . 0.3 OUTLIER -163.08 112.58 1.34 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.45 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.01 112.76 25.52 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.311 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -78.52 122.84 26.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.375 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.43 49.75 8.32 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.734 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.608 HD13 ' C ' ' A' ' 99' ' ' LEU . 3.0 tm? -108.02 -53.86 2.57 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.425 ' C ' HD13 ' A' ' 99' ' ' LEU . 0.3 OUTLIER 61.76 82.03 0.18 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.388 0.613 . . . . 0.0 109.63 -178.709 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.5 HD12 ' HB2' ' A' ' 107' ' ' ALA . 9.6 tt -69.12 147.34 51.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.134 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.564 HG23 ' HD2' ' A' ' 103' ' ' PRO . 95.1 m -117.32 144.54 34.1 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.847 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.564 ' HD2' HG23 ' A' ' 102' ' ' THR . 78.2 Cg_exo -40.76 110.7 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.727 2.284 . . . . 0.0 112.935 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.78 34.77 23.9 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.504 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.17 155.81 46.38 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.056 0.455 . . . . 0.0 111.202 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.671 HG23 ' HB3' ' A' ' 144' ' ' MET . 1.5 m -91.31 145.07 24.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.454 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.5 ' HB2' HD12 ' A' ' 101' ' ' LEU . . . -124.1 146.68 48.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.492 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.2 m -68.86 145.14 53.96 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.095 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.674 HD22 ' HG2' ' A' ' 141' ' ' GLU . 2.4 tt -129.95 133.19 46.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.805 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.2 -65.7 0.85 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.261 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -172.01 142.89 1.5 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.762 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.447 ' HA2' HG21 ' A' ' 95' ' ' THR . . . -72.01 -119.46 0.06 OUTLIER Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.126 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 58.7 45.5 94.69 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.207 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 62.09 87.03 0.1 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.85 0.357 . . . . 0.0 111.252 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -115.35 -139.79 6.92 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.264 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.85 122.88 33.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.585 0.231 . . . . 0.0 110.56 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.76 122.76 18.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.839 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -76.87 114.31 15.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.613 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.88 123.51 38.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.991 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.431 ' CG1' ' CE2' ' A' ' 81' ' ' PHE . 10.2 p -117.27 131.96 68.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.3 m -80.97 112.37 18.3 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.231 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.644 HD21 ' HE2' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -125.92 108.17 25.22 Favored Pre-proline 0 CA--C 1.529 0.164 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.301 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -84.72 8.35 4.68 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.641 2.227 . . . . 0.0 113.31 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.436 ' O ' HD12 ' A' ' 122' ' ' LEU . 16.3 tt0 -166.68 150.59 7.15 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.988 0.423 . . . . 0.0 111.504 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.87 142.25 40.26 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.998 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -178.13 163.8 32.18 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.871 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -65.3 137.57 57.62 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.748 0.309 . . . . 0.0 111.084 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.644 ' HE2' HD21 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -125.33 149.9 47.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.005 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.564 HG11 ' O ' ' A' ' 28' ' ' CYS . 26.4 m -124.61 127.76 73.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.34 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.628 ' CE2' HG11 ' A' ' 145' ' ' VAL . 0.9 OUTLIER -103.34 113.52 27.07 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.74 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.446 ' C ' HD13 ' A' ' 132' ' ' LEU . 78.6 p -134.97 126.25 28.22 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.147 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.617 ' N ' HD13 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -148.48 149.01 30.91 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.118 0.485 . . . . 0.0 111.244 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.494 ' HG3' HG22 ' A' ' 69' ' ' THR . 12.3 tttm -109.81 134.7 51.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.817 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.443 ' HE1' HD13 ' A' ' 109' ' ' LEU . 22.8 m-85 -114.72 144.83 42.84 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.379 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.49 HG21 ' N ' ' A' ' 139' ' ' ASP . 9.9 t -82.38 163.8 21.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.8 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -91.48 -43.06 9.92 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.203 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 p -68.77 -26.85 65.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.765 0.317 . . . . 0.0 111.524 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.21 30.58 7.31 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.223 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.554 ' CB ' ' HD3' ' A' ' 140' ' ' PRO . 0.6 OUTLIER -111.31 -73.95 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 117.036 0.418 . . . . 0.0 111.654 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 82.1 Cg_endo -78.19 124.6 6.69 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.424 2.083 . . . . 0.0 113.507 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.674 ' HG2' HD22 ' A' ' 109' ' ' LEU . 1.1 tt0 -142.72 113.17 7.29 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.817 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.61 150.0 44.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.503 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.535 HG21 HD12 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -146.86 136.64 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.874 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.671 ' HB3' HG23 ' A' ' 106' ' ' THR . 4.1 ppp? -145.27 150.98 37.63 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.86 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.628 HG11 ' CE2' ' A' ' 130' ' ' TRP . 35.1 m -136.61 146.0 29.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 120.756 0.312 . . . . 0.0 111.378 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 52.1 p -133.37 155.41 49.52 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.31 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.47 ' HB3' ' CE2' ' A' ' 128' ' ' TYR . 9.6 pttp -109.77 153.66 24.04 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.044 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 60.9 m -84.06 148.28 53.16 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.876 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 122.614 2.209 . . . . 0.0 112.415 -179.74 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.642 0.258 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.35 115.29 3.96 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.749 2.3 . . . . 0.0 112.576 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.51 167.81 11.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 60.11 74.92 0.43 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.437 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 t 63.88 95.35 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.381 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.79 -56.64 0.11 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.971 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 8' ' ' THR . 6.6 tt 69.58 -73.52 0.09 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.353 0.261 . . . . 0.0 110.769 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.561 ' O ' HD23 ' A' ' 7' ' ' LEU . 10.9 t 47.27 -173.06 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.85 119.15 35.6 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-O 120.798 0.333 . . . . 0.0 111.476 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 m -142.35 38.05 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.6 137.01 57.07 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.328 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.51 HG22 HG23 ' A' ' 13' ' ' VAL . 4.0 m -95.46 132.98 39.96 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.51 HG23 HG22 ' A' ' 12' ' ' THR . 25.8 t 63.85 90.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.198 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.3 p -109.47 149.59 29.36 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.173 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.37 124.25 47.61 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.144 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.55 114.17 10.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.004 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 p -116.52 137.16 52.39 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.04 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.2 m -164.94 91.15 0.54 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.995 0.426 . . . . 0.0 111.18 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mp -110.82 -19.48 12.81 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.662 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.615 ' H ' HD13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -120.23 141.33 41.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.726 0.298 . . . . 0.0 111.089 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.7 143.69 14.85 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.786 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.35 148.41 45.09 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.008 0.432 . . . . 0.0 111.084 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.26 34.05 3.71 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.707 -0.679 . . . . 0.0 113.111 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -68.07 -41.35 82.07 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.732 0.266 . . . . 0.0 110.832 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -63.09 -29.91 71.18 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.004 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.96 9.46 27.72 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.768 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.04 14.45 26.36 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.427 0.156 . . . . 0.0 111.417 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.473 ' HA ' HG21 ' A' ' 129' ' ' VAL . 3.8 m 59.3 55.92 4.05 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.565 0.222 . . . . 0.0 111.137 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -158.56 31.1 0.23 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -78.85 113.13 32.72 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.894 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -90.84 99.99 0.25 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.926 2.417 . . . . 0.0 113.03 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.512 ' O ' HG12 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -117.64 96.72 5.51 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.872 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -132.91 102.38 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.423 0.63 . . . . 0.0 112.322 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -147.1 106.42 3.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.292 177.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.39 -140.99 15.55 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.013 -1.089 . . . . 0.0 112.785 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.505 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 0.6 OUTLIER 59.04 -86.44 0.02 OUTLIER 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.224 0.61 . . . . 0.0 110.977 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.14 -69.54 0.21 Allowed Glycine 0 CA--C 1.521 0.428 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.894 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.85 89.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.122 2.548 . . . . 0.0 113.486 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.899 HG23 ' CE1' ' A' ' 64' ' ' TYR . 1.3 mp -69.7 153.33 8.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.781 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.16 39.34 27.41 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.704 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.83 132.28 35.17 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.67 0.272 . . . . 0.0 110.75 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.0 m -114.91 147.92 39.33 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.606 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.74 HD11 ' HD2' ' A' ' 70' ' ' TYR . 15.5 mt -136.21 170.6 15.76 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.696 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -125.19 118.81 26.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.906 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.473 ' HB ' ' CZ ' ' A' ' 85' ' ' TYR . 13.7 p -111.36 134.77 52.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.0 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.466 ' HB ' ' CD1' ' A' ' 54' ' ' TRP . 32.5 m -131.82 128.03 59.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.292 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 54' ' ' TRP . . . -101.49 173.37 23.87 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.243 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -160.86 89.17 0.79 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.235 0.54 . . . . 0.0 111.09 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 165.14 -82.15 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.043 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.918 ' HB1' ' HG2' ' A' ' 77' ' ' LYS . . . -89.11 -43.25 11.19 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -118.8 68.47 0.79 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.719 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.82 -7.52 59.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.886 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.1 m -50.81 -24.91 3.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.037 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.466 ' CD1' ' HB ' ' A' ' 46' ' ' VAL . 16.2 m0 65.83 62.35 0.63 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.899 0.381 . . . . 0.0 110.97 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -95.62 123.67 39.28 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.078 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -117.59 63.37 0.74 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.699 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 142.89 94.08 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.882 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.42 -51.69 1.85 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.419 2.079 . . . . 0.0 112.118 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -10.33 33.74 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 73' ' ' VAL . 5.2 mmt85 -94.21 -23.12 18.02 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.383 0.135 . . . . 0.0 110.955 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.51 64.73 1.45 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.75 0.31 . . . . 0.0 111.531 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -138.53 21.33 2.73 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.913 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 mmm-85 -106.05 114.44 28.59 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.821 0.343 . . . . 0.0 111.295 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.899 ' CE1' HG23 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -101.28 120.04 39.66 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.041 179.018 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -111.55 122.29 65.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.0 0.429 . . . . 0.0 110.349 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' A' ' 36' ' ' ASP . . . -51.77 169.58 0.48 Allowed Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.901 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER 78.69 30.89 0.35 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.644 0.377 . . . . 0.0 111.234 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 62.27 21.06 12.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.461 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.801 HG22 ' HA ' ' A' ' 133' ' ' LYS . 60.2 p -95.91 155.06 16.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.752 0.311 . . . . 0.0 110.75 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.74 ' HD2' HD11 ' A' ' 43' ' ' LEU . 6.8 m-85 -127.74 133.6 49.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.392 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.46 129.5 43.04 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.084 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.5 131.4 14.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.473 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.462 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 29.4 t -82.55 125.3 39.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.403 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.2 t -125.97 140.21 49.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.772 0.32 . . . . 0.0 111.082 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -115.83 124.26 50.25 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.37 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -137.67 166.29 24.3 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.092 0.472 . . . . 0.0 111.673 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.918 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -85.96 173.42 9.95 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.412 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.52 133.41 52.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.813 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.82 147.22 7.54 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.52 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.0 136.68 57.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.679 0.276 . . . . 0.0 110.738 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.558 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 7.3 p90 -142.19 147.07 35.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.587 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.733 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 2.8 mtt85 -103.29 131.62 50.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.498 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.462 ' CE ' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -136.21 164.96 26.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.029 0.442 . . . . 0.0 111.748 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -142.12 152.67 43.47 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.806 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.473 ' CZ ' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -117.8 142.01 47.78 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.345 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.401 ' HA ' ' HG2' ' A' ' 93' ' ' GLN . . . -161.54 134.35 6.13 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.115 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 91' ' ' SER . 0.4 OUTLIER -82.4 153.78 25.54 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.126 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -66.71 -30.15 70.31 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.504 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -95.72 30.09 2.45 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.352 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 10.9 m0 53.39 41.24 32.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 111.382 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.461 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.4 OUTLIER -86.05 169.58 15.12 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.388 179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 91' ' ' SER . 3.3 Cg_exo -40.11 126.6 1.95 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.185 2.59 . . . . 0.0 112.56 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.401 ' HG2' ' HA ' ' A' ' 86' ' ' ALA . 1.5 mt-30 -104.77 -178.03 3.54 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.504 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -128.53 122.94 32.27 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.656 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.78 129.3 11.43 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.86 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.04 108.17 19.16 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.6 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.11 95.03 0.08 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.624 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 53.88 82.45 0.05 OUTLIER Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.148 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.654 HD12 HD12 ' A' ' 101' ' ' LEU . 3.2 tm? -129.4 -77.94 0.55 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.806 0.303 . . . . 0.0 111.451 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 119' ' ' ALA . 34.9 mt-10 64.41 113.17 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.116 0.26 . . . . 0.0 110.969 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.836 HD21 HG12 ' A' ' 145' ' ' VAL . 0.0 OUTLIER -144.35 149.71 36.61 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.613 HG23 ' HD2' ' A' ' 103' ' ' PRO . 97.6 m -77.5 145.95 72.68 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.806 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.725 ' HD3' HG12 ' A' ' 120' ' ' VAL . 97.5 Cg_exo -43.56 130.39 7.08 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.678 2.252 . . . . 0.0 112.443 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.39 26.2 33.98 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.043 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.564 ' HB3' HD23 ' A' ' 101' ' ' LEU . 12.0 tttm -132.06 151.96 51.46 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.026 0.441 . . . . 0.0 111.119 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.7 m -77.98 145.58 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.49 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.82 132.99 46.68 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.246 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 m -69.19 127.92 34.8 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.68 HD13 HG12 ' A' ' 143' ' ' ILE . 16.1 tp -107.74 138.65 43.59 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.644 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.9 -61.18 1.77 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -167.8 -175.85 2.88 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.995 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -123.82 113.75 2.15 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.464 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -174.67 -108.49 0.22 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.515 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -127.38 48.46 2.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.923 0.392 . . . . 0.0 110.998 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.22 -135.2 5.47 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.466 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -100.4 136.78 39.76 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.667 0.27 . . . . 0.0 110.907 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.36 131.05 41.43 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.9 m -76.1 141.37 41.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.707 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.733 ' HB2' ' CG ' ' A' ' 82' ' ' ARG . . . -125.04 143.69 50.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.053 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.725 HG12 ' HD3' ' A' ' 103' ' ' PRO . 15.7 t -116.74 124.77 73.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.404 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.4 m -74.95 93.21 2.66 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.686 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.558 HD13 ' CZ ' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -105.74 113.16 64.25 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.94 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.64 8.28 4.71 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.695 2.263 . . . . 0.0 112.609 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -166.99 151.03 6.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.779 0.324 . . . . 0.0 110.948 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.29 136.02 49.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.854 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -178.69 169.76 41.4 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.161 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -85.31 132.24 34.28 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 111.199 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -134.75 148.68 50.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.66 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 28' ' ' CYS . 3.5 m -114.8 130.92 68.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.89 0.376 . . . . 0.0 111.459 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.41 ' CZ3' ' HB ' ' A' ' 145' ' ' VAL . 0.7 OUTLIER -88.92 115.54 26.55 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.559 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 28.1 t -114.58 134.85 54.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.152 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.609 ' HA ' HG22 ' A' ' 143' ' ' ILE . 4.0 mp -134.09 135.1 43.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.807 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.801 ' HA ' HG22 ' A' ' 69' ' ' THR . 6.8 tttm -148.8 121.83 8.83 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.909 0.385 . . . . 0.0 111.973 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -141.32 145.79 35.89 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.891 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.0 p -75.71 169.25 18.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.083 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.25 -1.82 50.55 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.801 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.65 -27.1 68.13 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.383 0.142 . . . . 0.0 111.383 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.57 -16.89 58.35 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.049 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.508 ' CB ' ' HD3' ' A' ' 140' ' ' PRO . 0.2 OUTLIER -102.01 -58.64 0.1 Allowed Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 117.005 0.403 . . . . 0.0 111.567 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 47.5 Cg_exo -57.81 94.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.562 2.175 . . . . 0.0 112.598 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -130.76 104.69 7.32 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.575 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.49 138.39 47.54 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.749 0.309 . . . . 0.0 111.268 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.68 HG12 HD13 ' A' ' 109' ' ' LEU . 1.7 pp -137.86 141.83 37.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -139.82 156.26 46.83 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.03 0.443 . . . . 0.0 111.47 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.836 HG12 HD21 ' A' ' 101' ' ' LEU . 10.8 p -122.73 139.79 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.666 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 67.7 m -129.03 135.48 49.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.129 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -112.88 135.76 53.28 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.771 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 2.1 p -117.73 109.35 41.63 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.787 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--O 1.251 1.143 0 C-N-CA 122.539 2.159 . . . . 0.0 112.55 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.548 0.213 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.04 165.02 33.04 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.808 2.338 . . . . 0.0 112.416 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 t -116.15 123.34 47.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.62 135.59 51.67 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 p -127.21 37.61 4.23 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.972 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.51 28.62 69.92 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.841 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.16 82.23 1.13 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.927 0.394 . . . . 0.0 110.588 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.6 p -129.06 -65.55 0.86 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.783 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -115.78 109.78 18.16 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.614 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.7 t -148.63 -65.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.4 115.37 20.71 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.117 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.7 m -92.62 122.12 34.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.713 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.9 m -124.86 122.53 63.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.172 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -152.65 118.65 5.46 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.963 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.19 96.38 5.77 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.003 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.46 97.56 1.62 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.216 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.7 p -146.99 131.62 17.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.154 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.75 123.58 37.77 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.985 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.6 tp 61.47 89.87 0.07 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.956 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.623 ' H ' HD13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -135.22 139.81 46.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.367 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.36 144.22 15.97 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.6 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.41 138.96 44.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.639 0.257 . . . . 0.0 110.905 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.91 152.68 20.61 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.061 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -65.42 -39.25 91.91 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.486 0.184 . . . . 0.0 111.247 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -26.41 68.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.121 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.88 -11.82 59.43 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.13 -30.42 39.04 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.529 0.204 . . . . 0.0 110.725 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.496 ' O ' HG11 ' A' ' 129' ' ' VAL . 35.2 t -63.03 -37.46 87.29 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.691 0.282 . . . . 0.0 110.306 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -145.11 103.18 3.84 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.541 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -71.0 137.56 84.9 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.556 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -53.48 117.03 3.38 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.683 2.255 . . . . 0.0 112.126 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.928 HG22 ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -108.12 97.6 7.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.342 0.592 . . . . 0.0 111.119 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 tt -92.83 160.51 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.271 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -64.11 107.26 1.23 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.772 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.658 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -107.46 -119.49 4.43 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.894 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -113.44 29.53 7.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.648 0.261 . . . . 0.0 110.805 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.11 117.39 10.7 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.312 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.4 112.65 1.11 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.742 2.295 . . . . 0.0 112.246 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.499 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.7 mp -70.24 153.63 8.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.98 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.95 22.82 76.2 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.485 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.493 ' HA ' ' HG2' ' A' ' 88' ' ' LYS . 1.7 mttp -127.94 132.23 49.27 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.855 0.359 . . . . 0.0 111.296 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.412 HG23 ' CD2' ' A' ' 62' ' ' TYR . 20.9 m -115.32 140.18 49.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.718 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.6 123.19 47.5 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.416 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.464 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -93.99 130.82 39.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.908 0.385 . . . . 0.0 111.162 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.777 HG12 ' CE2' ' A' ' 85' ' ' TYR . 8.0 m -112.34 132.83 59.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.307 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 84' ' ' GLN . 8.1 t -137.76 161.06 33.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.869 0.366 . . . . 0.0 110.76 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.43 ' N ' HG12 ' A' ' 46' ' ' VAL . . . -125.34 -159.07 10.2 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.916 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER 172.19 135.66 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.05 0.453 . . . . 0.0 111.259 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 48' ' ' ASP . 1.8 m-85 72.16 130.24 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.549 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 63.53 10.2 4.75 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.535 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 t0 40.25 64.85 0.84 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.935 0.398 . . . . 0.0 111.192 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.88 -37.73 12.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.658 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.428 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 13.4 t -122.99 -101.42 0.4 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.224 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 15.8 m95 49.35 30.99 3.52 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.873 0.368 . . . . 0.0 110.949 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -132.81 117.07 17.32 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.367 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.464 ' HG3' ' CE1' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -114.29 103.79 11.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.887 -179.306 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -98.28 116.23 65.58 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.923 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.95 -33.48 72.53 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.846 2.364 . . . . 0.0 112.871 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -59.35 -27.68 66.16 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.444 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.426 ' HD3' ' HB ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -130.62 20.65 5.12 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.151 179.709 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.45 -30.62 71.71 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.366 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.488 ' HB2' ' CE2' ' A' ' 70' ' ' TYR . 2.3 p90 -151.76 120.91 6.72 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.833 0.349 . . . . 0.0 111.311 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.45 120.41 38.05 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.187 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -62.44 118.36 7.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.317 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.928 ' HA ' HG22 ' A' ' 32' ' ' THR . 3.4 t -105.09 122.7 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.658 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -66.4 76.11 0.13 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.411 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' CG ' ' O ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER 167.83 29.24 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 O-C-N 123.849 0.382 . . . . 0.0 111.965 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 t30 61.91 24.95 14.93 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.891 0.376 . . . . 0.0 110.529 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.772 HG22 ' HA ' ' A' ' 133' ' ' LYS . 0.7 OUTLIER -113.75 156.02 24.57 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.398 -179.18 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.488 ' CE2' ' HB2' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -127.43 133.91 49.92 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.088 179.166 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -143.25 157.7 44.27 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 111.828 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.5 132.13 14.88 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.209 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.426 ' HB ' ' HD3' ' A' ' 60' ' ' ARG . 15.0 t -74.63 127.08 36.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.555 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.9 t -130.52 143.88 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.083 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -101.88 136.83 41.04 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.174 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -131.22 166.6 20.8 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.036 0.446 . . . . 0.0 112.05 -179.339 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -99.8 171.39 7.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.357 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.09 120.57 21.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.406 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 122' ' ' LEU . . . 129.61 152.79 7.67 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.505 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.36 126.14 27.28 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.754 0.311 . . . . 0.0 111.494 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 9.5 p90 -141.27 152.8 44.82 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.068 0.461 . . . . 0.0 111.497 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.851 ' HG3' ' HB2' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -103.59 149.55 24.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.794 178.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.7 137.86 37.19 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.504 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.493 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -111.97 148.33 34.0 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.415 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.777 ' CE2' HG12 ' A' ' 45' ' ' VAL . 6.2 m-85 -128.07 159.77 34.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.394 0.616 . . . . 0.0 112.3 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.514 ' CB ' ' HA ' ' A' ' 92' ' ' PRO . . . -121.27 153.62 37.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.069 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.52 173.6 6.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.051 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.493 ' HG2' ' HA ' ' A' ' 41' ' ' LYS . 39.1 tptt -76.92 -9.58 58.79 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.79 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.04 31.91 0.77 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.724 0.297 . . . . 0.0 111.051 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 10.6 m0 60.32 17.35 7.01 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.1 t -97.6 117.56 65.22 Favored Pre-proline 0 C--O 1.231 0.086 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.514 ' HA ' ' CB ' ' A' ' 86' ' ' ALA . 57.3 Cg_endo -97.75 61.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.158 2.572 . . . . 0.0 113.429 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -157.78 124.44 4.91 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.648 ' CG ' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -141.71 126.15 17.71 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.544 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 94' ' ' PHE . 11.6 p -157.2 164.13 38.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.921 0.391 . . . . 0.0 111.666 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 108' ' ' SER . . . -133.24 97.54 4.01 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.679 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.02 110.4 0.39 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.379 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.01 78.06 0.14 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.215 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.811 HD21 ' HB1' ' A' ' 107' ' ' ALA . 19.1 tp -135.62 -66.96 0.55 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 69.94 83.44 0.15 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.324 0.583 . . . . 0.0 110.003 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.714 HD11 HG21 ' A' ' 145' ' ' VAL . 1.5 tt -60.41 144.96 49.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.421 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.808 HG22 ' HD2' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -135.5 151.2 74.18 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.979 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.808 ' HD2' HG22 ' A' ' 102' ' ' THR . 69.9 Cg_exo -52.07 118.63 4.73 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.799 2.333 . . . . 0.0 112.451 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.84 34.47 65.93 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.415 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.82 144.58 51.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.841 0.353 . . . . 0.0 111.111 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.498 HG22 ' HG2' ' A' ' 144' ' ' MET . 71.8 p -72.63 143.04 48.32 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.112 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.811 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -119.65 137.18 54.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.3 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -72.95 138.12 45.93 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.859 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.947 ' HG ' HD11 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -116.69 101.71 8.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.661 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.78 -70.62 0.54 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -179.55 -64.82 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.979 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 149.62 -131.67 3.74 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.303 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.89 48.4 66.6 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.516 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 59.74 65.82 1.08 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.89 0.376 . . . . 0.0 111.091 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.2 -137.12 9.12 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.216 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -102.92 113.41 26.83 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.822 0.311 . . . . 0.0 111.079 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -64.64 145.27 56.42 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.154 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.579 ' CG2' HD23 ' A' ' 99' ' ' LEU . 0.7 OUTLIER -86.65 119.55 27.02 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.351 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.851 ' HB2' ' HG3' ' A' ' 82' ' ' ARG . . . -110.34 138.32 46.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.66 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.512 ' HB ' HD23 ' A' ' 101' ' ' LEU . 14.7 p -116.54 126.07 73.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 120.898 0.38 . . . . 0.0 110.998 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.5 m -80.47 95.42 6.45 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.032 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 122' ' ' LEU . 10.0 mt -124.91 114.04 26.66 Favored Pre-proline 0 C--O 1.225 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.437 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.92 8.9 4.19 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.87 2.38 . . . . 0.0 113.292 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -155.02 151.81 28.88 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.016 0.436 . . . . 0.0 111.376 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.11 143.38 28.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.419 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -178.11 172.26 44.77 Favored Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.611 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -66.67 139.24 57.84 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.784 0.326 . . . . 0.0 111.076 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.88 142.39 50.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.055 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.496 HG11 ' O ' ' A' ' 28' ' ' CYS . 12.5 m -116.2 121.18 66.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 120.957 0.408 . . . . 0.0 110.639 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -98.51 117.04 32.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.536 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.677 ' C ' HD12 ' A' ' 132' ' ' LEU . 18.1 t -126.41 142.55 51.49 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.186 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.716 ' HG ' HG23 ' A' ' 143' ' ' ILE . 10.3 mp -133.86 142.76 47.94 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.758 0.313 . . . . 0.0 111.021 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.772 ' HA ' HG22 ' A' ' 69' ' ' THR . 0.0 OUTLIER -111.82 120.23 41.25 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.11 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.4 ' HE2' HD13 ' A' ' 109' ' ' LEU . 67.4 m-85 -114.12 144.96 42.29 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.795 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.891 HG21 ' HD2' ' A' ' 140' ' ' PRO . 9.4 t -86.86 -178.57 6.35 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.123 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -92.41 -41.05 10.54 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.333 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 p -66.41 -22.84 66.24 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.685 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.751 ' H ' HG23 ' A' ' 135' ' ' THR . . . 86.4 17.0 61.28 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.039 -0.6 . . . . 0.0 113.01 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.535 ' CB ' ' CD ' ' A' ' 140' ' ' PRO . 0.5 OUTLIER -102.97 -73.32 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.999 0.4 . . . . 0.0 111.033 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.891 ' HD2' HG21 ' A' ' 135' ' ' THR . 54.3 Cg_endo -69.12 127.47 15.15 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.304 2.003 . . . . 0.0 112.509 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 109' ' ' LEU . 6.7 mm-40 -138.99 116.97 11.64 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.139 0.495 . . . . 0.0 110.618 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.88 158.01 31.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.988 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.947 HD11 ' HG ' ' A' ' 109' ' ' LEU . 2.7 mt -123.47 153.42 29.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.171 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.498 ' HG2' HG22 ' A' ' 106' ' ' THR . 0.0 OUTLIER -137.81 116.84 12.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.611 179.394 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.714 HG21 HD11 ' A' ' 101' ' ' LEU . 30.1 m -122.88 148.68 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.818 0.342 . . . . 0.0 111.406 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 60.1 p -154.11 157.79 39.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.906 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.24 147.24 41.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.76 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 49.1 m -70.34 138.52 86.68 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.886 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.658 2.239 . . . . 0.0 112.814 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 120.475 0.178 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.82 -33.9 42.79 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.523 2.149 . . . . 0.0 112.395 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.3 m -141.66 131.55 24.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.942 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.4 149.34 20.6 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.637 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 m -143.35 110.93 5.87 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.084 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.26 -145.05 11.11 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.73 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.63 34.27 22.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.751 0.31 . . . . 0.0 111.211 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.9 p -128.68 107.37 9.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.03 112.27 4.92 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.276 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.79 161.51 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.496 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.48 115.35 4.16 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.321 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.9 m -101.05 131.03 47.14 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.3 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.3 m -145.85 132.71 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.179 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.8 78.13 1.52 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.296 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 68.2 115.13 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.69 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -116.32 122.3 44.49 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.319 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.59 137.31 42.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.577 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.4 m -128.12 118.17 22.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.818 0.342 . . . . 0.0 111.182 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.08 32.39 5.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.229 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.637 ' H ' HD13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -138.48 140.71 39.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.215 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.12 146.55 13.87 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.572 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -128.8 145.18 51.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.794 0.331 . . . . 0.0 111.028 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -120.3 -156.94 10.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.174 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -54.47 -34.32 61.34 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.3 mtm -55.89 -30.48 61.64 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -109.55 10.02 25.17 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.96 -30.56 14.68 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.7 t -171.0 64.16 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.874 0.368 . . . . 0.0 110.833 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -155.23 23.38 0.42 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.818 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -97.46 114.41 64.81 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.805 -0.18 . . . . 0.0 111.385 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -70.24 142.33 45.56 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.025 2.484 . . . . 0.0 112.441 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.884 HG22 ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -108.38 117.02 33.08 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.398 0.618 . . . . 0.0 111.874 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.407 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 5.7 tt -131.56 164.15 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.177 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.08 107.45 0.64 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.547 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.745 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -116.95 -134.96 5.41 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.314 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -105.71 36.72 2.44 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.632 0.253 . . . . 0.0 111.173 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.1 129.32 23.51 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.599 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HB2' ' HG2' ' A' ' 41' ' ' LYS . 48.9 Cg_exo -56.23 116.85 3.48 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.943 2.429 . . . . 0.0 112.523 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 mp -80.36 154.82 4.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.552 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.18 14.71 81.96 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.706 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.473 ' HG2' ' HB2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -131.0 132.31 44.92 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.018 0.409 . . . . 0.0 111.169 179.539 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.64 144.05 44.47 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.08 122.81 31.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.322 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -105.0 118.7 37.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.617 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.429 HG23 ' CZ ' ' A' ' 85' ' ' TYR . 8.0 p -115.46 135.24 56.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.28 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 46' ' ' VAL . 33.2 m -131.77 120.89 46.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.591 ' HA3' ' HB1' ' A' ' 52' ' ' ALA . . . -77.79 115.67 4.3 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.759 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.73 88.35 7.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.079 0.466 . . . . 0.0 111.149 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.417 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER 73.2 -176.85 0.17 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.552 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' CB ' ' HB3' ' A' ' 81' ' ' PHE . . . 72.55 49.9 0.19 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.322 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 56.97 31.98 20.79 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.572 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.591 ' HB1' ' HA3' ' A' ' 47' ' ' GLY . . . -97.93 -40.78 8.31 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.966 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.2 t 57.28 25.28 10.93 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.731 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 49.35 62.64 2.52 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.927 0.394 . . . . 0.0 111.151 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.3 mtmm -94.75 137.86 33.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.137 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.416 ' OE1' HG12 ' A' ' 46' ' ' VAL . 4.6 pm0 -141.99 90.59 2.27 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.132 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -77.78 130.21 74.08 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.134 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.64 -26.5 46.69 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.972 2.448 . . . . 0.0 112.852 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -70.67 -7.51 45.1 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.906 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.447 ' HG2' ' HB ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -127.8 20.64 6.51 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.51 0.195 . . . . 0.0 111.032 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.8 -86.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.04 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.461 ' CE1' ' HE3' ' A' ' 41' ' ' LYS . 8.9 t80 -129.36 137.12 50.78 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.833 0.349 . . . . 0.0 111.046 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.68 121.68 41.52 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.136 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -62.61 118.35 7.5 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.832 0.349 . . . . 0.0 111.623 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.884 ' HA ' HG22 ' A' ' 32' ' ' THR . 1.8 t -107.28 107.12 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.745 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -54.32 87.72 0.01 OUTLIER Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.558 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 66' ' ' GLY . 0.4 OUTLIER 160.12 25.84 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 t30 61.74 23.21 13.58 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.935 0.398 . . . . 0.0 110.358 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.808 HG22 ' HA ' ' A' ' 133' ' ' LYS . 19.7 p -116.68 155.82 28.17 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.23 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.439 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -112.37 148.82 33.47 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.986 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.494 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -146.7 140.2 25.76 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.091 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.4 130.64 13.65 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.182 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.447 ' HB ' ' HG2' ' A' ' 60' ' ' ARG . 23.2 t -81.15 136.31 23.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.856 0.36 . . . . 0.0 110.691 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.469 HG21 ' OH ' ' A' ' 85' ' ' TYR . 12.1 t -129.94 146.05 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.25 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.64 131.63 54.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.124 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.26 165.72 23.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.841 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.55 168.22 9.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.39 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 123' ' ' PRO . . . -63.43 124.74 22.07 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.718 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.67 149.19 8.6 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.133 -0.555 . . . . 0.0 112.605 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.66 128.55 20.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.742 0.306 . . . . 0.0 111.516 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.474 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 22.3 p90 -142.87 148.33 36.83 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.825 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.458 ' HG3' ' HB2' ' A' ' 119' ' ' ALA . 0.4 OUTLIER -110.99 156.36 21.36 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.58 179.154 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -144.22 150.44 37.98 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.424 ' HB3' ' CG2' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -118.7 144.72 46.04 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.573 178.179 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.473 ' HB2' ' CG ' ' A' ' 94' ' ' PHE . 16.0 m-85 -128.22 160.09 33.18 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.589 0.709 . . . . 0.0 112.574 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.59 ' CB ' ' HA ' ' A' ' 92' ' ' PRO . . . -111.2 123.81 50.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.489 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.03 -178.03 0.72 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.101 0.476 . . . . 0.0 111.904 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -80.98 -14.95 57.48 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.012 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -87.94 42.21 1.04 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.486 0.184 . . . . 0.0 111.363 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 51.95 23.28 2.09 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.651 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 t -101.42 118.11 60.63 Favored Pre-proline 0 CA--C 1.522 -0.098 0 CA-C-O 120.499 0.19 . . . . 0.0 110.67 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.59 ' HA ' ' CB ' ' A' ' 86' ' ' ALA . 70.4 Cg_endo -89.13 53.47 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.739 2.293 . . . . 0.0 112.582 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 3.0 mt-30 -152.43 124.59 8.1 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.473 ' CG ' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -141.92 120.63 12.62 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.077 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.404 ' HB ' ' N ' ' A' ' 116' ' ' GLN . 69.2 p -152.36 125.97 8.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.676 0.274 . . . . 0.0 111.248 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.62 99.59 11.2 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.766 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.79 114.31 2.02 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.665 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.06 85.54 0.04 OUTLIER Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.494 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.747 HD21 ' HB1' ' A' ' 107' ' ' ALA . 12.8 tp -152.5 -57.1 0.14 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 64.45 79.85 0.25 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.44 0.638 . . . . 0.0 109.426 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.03 HD21 HG11 ' A' ' 145' ' ' VAL . 0.5 OUTLIER -53.03 143.85 16.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.149 -178.559 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.842 HG22 ' HD2' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -131.6 151.47 78.73 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.452 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.842 ' HD2' HG22 ' A' ' 102' ' ' THR . 50.3 Cg_exo -56.15 118.75 5.6 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.875 2.383 . . . . 0.0 112.267 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.0 34.77 89.39 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.025 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.89 147.57 48.75 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.91 0.386 . . . . 0.0 111.542 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.5 t -71.56 145.48 49.04 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.305 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.747 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -128.9 144.23 51.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.671 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.8 m -82.09 129.38 34.79 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.915 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.679 HD12 HD13 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -95.53 95.72 8.58 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.601 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -73.89 -65.37 0.84 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -176.54 -66.25 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.563 0.22 . . . . 0.0 111.45 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.68 114.73 2.8 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.467 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.86 75.97 0.03 OUTLIER Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.237 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 58.92 34.76 23.83 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.739 0.304 . . . . 0.0 111.169 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.58 -128.89 4.78 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.303 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.404 ' N ' ' HB ' ' A' ' 95' ' ' THR . 14.7 tt0 -109.38 111.71 23.42 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.731 0.3 . . . . 0.0 110.993 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.67 150.37 47.29 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.586 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.52 ' CG2' HD23 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -83.44 113.96 21.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.765 0.317 . . . . 0.0 110.756 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.458 ' HB2' ' HG3' ' A' ' 82' ' ' ARG . . . -102.12 126.46 49.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.061 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.88 ' HB ' HD23 ' A' ' 101' ' ' LEU . 11.3 p -116.68 124.99 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.452 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 m -85.65 92.74 8.65 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.272 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.9 tp -131.5 101.15 16.04 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.341 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.55 ' O ' ' HB1' ' A' ' 78' ' ' ALA . 15.5 Cg_exo -68.91 8.62 0.56 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.467 2.778 . . . . 0.0 113.816 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -123.08 142.97 50.29 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.659 0.266 . . . . 0.0 111.038 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -98.57 142.33 30.3 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.34 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.03 175.27 40.73 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.248 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -67.26 140.35 57.36 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.761 0.315 . . . . 0.0 111.012 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.543 ' CE1' HG22 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -130.33 148.48 52.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.268 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.42 129.44 73.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.848 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.565 ' HE3' HD11 ' A' ' 132' ' ' LEU . 4.9 m95 -106.48 112.3 25.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.039 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.802 ' O ' HD13 ' A' ' 132' ' ' LEU . 66.3 p -109.33 134.38 51.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.294 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 131' ' ' SER . 0.4 OUTLIER -132.84 135.66 45.77 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.679 0.276 . . . . 0.0 110.643 -179.38 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.808 ' HA ' HG22 ' A' ' 69' ' ' THR . 11.2 tptm -106.63 130.57 54.35 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.644 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 132' ' ' LEU . 21.8 m-85 -139.84 145.05 37.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.918 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.4 p -110.65 -179.63 3.81 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.365 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -89.57 -20.84 23.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.582 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.2 m -65.61 -27.14 68.19 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.78 -17.26 55.71 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.256 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.513 ' CB ' ' HD3' ' A' ' 140' ' ' PRO . 0.3 OUTLIER -86.1 -56.85 0.36 Allowed Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 117.154 0.477 . . . . 0.0 110.897 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 22.6 Cg_exo -63.77 98.59 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.613 2.209 . . . . 0.0 112.0 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.652 ' HG2' HD22 ' A' ' 109' ' ' LEU . 1.3 tt0 -134.2 106.78 7.33 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.63 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.95 144.97 51.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.256 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.739 ' HB ' HD12 ' A' ' 132' ' ' LEU . 21.3 pt -134.91 139.18 47.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.006 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -147.93 161.23 41.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.973 0.416 . . . . 0.0 111.487 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 1.03 HG11 HD21 ' A' ' 101' ' ' LEU . 8.3 p -125.29 145.77 32.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.6 m -144.43 151.52 39.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -105.67 141.18 37.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.063 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 149' ' ' PRO . 62.0 m -121.32 131.35 24.48 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.696 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 148' ' ' CYS . 50.9 Cg_exo . . . . . 0 C--O 1.252 1.18 0 C-N-CA 122.697 2.265 . . . . 0.0 112.313 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.488 0.185 . . . . 0.0 111.308 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 1' ' ' THR . 43.0 Cg_exo -56.73 154.37 31.88 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.109 2.539 . . . . 0.0 113.127 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.2 m -150.61 144.01 24.98 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.218 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.14 128.54 33.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.854 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.4 101.38 14.06 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.116 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.67 -56.87 5.24 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.536 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.12 90.01 2.22 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.88 0.371 . . . . 0.0 111.076 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.21 -49.4 0.08 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.075 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -62.9 136.85 58.07 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.368 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.2 p -93.77 150.21 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.207 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.97 115.83 4.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.134 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -107.72 126.3 52.44 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.335 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 t 67.43 109.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.688 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 m 66.78 95.53 0.06 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.513 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.92 98.07 1.18 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.654 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -172.24 122.75 0.47 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.317 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.04 90.89 1.08 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.34 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 m 64.5 104.74 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.825 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.2 -44.1 69.36 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.154 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.442 HD13 ' N ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -73.55 141.33 16.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.877 0.37 . . . . 0.0 111.251 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.442 ' N ' HD13 ' A' ' 20' ' ' ILE . . . 168.81 141.28 3.16 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.683 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -121.16 138.44 54.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.642 0.258 . . . . 0.0 110.9 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.04 -26.66 58.7 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.881 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.4 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -61.58 -50.0 74.39 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.71 0.255 . . . . 0.0 111.11 179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.405 ' CE ' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -82.19 -19.42 39.87 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.085 179.465 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.405 ' HB2' ' CE ' ' A' ' 25' ' ' MET . . . -86.29 11.51 12.01 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -91.01 -30.34 16.86 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 122.283 -0.261 . . . . 0.0 111.018 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.3 p -116.35 -32.83 5.15 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -117.06 99.04 6.79 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.942 0.401 . . . . 0.0 111.5 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -97.24 152.76 38.45 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.644 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.24 119.93 7.26 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.311 2.007 . . . . 0.0 112.456 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.19 141.44 31.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.123 0.487 . . . . 0.0 110.623 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.604 HG23 ' HA3' ' A' ' 66' ' ' GLY . 15.5 tt -148.75 164.65 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.714 -178.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -61.55 108.05 0.9 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.804 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.772 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -147.65 -159.57 8.45 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.978 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 61.12 -73.92 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.235 0.214 . . . . 0.0 111.558 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 35' ' ' GLY . . . 96.8 -114.51 4.98 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.37 -19.19 33.54 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.471 2.114 . . . . 0.0 112.998 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.521 HG22 ' H ' ' A' ' 40' ' ' GLY . 3.8 mt -89.02 167.68 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.11 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.521 ' H ' HG22 ' A' ' 39' ' ' ILE . . . 78.54 51.15 5.71 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.614 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.29 157.92 21.38 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.035 0.445 . . . . 0.0 111.155 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.543 ' HB ' ' CD1' ' A' ' 62' ' ' TYR . 1.5 t -54.47 120.79 7.13 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.432 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.775 HD23 ' HB2' ' A' ' 87' ' ' SER . 1.0 OUTLIER -119.31 177.02 5.06 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.982 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -130.77 118.89 21.5 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.094 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.648 HG12 ' OE1' ' A' ' 56' ' ' GLN . 12.1 p -97.4 130.87 45.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.522 ' HB ' ' CG ' ' A' ' 54' ' ' TRP . 1.3 m -141.5 -179.1 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.29 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.08 -18.25 12.42 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.912 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.807 ' HB3' ' HB3' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -43.0 -80.64 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 68.41 4.49 4.27 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.44 60.77 0.6 Allowed 'General case' 0 C--O 1.231 0.091 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.6 t70 71.7 20.66 4.57 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.009 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.807 ' HB3' ' HB3' ' A' ' 48' ' ' ASP . . . -100.99 -44.21 5.8 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.52 0.2 . . . . 0.0 110.875 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.9 m 71.56 25.42 3.36 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.576 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.522 ' CG ' ' HB ' ' A' ' 46' ' ' VAL . 23.1 m0 48.88 62.19 2.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 111.558 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -95.26 136.88 35.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.283 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.648 ' OE1' HG12 ' A' ' 45' ' ' VAL . 40.9 tp60 -136.15 96.01 3.31 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.725 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.8 116.32 17.93 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.714 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 51.8 Cg_exo -54.66 -32.52 75.77 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.765 2.31 . . . . 0.0 112.538 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -58.34 -24.58 60.18 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.581 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.406 ' HD3' ' HB ' ' A' ' 73' ' ' VAL . 92.4 mtt180 -130.62 22.86 5.06 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.748 0.309 . . . . 0.0 110.917 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . . . -53.06 -30.11 34.03 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.759 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.543 ' CD1' ' HB ' ' A' ' 42' ' ' THR . 1.9 p90 -163.95 131.71 3.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.777 0.322 . . . . 0.0 111.241 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.74 115.4 23.83 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.992 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -60.96 118.18 6.4 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.915 0.388 . . . . 0.0 111.367 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.515 ' CG2' ' HB2' ' A' ' 71' ' ' GLN . 2.4 t -101.46 96.42 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.772 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -45.23 87.9 0.01 OUTLIER Glycine 0 C--N 1.337 0.618 0 O-C-N 123.89 0.744 . . . . 0.0 112.726 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER 156.52 26.05 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.377 0.692 . . . . 0.0 112.451 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t30 62.27 25.18 15.04 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 122.071 -0.393 . . . . 0.0 111.052 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.563 HG22 ' O ' ' A' ' 132' ' ' LEU . 0.6 OUTLIER -112.8 154.75 25.75 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.497 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.487 ' HB2' HD21 ' A' ' 132' ' ' LEU . 1.2 m-85 -117.35 133.56 55.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.833 0.349 . . . . 0.0 111.115 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.515 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . 0.3 OUTLIER -141.49 133.71 27.9 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.972 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.7 120.24 7.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.718 HG22 HG12 ' A' ' 129' ' ' VAL . 28.7 t -76.71 130.43 36.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.495 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.444 HG11 HG11 ' A' ' 45' ' ' VAL . 6.6 m -127.26 134.02 66.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -104.72 99.86 9.52 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.343 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -126.37 166.76 16.57 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.427 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 169.57 3.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.243 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.771 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -119.39 143.92 47.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.158 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.52 97.28 1.95 Allowed Glycine 0 C--N 1.335 0.485 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.387 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.97 72.33 0.49 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.679 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -134.34 139.04 45.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.706 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -120.55 155.84 32.83 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.929 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.5 ptm -154.58 155.06 34.07 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.939 0.4 . . . . 0.0 111.992 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.13 140.7 17.91 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.302 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.42 ' CE1' ' HB ' ' A' ' 45' ' ' VAL . 7.5 m-85 -97.09 142.37 29.1 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 111.725 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.513 ' HA ' ' CB ' ' A' ' 93' ' ' GLN . . . -163.76 122.98 2.02 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.123 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.775 ' HB2' HD23 ' A' ' 43' ' ' LEU . 8.8 t -74.6 165.08 25.8 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.842 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.2 mtmm -69.97 -50.2 44.14 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.332 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.93 35.66 0.85 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.924 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 1.3 t90 52.31 40.84 29.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.004 0.43 . . . . 0.0 111.452 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.67 177.14 2.98 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.895 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.419 ' O ' HD21 ' A' ' 43' ' ' LEU . 81.4 Cg_exo -45.62 111.49 0.33 Allowed 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.905 2.403 . . . . 0.0 112.849 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.513 ' CB ' ' HA ' ' A' ' 86' ' ' ALA . 10.3 pt20 -128.09 -174.76 3.3 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.948 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.608 ' HA ' HD11 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -122.87 120.0 32.18 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.956 0.408 . . . . 0.0 110.3 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.542 HG22 ' HA3' ' A' ' 115' ' ' GLY . 9.9 p -129.07 134.48 48.11 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.019 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.532 ' HB1' ' CD2' ' A' ' 99' ' ' LEU . . . -125.75 140.65 52.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.129 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 116' ' ' GLN . 0.1 OUTLIER -128.15 104.79 7.96 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.879 0.371 . . . . 0.0 111.854 -179.541 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.57 102.55 0.01 OUTLIER Glycine 0 C--N 1.337 0.585 0 CA-C-N 116.019 -0.537 . . . . 0.0 113.213 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.532 ' CD2' ' HB1' ' A' ' 96' ' ' ALA . 1.1 pt? -169.74 -38.86 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 60.1 76.36 0.37 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.757 0.789 . . . . 0.0 109.534 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.784 HD21 HG11 ' A' ' 145' ' ' VAL . 9.6 tt -55.65 143.67 29.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.078 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.513 HG22 ' HD2' ' A' ' 103' ' ' PRO . 1.9 m -130.02 143.1 47.74 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.13 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.77 ' HG3' HD23 ' A' ' 122' ' ' LEU . 82.9 Cg_exo -46.55 118.36 2.54 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.899 2.399 . . . . 0.0 112.448 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.07 34.52 29.87 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.537 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.792 ' O ' HG12 ' A' ' 145' ' ' VAL . 0.0 OUTLIER -130.29 144.65 51.5 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.798 0.333 . . . . 0.0 111.15 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.2 t -78.65 137.27 37.74 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 143' ' ' ILE . . . -108.83 145.57 35.05 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.18 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.6 m -81.62 134.25 35.47 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.888 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.608 HD11 ' HA ' ' A' ' 94' ' ' PHE . 49.5 tp -104.05 142.59 34.19 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.812 0.339 . . . . 0.0 110.798 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -102.74 -70.91 0.74 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.178 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 179.99 -66.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.723 0.297 . . . . 0.0 111.035 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 155.58 146.79 4.53 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.502 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.79 -33.23 6.02 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.442 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -147.16 97.11 2.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.718 0.294 . . . . 0.0 110.369 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.542 ' HA3' HG22 ' A' ' 95' ' ' THR . . . -127.49 102.12 0.59 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.206 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.414 ' HB2' ' HA ' ' A' ' 97' ' ' ASP . 0.4 OUTLIER -50.93 143.77 9.67 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.82 0.343 . . . . 0.0 110.772 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 82' ' ' ARG . 13.5 m-20 -64.09 122.44 16.57 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.082 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 82' ' ' ARG . 94.3 m -93.82 113.98 26.13 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.918 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.55 137.77 32.02 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.017 0.437 . . . . 0.0 111.78 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.507 ' CG2' HD22 ' A' ' 101' ' ' LEU . 16.0 t -125.23 133.76 68.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.581 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.1 m -92.5 93.23 8.45 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.747 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.771 ' O ' ' HB1' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -131.5 107.31 14.46 Favored Pre-proline 0 C--O 1.226 -0.184 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.611 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -76.76 8.55 3.03 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.723 2.282 . . . . 0.0 113.785 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.406 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.8 tt0 -122.43 117.02 24.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.741 0.305 . . . . 0.0 111.181 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . . . -79.94 140.9 36.47 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.286 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 171.11 -165.34 38.47 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.84 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -95.8 121.61 37.71 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 110.822 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.452 ' CD1' ' HG3' ' A' ' 147' ' ' LYS . 0.9 OUTLIER -105.91 154.53 20.43 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.544 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.718 HG12 HG22 ' A' ' 73' ' ' VAL . 32.4 m -110.56 120.54 61.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.048 0.452 . . . . 0.0 111.623 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.409 ' CZ3' HG23 ' A' ' 145' ' ' VAL . 0.9 OUTLIER -101.31 112.09 24.5 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.336 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.68 ' C ' HD13 ' A' ' 132' ' ' LEU . 79.7 p -123.24 133.55 54.19 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.218 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.68 HD13 ' C ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -135.82 136.66 40.83 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.729 0.3 . . . . 0.0 110.853 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.519 ' HA ' HG22 ' A' ' 69' ' ' THR . 13.3 tptm -124.23 119.75 30.25 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.066 0.46 . . . . 0.0 110.735 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 141' ' ' GLU . 1.9 p90 -142.85 152.52 42.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.395 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.52 HG21 ' HB3' ' A' ' 139' ' ' ASP . 6.2 p -72.12 157.2 38.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.057 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -93.96 -12.01 29.67 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.782 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.1 t -93.07 15.35 15.33 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.1 -8.38 79.91 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.674 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.643 ' HB3' ' HD2' ' A' ' 140' ' ' PRO . 1.2 m-20 -61.68 -178.07 0.17 Allowed Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 117.012 0.406 . . . . 0.0 111.441 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.643 ' HD2' ' HB3' ' A' ' 139' ' ' ASP . 68.3 Cg_exo -41.16 154.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.397 2.731 . . . . 0.0 113.851 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.581 ' HB3' ' HB2' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -140.2 115.27 9.74 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.085 -178.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.42 154.03 38.29 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.012 0.434 . . . . 0.0 111.77 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.622 HG23 ' HB3' ' A' ' 132' ' ' LEU . 10.4 mt -123.63 155.95 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.97 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.72 132.81 39.27 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.793 0.33 . . . . 0.0 111.146 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.792 HG12 ' O ' ' A' ' 105' ' ' LYS . 13.0 p -125.42 129.21 72.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.817 0.341 . . . . 0.0 111.105 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 95.1 p -143.8 144.99 32.04 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.967 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.452 ' HG3' ' CD1' ' A' ' 128' ' ' TYR . 8.8 ttpp -117.06 104.01 10.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -114.97 141.52 27.05 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.753 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.251 1.149 0 C-N-CA 122.438 2.092 . . . . 0.0 112.494 -179.775 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.537 0.208 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.91 -34.28 6.79 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.908 2.405 . . . . 0.0 112.826 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 p 58.75 178.53 0.07 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.976 0.417 . . . . 0.0 111.737 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.65 97.69 3.2 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.2 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.7 t -73.41 -68.38 0.5 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.879 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.92 45.9 0.4 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.719 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.1 tp -116.8 126.7 53.47 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.652 0.263 . . . . 0.0 111.084 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.2 p -136.95 -56.57 0.72 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.015 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.2 137.72 32.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.054 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 m -86.99 137.57 20.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.27 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.36 129.17 38.15 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.446 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.94 137.11 38.85 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.216 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 t -80.83 128.69 38.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.94 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.6 t 64.99 -81.91 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.177 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.17 132.34 0.17 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.622 0.248 . . . . 0.0 111.108 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.48 98.79 0.7 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.083 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.8 m -66.08 106.59 1.66 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.751 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.3 t -113.79 95.75 5.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.14 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mp -87.82 -26.71 22.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.025 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.641 ' H ' HD13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -132.71 139.17 50.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.938 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.63 144.46 15.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.897 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -100.84 148.12 25.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.859 0.361 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.74 69.58 0.97 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.756 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.11 -34.62 76.72 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.552 0.215 . . . . 0.0 111.093 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 45.2 mtm -59.73 -23.61 63.33 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.506 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.11 -9.4 55.42 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.2 11.52 11.82 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.7 m 64.69 49.14 2.35 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.929 0.395 . . . . 0.0 111.233 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.91 103.8 7.0 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.631 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -77.53 154.0 81.42 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.781 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.74 123.51 12.11 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.587 2.192 . . . . 0.0 112.07 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.898 HG22 ' HA ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -108.75 97.83 7.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.258 0.552 . . . . 0.0 111.374 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.418 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 2.5 tt -98.24 164.59 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.664 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -61.86 107.52 0.86 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.499 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.728 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -115.05 -143.56 8.12 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.272 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.18 41.9 1.4 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.907 0.384 . . . . 0.0 110.816 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.6 174.93 53.65 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.385 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.06 91.12 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.653 2.235 . . . . 0.0 112.212 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.726 HD13 ' CE2' ' A' ' 64' ' ' TYR . 38.1 mm -69.47 153.71 8.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.2 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 58.48 23.56 54.55 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.726 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 mmtm -128.14 132.01 48.95 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.605 0.24 . . . . 0.0 111.441 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.4 m -115.61 143.91 44.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.728 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.503 ' HB3' ' CE1' ' A' ' 85' ' ' TYR . 4.1 mm? -112.54 138.36 49.43 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.841 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.25 121.78 33.67 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.152 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.786 HG11 HG11 ' A' ' 74' ' ' VAL . 7.2 p -111.93 136.46 48.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.098 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.456 ' HB ' ' CD1' ' A' ' 54' ' ' TRP . 35.8 m -128.2 120.73 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.321 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 52' ' ' ALA . . . -95.51 142.25 15.99 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.426 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -150.19 117.41 6.02 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.963 0.411 . . . . 0.0 111.503 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -175.96 -69.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.692 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.21 -28.0 9.26 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.544 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.562 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 5.9 p-10 -110.05 -70.22 0.82 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.897 -0.138 . . . . 0.0 111.261 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 51' ' ' ASP . . . 80.55 31.51 0.18 Allowed 'General case' 0 C--N 1.343 0.297 0 CA-C-O 121.444 0.64 . . . . 0.0 109.826 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.7 m -62.63 -39.37 93.61 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.637 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.456 ' CD1' ' HB ' ' A' ' 46' ' ' VAL . 53.5 m0 58.13 48.13 13.42 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.918 0.39 . . . . 0.0 110.818 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -97.02 139.0 33.67 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.453 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.11 93.74 2.43 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.359 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -62.53 135.12 95.37 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.832 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.6 -37.93 20.45 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.742 2.295 . . . . 0.0 112.702 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.8 -26.13 65.51 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.371 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.437 ' HD3' HG21 ' A' ' 73' ' ' VAL . 27.4 mtt180 -125.42 17.23 8.26 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.083 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.73 -23.47 66.11 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.492 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -163.82 106.73 0.96 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.893 0.378 . . . . 0.0 111.427 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -105.55 131.11 53.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.295 179.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.726 ' CE2' HD13 ' A' ' 39' ' ' ILE . 62.3 m-85 -91.68 118.93 31.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.159 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.898 ' HA ' HG22 ' A' ' 32' ' ' THR . 4.3 t -93.97 116.31 34.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.293 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.728 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -65.6 79.81 0.09 OUTLIER Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.618 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 169.68 32.57 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.867 0.392 . . . . 0.0 111.724 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.0 m120 61.98 22.69 13.25 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.847 0.356 . . . . 0.0 110.119 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -115.44 155.31 27.67 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.363 -179.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.44 ' CZ ' HD23 ' A' ' 43' ' ' LEU . 24.5 t80 -120.71 139.46 53.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.439 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 130' ' ' TRP . 1.5 mt-30 -136.96 139.36 41.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.177 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.59 111.78 4.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.114 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 1.013 HG12 HG12 ' A' ' 129' ' ' VAL . 27.1 m -74.57 129.26 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.726 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.786 HG11 HG11 ' A' ' 45' ' ' VAL . 15.0 m -130.78 139.97 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -113.66 120.37 40.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.914 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -137.52 166.91 22.74 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.811 0.338 . . . . 0.0 111.831 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.17 172.92 1.27 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.642 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.547 ' HB2' ' CA ' ' A' ' 125' ' ' ALA . . . -110.31 143.23 40.82 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.344 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 122' ' ' LEU . . . 87.51 91.17 1.02 Allowed Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.297 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 57.28 101.6 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.83 0.347 . . . . 0.0 111.928 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.407 ' CE2' ' HB ' ' A' ' 120' ' ' VAL . 3.1 p90 -142.05 135.66 29.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.936 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.6 mtm105 -109.57 145.21 36.75 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.426 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -149.14 161.63 41.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.866 0.365 . . . . 0.0 111.386 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -141.55 152.0 43.71 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.903 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.503 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -118.4 132.85 56.24 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.819 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -164.05 151.43 12.14 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.316 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.72 177.3 6.37 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.085 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.46 -34.82 19.97 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.474 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.1 38.19 1.26 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.658 0.266 . . . . 0.0 111.22 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 50.28 40.6 22.78 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.965 0.412 . . . . 0.0 111.193 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.429 ' HB3' ' HD2' ' A' ' 92' ' ' PRO . 0.8 OUTLIER -86.06 176.99 3.11 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.514 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 91' ' ' SER . 96.2 Cg_exo -43.57 116.14 0.8 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.877 2.384 . . . . 0.0 112.854 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -111.68 -175.69 2.76 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.252 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.463 ' HB3' ' CB ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -125.63 128.09 47.33 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.117 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.38 111.92 9.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.816 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.842 ' HB1' ' HB3' ' A' ' 99' ' ' LEU . . . -96.12 88.93 4.99 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.157 0.503 . . . . 0.0 111.02 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.55 108.46 10.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.959 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.04 31.8 65.78 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.323 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.842 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 2.6 tm? -85.28 -52.1 6.13 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.183 0.193 . . . . 0.0 111.158 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.437 ' C ' HD13 ' A' ' 99' ' ' LEU . 0.2 OUTLIER 57.38 86.02 0.08 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.384 0.611 . . . . 0.0 110.233 -179.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.873 HD12 ' HB2' ' A' ' 107' ' ' ALA . 9.4 tt -76.76 146.77 37.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.594 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.86 HG22 ' HD2' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -129.72 152.93 80.63 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.02 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.86 ' HD2' HG22 ' A' ' 102' ' ' THR . 81.9 Cg_exo -46.77 110.66 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.598 2.198 . . . . 0.0 112.386 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.98 34.61 20.91 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.559 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.45 150.16 48.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.998 0.427 . . . . 0.0 111.127 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 35.9 p -84.8 144.91 28.16 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.315 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.873 ' HB2' HD12 ' A' ' 101' ' ' LEU . . . -119.82 149.08 42.64 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.417 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.33 131.15 36.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.958 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.585 ' CD1' HD11 ' A' ' 143' ' ' ILE . 7.1 tp -92.72 99.38 12.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.709 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -107.65 -160.57 0.74 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.647 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.25 165.83 26.35 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.752 0.311 . . . . 0.0 111.262 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.72 123.43 5.17 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.112 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.97 50.08 3.38 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.835 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -172.29 38.67 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.705 0.288 . . . . 0.0 111.478 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.26 -138.59 10.35 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.532 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.2 140.34 36.61 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.688 0.28 . . . . 0.0 111.048 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.73 149.83 31.03 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.226 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.622 HG22 ' H ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -97.36 114.37 26.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.68 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.82 129.01 44.32 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.05 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.418 HG22 ' HB3' ' A' ' 101' ' ' LEU . 22.9 t -117.55 131.33 70.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.074 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.5 m -91.66 97.55 11.09 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.822 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.729 HD11 ' CD ' ' A' ' 147' ' ' LYS . 13.6 tp -130.89 105.62 15.28 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.776 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.32 8.37 1.49 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.918 2.412 . . . . 0.0 113.752 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -128.43 133.1 48.48 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.553 0.216 . . . . 0.0 111.031 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.547 ' CA ' ' HB2' ' A' ' 78' ' ' ALA . . . -85.07 142.34 29.62 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.427 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 160.41 -174.74 37.16 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.706 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.58 134.3 49.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.803 0.335 . . . . 0.0 111.007 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.06 161.29 16.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.281 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.013 HG12 HG12 ' A' ' 73' ' ' VAL . 13.2 m -108.3 125.08 65.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.533 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.593 ' CZ3' HG21 ' A' ' 143' ' ' ILE . 10.1 m95 -96.15 112.08 23.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.923 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.529 ' C ' HD23 ' A' ' 132' ' ' LEU . 34.2 t -110.53 125.26 53.16 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.693 HD12 ' CZ ' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -148.75 143.98 26.75 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.607 -178.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -108.11 134.59 50.77 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.568 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.693 ' CZ ' HD12 ' A' ' 132' ' ' LEU . 23.5 m-85 -112.15 144.92 40.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.123 0.487 . . . . 0.0 110.953 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.637 HG21 ' N ' ' A' ' 139' ' ' ASP . 5.0 t -68.84 164.01 22.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.752 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -94.03 -39.61 10.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.819 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.4 t -79.52 -27.27 41.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.322 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.31 35.18 4.24 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.48 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.637 ' N ' HG21 ' A' ' 135' ' ' THR . 0.9 OUTLIER -112.87 -73.83 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 117.303 0.551 . . . . 0.0 111.418 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.569 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 97.0 Cg_endo -78.95 144.57 19.03 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.521 2.147 . . . . 0.0 113.077 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.2 120.7 4.14 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.963 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.01 147.65 51.78 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 111.338 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.593 HG21 ' CZ3' ' A' ' 130' ' ' TRP . 38.6 mt -123.36 147.2 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.919 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.25 132.68 22.04 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.063 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.793 HG12 HD11 ' A' ' 101' ' ' LEU . 12.0 p -141.13 139.62 33.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.964 0.411 . . . . 0.0 111.614 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.34 158.77 43.63 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.809 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.729 ' CD ' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -102.45 134.92 44.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 13.5 t -117.76 117.37 35.83 Favored Pre-proline 0 C--O 1.233 0.186 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.874 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--O 1.251 1.15 0 C-N-CA 122.841 2.361 . . . . 0.0 112.791 179.891 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.569 0.223 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.4 128.36 12.72 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.8 2.333 . . . . 0.0 112.548 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 t -156.02 145.82 21.19 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.143 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -161.31 -67.51 0.06 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.252 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.52 -175.46 4.2 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.985 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.86 -121.17 5.68 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.356 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.5 tp 56.88 77.35 0.27 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 111.325 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.2 100.82 8.43 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.679 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.64 119.31 23.66 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.943 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.5 t -115.48 -58.63 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.151 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.91 123.57 22.31 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.251 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.78 137.96 33.48 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.821 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -96.89 99.37 8.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.301 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 t -98.98 35.89 1.8 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.057 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.73 128.09 16.86 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.491 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.39 105.23 0.59 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.877 0.37 . . . . 0.0 111.222 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.479 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -80.84 149.04 29.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.995 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.67 126.44 28.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.394 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 46.62 48.72 14.23 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.154 0.502 . . . . 0.0 111.18 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 17' ' ' SER . 10.4 tt -104.9 147.29 11.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.692 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.79 140.64 15.15 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.452 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -141.44 138.46 32.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.874 0.369 . . . . 0.0 111.161 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.19 75.9 1.99 Allowed Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.459 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -60.76 -38.18 84.35 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.647 0.26 . . . . 0.0 110.823 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -66.68 -30.2 70.39 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.978 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.75 -31.27 70.2 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.106 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.22 8.27 38.45 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.674 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.8 m 59.58 76.58 0.35 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.731 0.3 . . . . 0.0 111.085 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -141.21 111.89 7.04 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.554 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -72.29 115.01 34.6 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.832 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.99 121.2 9.31 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.446 2.097 . . . . 0.0 112.157 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.645 ' CG2' HG13 ' A' ' 65' ' ' VAL . 1.2 p -114.7 137.63 51.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.493 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.441 ' H ' HD12 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -118.98 150.51 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.1 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.439 ' HA ' ' HB3' ' A' ' 64' ' ' TYR . 4.4 pt-20 -53.8 107.33 0.25 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.029 0.442 . . . . 0.0 111.85 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.7 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -100.77 -88.82 2.03 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.781 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -126.56 30.03 5.62 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.663 0.268 . . . . 0.0 110.997 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.51 123.38 6.73 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.794 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -57.18 113.22 1.38 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.011 2.474 . . . . 0.0 112.434 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 40' ' ' GLY . 3.6 mt -78.63 158.12 4.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.45 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.442 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 78.32 15.47 80.93 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.461 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -130.87 131.48 44.58 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 117.078 0.439 . . . . 0.0 110.845 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.451 HG23 ' HB1' ' A' ' 61' ' ' ALA . 41.6 m -116.17 139.27 50.5 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.081 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.454 ' C ' HD12 ' A' ' 43' ' ' LEU . 4.6 pp -109.87 148.34 31.7 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.289 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.61 136.02 43.19 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.157 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.618 HG22 ' HG2' ' A' ' 56' ' ' GLN . 8.4 m -113.53 115.81 50.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.983 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.78 156.5 28.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.033 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . 172.89 134.12 1.76 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.336 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -84.42 86.83 7.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.117 0.484 . . . . 0.0 110.339 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 52' ' ' ALA . 16.4 m-85 -90.24 -171.29 3.05 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.079 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.3 -49.25 8.92 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.597 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.27 49.4 1.79 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.954 0.407 . . . . 0.0 111.361 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.56 ' HB1' ' HG3' ' A' ' 55' ' ' LYS . . . -153.62 -57.43 0.12 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.865 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 m 50.51 86.98 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.66 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 12.6 m0 62.1 60.87 1.42 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.044 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.56 ' HG3' ' HB1' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -95.6 120.14 35.33 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.22 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.618 ' HG2' HG22 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -128.42 101.15 6.07 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.657 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.62 121.83 80.05 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.63 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.97 -38.46 86.52 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.736 2.29 . . . . 0.0 112.484 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -67.4 -15.05 63.46 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.682 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.722 ' HD3' HG12 ' A' ' 73' ' ' VAL . 1.7 mmp_? -122.77 16.64 10.23 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.615 0.245 . . . . 0.0 110.953 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.451 ' HB1' HG23 ' A' ' 42' ' ' THR . . . -50.88 -32.79 21.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.328 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -172.06 120.86 0.45 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.876 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.96 140.37 36.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.641 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.439 ' HB3' ' HA ' ' A' ' 34' ' ' GLU . 58.8 m-85 -86.43 118.34 25.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.8 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.645 HG13 ' CG2' ' A' ' 32' ' ' THR . 4.3 t -101.71 123.17 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.7 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -67.23 78.99 0.16 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.84 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER 161.44 31.6 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.104 0.532 . . . . 0.0 112.406 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.3 t30 61.41 25.19 15.18 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.999 0.428 . . . . 0.0 110.525 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.838 HG22 ' HA ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -109.02 156.17 20.06 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.264 -178.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.463 ' O ' HD12 ' A' ' 132' ' ' LEU . 7.6 m-85 -118.15 136.56 53.54 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.602 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.455 ' CG ' ' HA ' ' A' ' 131' ' ' SER . 8.6 mt-30 -144.76 148.69 34.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.057 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.64 130.32 13.15 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.469 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.722 HG12 ' HD3' ' A' ' 60' ' ' ARG . 14.5 p -89.27 131.51 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.692 0.282 . . . . 0.0 110.76 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.38 145.56 35.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.542 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -114.27 122.31 46.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.515 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.6 163.95 24.91 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.899 0.38 . . . . 0.0 111.434 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -101.22 175.53 5.56 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.159 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.534 ' HB2' ' N ' ' A' ' 125' ' ' ALA . . . -60.4 137.69 58.1 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.63 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.14 145.33 7.19 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.481 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.61 136.98 57.91 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.707 0.289 . . . . 0.0 111.126 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.571 ' CE1' HD22 ' A' ' 122' ' ' LEU . 2.8 p90 -140.94 148.68 40.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.059 0.457 . . . . 0.0 111.484 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.461 ' NH2' ' HB2' ' A' ' 117' ' ' ASP . 10.7 mtp-105 -117.96 140.66 49.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.081 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.45 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -147.99 177.83 9.03 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.085 0.469 . . . . 0.0 111.928 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.63 145.34 5.43 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.357 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.542 ' CE1' HG12 ' A' ' 45' ' ' VAL . 3.3 m-85 -97.15 142.85 28.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.617 0.246 . . . . 0.0 111.139 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.468 ' HA ' ' CB ' ' A' ' 93' ' ' GLN . . . -162.91 122.41 2.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.76 148.92 44.13 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.74 0.305 . . . . 0.0 111.355 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -35.45 76.61 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.703 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -96.76 31.26 2.38 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.617 0.246 . . . . 0.0 111.388 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 51.97 40.81 28.97 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 111.244 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.472 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.6 OUTLIER -85.75 169.88 14.52 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.433 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 91' ' ' SER . 1.2 Cg_endo -43.89 105.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.008 2.472 . . . . 0.0 112.43 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 85' ' ' TYR . 5.0 pt20 -106.74 -174.68 2.59 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.175 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.09 122.82 39.41 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.108 0.48 . . . . 0.0 110.814 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.9 p -132.19 130.79 41.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.364 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.06 120.35 38.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.625 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 99' ' ' LEU . 3.0 p30 -64.88 -157.61 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.617 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.81 74.08 0.05 OUTLIER Glycine 0 C--N 1.342 0.91 0 C-N-CA 121.165 -0.541 . . . . 0.0 111.978 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.615 ' C ' HD13 ' A' ' 99' ' ' LEU . 1.4 tm? -109.41 -44.66 3.85 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.918 0.487 . . . . 0.0 110.938 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.48 ' C ' HD13 ' A' ' 99' ' ' LEU . 19.3 mt-10 62.21 81.99 0.19 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.313 0.578 . . . . 0.0 109.863 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.837 HD12 ' HB2' ' A' ' 107' ' ' ALA . 8.0 tt -73.8 146.05 44.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.681 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.811 HG22 ' HD2' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -124.38 153.23 69.0 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.463 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.811 ' HD2' HG22 ' A' ' 102' ' ' THR . 91.5 Cg_exo -44.6 110.92 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.817 2.345 . . . . 0.0 112.434 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.46 34.58 22.47 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.421 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.87 150.73 46.17 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.049 0.452 . . . . 0.0 111.34 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.11 140.9 43.75 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.225 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.877 ' HB3' ' HB ' ' A' ' 143' ' ' ILE . . . -111.47 149.04 31.89 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.035 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.7 m -93.58 139.47 30.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.307 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.96 ' HB2' HD11 ' A' ' 143' ' ' ILE . 51.5 tp -120.6 97.83 5.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.205 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.94 -73.02 0.47 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.504 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -169.07 125.5 0.92 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.666 0.27 . . . . 0.0 111.044 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.98 161.35 10.69 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 116.187 -0.461 . . . . 0.0 113.243 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 142.27 -90.31 0.17 Allowed Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.198 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -157.58 99.72 1.75 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.866 0.365 . . . . 0.0 111.146 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -134.23 -130.55 3.02 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.296 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.56 145.31 36.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.856 0.36 . . . . 0.0 110.792 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.461 ' HB2' ' NH2' ' A' ' 82' ' ' ARG . 1.1 m-20 -83.45 129.29 34.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.171 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.67 114.03 4.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.481 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.34 124.78 34.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.94 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 21.7 t -117.07 124.99 73.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.852 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.6 m -89.62 121.25 31.63 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.426 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.571 HD22 ' CE1' ' A' ' 81' ' ' PHE . 4.8 tp -127.28 110.64 21.34 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.977 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -85.21 8.94 4.34 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.864 2.376 . . . . 0.0 113.117 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -165.19 150.88 9.62 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.826 0.346 . . . . 0.0 110.965 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.534 ' N ' ' HB2' ' A' ' 78' ' ' ALA . . . -67.75 141.43 56.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.326 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.17 142.53 3.88 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.46 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.82 125.93 33.02 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.847 0.356 . . . . 0.0 110.934 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.405 ' HE1' ' CD1' ' A' ' 130' ' ' TRP . 23.3 p90 -102.63 155.65 18.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.88 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 145' ' ' VAL . 23.7 m -108.19 121.79 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.001 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.464 ' CE3' ' HB ' ' A' ' 145' ' ' VAL . 4.5 m95 -88.48 112.29 22.8 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.669 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.455 ' HA ' ' CG ' ' A' ' 71' ' ' GLN . 26.9 t -124.97 131.39 53.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.367 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.815 HD23 HG12 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -133.9 135.15 43.44 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.73 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.838 ' HA ' HG22 ' A' ' 69' ' ' THR . 1.9 tptm -122.03 131.19 53.86 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.051 0.453 . . . . 0.0 111.479 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -141.59 144.86 34.44 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.156 179.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.481 HG21 ' HG2' ' A' ' 140' ' ' PRO . 13.3 t -96.48 168.84 10.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.145 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -79.56 -5.97 56.04 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.812 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.9 m -65.4 -26.81 68.15 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.05 28.42 49.81 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.971 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.619 ' CB ' ' HD3' ' A' ' 140' ' ' PRO . 0.3 OUTLIER -139.69 -62.86 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 122.295 0.238 . . . . 0.0 111.188 179.763 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.619 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 22.0 Cg_exo -64.81 123.43 11.65 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.529 2.153 . . . . 0.0 111.883 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.731 ' HG2' HD23 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -150.77 117.36 5.76 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.23 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.55 149.63 45.51 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.23 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.96 HD11 ' HB2' ' A' ' 109' ' ' LEU . 2.4 mp -123.89 149.59 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.136 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -141.2 121.52 13.96 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.765 0.317 . . . . 0.0 111.307 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.649 HG12 HD11 ' A' ' 101' ' ' LEU . 14.9 p -130.6 135.82 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.95 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.0 p -141.09 154.36 45.89 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.251 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.412 ' HG2' ' HB3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -117.5 122.39 43.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.778 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.09 122.39 40.81 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 C--O 1.251 1.14 0 C-N-CA 122.843 2.362 . . . . 0.0 112.412 -179.914 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.498 0.19 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.92 -31.44 63.01 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.687 2.258 . . . . 0.0 112.542 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 m -68.34 96.26 0.65 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.96 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.84 -46.62 2.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.018 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.5 m -142.48 79.42 1.66 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.738 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.14 -140.93 14.93 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.891 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.1 mt 57.65 44.27 20.99 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.864 0.364 . . . . 0.0 111.489 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -77.78 -40.96 39.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.306 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -115.79 118.15 32.22 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.744 0.307 . . . . 0.0 111.02 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 10' ' ' VAL . 9.0 t -95.54 19.09 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.277 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.9 143.06 29.26 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.097 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.7 t -76.81 129.87 36.86 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.017 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.97 -52.52 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.045 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.99 151.29 28.53 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.069 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.84 138.27 48.15 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.242 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.24 130.14 56.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.324 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.3 m -68.7 147.15 52.26 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.96 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.93 123.03 7.38 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.384 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 mp -96.33 86.17 4.13 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.58 ' H ' HD13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -139.53 137.32 40.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.84 144.92 12.77 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.701 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -127.29 138.61 53.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.661 0.267 . . . . 0.0 111.159 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.75 136.6 3.38 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.604 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -61.1 -34.21 74.58 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.697 0.284 . . . . 0.0 111.222 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -13.36 5.57 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.257 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.73 11.36 1.38 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.57 -19.3 45.93 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.58 88.27 2.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.74 0.305 . . . . 0.0 111.563 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -174.86 131.61 0.32 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.655 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -78.6 145.78 68.0 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.69 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -61.81 116.38 3.41 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.655 2.237 . . . . 0.0 112.049 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.915 HG22 ' HA ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -102.82 97.54 7.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 111.06 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 tt -95.72 161.27 2.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.399 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.9 107.35 0.97 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.971 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.704 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -109.41 -130.89 6.1 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.979 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -105.92 42.45 1.25 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.74 0.305 . . . . 0.0 110.776 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.6 163.48 37.02 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.812 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.74 117.58 5.22 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.908 2.405 . . . . 0.0 112.978 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.3 tt -69.82 153.12 8.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.612 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 50.81 14.25 1.04 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.117 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.22 131.84 47.01 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 117.35 0.575 . . . . 0.0 111.102 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.9 m -115.7 142.12 47.17 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.542 HD12 ' CD1' ' A' ' 70' ' ' TYR . 6.1 mt -112.24 122.67 48.38 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.406 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.51 118.74 37.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.766 0.317 . . . . 0.0 111.435 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.719 HG13 ' HG3' ' A' ' 56' ' ' GLN . 8.8 p -113.32 136.39 49.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.686 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.458 ' HB ' ' CD1' ' A' ' 54' ' ' TRP . 28.1 m -126.51 126.91 69.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.404 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.93 129.87 9.95 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.016 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 49' ' ' PHE . 6.3 t0 -120.02 94.46 4.4 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.568 ' CB ' ' HA ' ' A' ' 81' ' ' PHE . 0.3 OUTLIER 157.6 159.9 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.455 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.672 ' HB1' ' HB3' ' A' ' 78' ' ' ALA . . . 51.84 36.11 17.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.616 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.3 t70 57.05 65.01 1.48 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.199 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.48 -39.92 8.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.856 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 55.82 31.97 18.68 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.422 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.458 ' CD1' ' HB ' ' A' ' 46' ' ' VAL . 40.2 m0 53.96 62.54 2.55 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.921 0.391 . . . . 0.0 110.852 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -94.98 122.23 37.41 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.37 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.719 ' HG3' HG13 ' A' ' 45' ' ' VAL . 1.1 mm-40 -169.15 111.35 0.5 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.993 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.29 126.7 89.96 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.957 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.66 -32.96 77.75 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.79 2.327 . . . . 0.0 112.585 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -57.04 -24.29 52.69 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.778 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.414 ' HB3' ' CG2' ' A' ' 73' ' ' VAL . 77.5 mtt180 -118.8 12.92 13.09 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.555 0.217 . . . . 0.0 111.04 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 43' ' ' LEU . . . -87.0 7.79 26.11 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -157.68 90.46 1.08 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.055 0.455 . . . . 0.0 111.033 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.742 ' CZ ' HG13 ' A' ' 73' ' ' VAL . 47.1 mtm180 -110.83 114.9 28.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.523 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -77.41 118.39 19.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.207 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.915 ' HA ' HG22 ' A' ' 32' ' ' THR . 2.5 t -96.55 118.01 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.704 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -65.9 79.05 0.1 OUTLIER Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.545 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 171.55 28.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.959 0.446 . . . . 0.0 112.067 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.9 t30 62.02 22.39 13.05 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.889 0.376 . . . . 0.0 110.521 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.65 HG22 ' HA ' ' A' ' 133' ' ' LYS . 18.8 p -119.44 156.01 30.98 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.91 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.542 ' CD1' HD12 ' A' ' 43' ' ' LEU . 0.8 OUTLIER -125.52 144.96 50.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.271 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.504 ' HG2' HG22 ' A' ' 65' ' ' VAL . 3.3 pt20 -149.63 158.84 44.54 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.538 ' HB3' ' OH ' ' A' ' 85' ' ' TYR . . . -150.57 122.58 8.22 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.362 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.932 HG12 HG12 ' A' ' 129' ' ' VAL . 5.0 m -75.24 129.23 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.7 0.286 . . . . 0.0 110.847 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.2 t -130.23 139.11 52.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.533 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.53 135.0 35.58 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.443 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -111.49 143.56 42.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.51 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.464 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -141.61 104.29 4.53 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.313 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.672 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . 69.61 143.36 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.488 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 80' ' ' ALA . . . -68.85 160.47 52.15 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.816 -0.629 . . . . 0.0 114.296 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 79' ' ' GLY . . . 77.17 74.87 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.668 -0.766 . . . . 0.0 111.182 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.568 ' HA ' ' CB ' ' A' ' 49' ' ' PHE . 30.7 p90 -138.86 136.42 35.54 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.96 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -109.06 135.98 49.32 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.558 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.1 ptm -143.37 162.52 35.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.919 0.39 . . . . 0.0 111.813 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -149.91 141.89 23.88 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.784 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.538 ' OH ' ' HB3' ' A' ' 72' ' ' ALA . 14.4 m-85 -97.62 141.19 30.96 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.19 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.468 ' HA ' ' HB3' ' A' ' 93' ' ' GLN . . . -158.22 124.39 4.67 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.254 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.1 t -69.76 167.81 16.35 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.957 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -77.82 -40.83 39.19 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.635 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.62 35.48 1.36 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.739 0.304 . . . . 0.0 111.416 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 51.47 38.47 22.16 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.931 0.396 . . . . 0.0 111.305 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.49 177.86 2.67 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.5 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -43.1 119.32 1.57 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.845 2.363 . . . . 0.0 113.081 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 86' ' ' ALA . 3.6 mt-30 -118.89 -175.3 2.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.933 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.468 ' HB3' ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -123.33 119.8 31.18 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.173 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.2 p -141.64 122.78 14.69 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.053 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.434 ' HB1' ' CD2' ' A' ' 99' ' ' LEU . . . -104.04 154.05 20.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.772 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.62 26.55 4.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.566 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.19 135.87 9.08 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.424 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.434 ' CD2' ' HB1' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -174.59 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 62.77 78.57 0.29 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.515 0.674 . . . . 0.0 109.727 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.653 ' CD1' ' HB2' ' A' ' 107' ' ' ALA . 7.5 tt -70.46 147.69 49.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.931 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.523 HG23 ' HD2' ' A' ' 103' ' ' PRO . 93.3 m -113.57 143.52 29.57 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.155 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.523 ' HD2' HG23 ' A' ' 102' ' ' THR . 72.7 Cg_exo -41.16 116.36 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.885 2.39 . . . . 0.0 112.954 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.81 34.52 11.16 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.479 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.564 ' O ' HD11 ' A' ' 101' ' ' LEU . 16.8 tttt -131.38 152.55 50.52 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.077 0.465 . . . . 0.0 111.088 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.41 ' N ' ' HG2' ' A' ' 105' ' ' LYS . 2.2 p -81.28 140.2 34.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.91 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.653 ' HB2' ' CD1' ' A' ' 101' ' ' LEU . . . -104.09 148.93 25.69 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.111 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 m -86.06 133.31 33.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.855 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.683 HD23 ' HG2' ' A' ' 141' ' ' GLU . 69.4 tp -109.15 137.19 47.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.991 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -97.64 -67.89 0.83 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.924 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -178.15 -45.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.906 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 134.52 141.6 4.48 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.336 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.51 -108.31 0.39 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.117 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -145.04 99.52 3.34 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.831 0.348 . . . . 0.0 110.782 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.58 -137.22 5.05 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.589 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.95 129.56 55.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.632 0.253 . . . . 0.0 110.854 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -64.86 141.59 58.72 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.044 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 67.9 m -85.7 129.02 34.94 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.912 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -102.0 132.59 47.75 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.346 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.505 ' HB ' ' CZ ' ' A' ' 81' ' ' PHE . 15.8 t -119.92 129.96 74.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 121' ' ' THR . 5.6 m -95.44 93.02 6.97 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.911 0.386 . . . . 0.0 111.123 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.647 HD13 ' HD3' ' A' ' 147' ' ' LYS . 41.7 tp -131.91 100.3 16.04 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.192 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.66 -0.8 9.38 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.567 2.178 . . . . 0.0 113.891 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -110.33 122.43 47.66 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.7 0.286 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.428 ' HB2' ' HE2' ' A' ' 77' ' ' LYS . . . -72.99 120.76 19.07 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -165.18 168.11 39.12 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.79 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -68.05 131.8 46.11 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.934 0.397 . . . . 0.0 111.293 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.609 ' CE1' HG22 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -112.84 146.65 38.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.424 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.932 HG12 HG12 ' A' ' 73' ' ' VAL . 27.2 m -124.44 120.1 58.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.95 0.405 . . . . 0.0 110.988 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.81 ' CE3' HG21 ' A' ' 145' ' ' VAL . 4.5 t-105 -100.16 112.16 24.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.379 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 t -121.09 149.38 42.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.522 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.811 HD23 HD12 ' A' ' 143' ' ' ILE . 3.0 mp -133.68 135.41 44.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.527 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.65 ' HA ' HG22 ' A' ' 69' ' ' THR . 1.1 tptm -123.72 120.03 31.5 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.972 0.415 . . . . 0.0 111.203 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.417 ' HB3' ' CG ' ' A' ' 141' ' ' GLU . 0.1 OUTLIER -141.77 145.12 34.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.667 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.2 p -89.69 171.8 9.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.06 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -88.12 7.64 30.64 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.639 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.6 t -69.98 -26.73 64.23 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.454 0.169 . . . . 0.0 111.335 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.05 42.39 8.83 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.556 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.445 ' CB ' ' CD ' ' A' ' 140' ' ' PRO . 0.4 OUTLIER -158.93 -65.63 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 120.294 0.092 . . . . 0.0 111.018 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 139' ' ' ASP . 39.7 Cg_endo -66.55 122.55 10.0 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.5 2.134 . . . . 0.0 112.226 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.683 ' HG2' HD23 ' A' ' 109' ' ' LEU . 4.6 mt-10 -142.43 111.23 6.29 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.804 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.534 ' O ' HD13 ' A' ' 143' ' ' ILE . 1.2 tp60 -122.96 149.94 43.62 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.914 0.388 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.811 HD12 HD23 ' A' ' 132' ' ' LEU . 12.1 mm -123.37 147.73 27.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.535 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.65 124.51 19.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.814 0.34 . . . . 0.0 111.068 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.81 HG21 ' CE3' ' A' ' 130' ' ' TRP . 14.8 p -132.92 137.56 53.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.5 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.1 p -139.93 155.64 47.06 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.795 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.647 ' HD3' HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -117.61 125.38 50.67 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.892 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 84.0 m -123.63 116.4 27.94 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.936 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 C--O 1.25 1.1 0 C-N-CA 122.709 2.273 . . . . 0.0 112.729 179.968 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.396 0.141 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.62 91.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.834 2.356 . . . . 0.0 112.069 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.49 150.31 34.32 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.995 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.41 -27.94 56.48 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.744 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 t -58.99 -53.67 55.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.505 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.37 52.47 0.63 Allowed Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.412 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.76 142.67 31.9 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.758 0.313 . . . . 0.0 110.786 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 t -169.23 161.23 10.07 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.189 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -98.37 113.79 25.89 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.725 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.28 81.31 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.034 0.445 . . . . 0.0 111.148 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.74 138.52 37.33 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.538 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 p -97.74 130.7 44.69 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.035 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 m 40.14 82.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.337 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -127.83 136.94 52.13 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.336 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 65.58 111.97 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.841 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 70.85 131.46 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.532 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 m -162.18 117.05 1.89 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.323 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.4 135.6 54.25 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.775 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 tp -135.27 84.17 2.07 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.95 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.3 tt -88.22 135.73 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.822 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.05 141.74 5.5 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.67 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -151.76 138.65 18.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.668 0.271 . . . . 0.0 111.153 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.04 95.27 2.26 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.694 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -64.53 -34.98 79.49 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.564 0.221 . . . . 0.0 111.018 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.0 ptp -70.7 -25.9 63.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.126 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -101.19 11.45 39.38 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -80.24 -28.89 38.4 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 122.337 -0.227 . . . . 0.0 111.101 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.65 ' O ' HG21 ' A' ' 129' ' ' VAL . 31.2 p -87.49 2.69 49.93 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.79 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -174.37 125.27 0.32 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.875 0.369 . . . . 0.0 111.303 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -95.88 152.9 39.32 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.588 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.41 127.67 26.19 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.821 2.347 . . . . 0.0 112.45 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.925 HG22 ' HA ' ' A' ' 65' ' ' VAL . 0.5 OUTLIER -100.62 126.31 47.09 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.202 0.525 . . . . 0.0 111.997 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.419 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 12.4 tt -135.94 162.61 36.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.043 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -56.76 107.85 0.44 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.95 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.758 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -119.94 -130.59 4.02 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.239 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.76 33.63 5.56 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.566 0.222 . . . . 0.0 111.584 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.12 178.81 12.37 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.972 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.58 125.63 5.68 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.811 2.34 . . . . 0.0 113.173 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.479 HD11 ' CZ ' ' A' ' 64' ' ' TYR . 21.0 mm -104.97 153.87 6.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.134 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 62.33 22.76 63.66 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.542 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -129.59 132.41 46.77 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.698 0.285 . . . . 0.0 111.029 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.457 HG23 ' HB1' ' A' ' 61' ' ' ALA . 72.5 m -115.09 128.43 56.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.706 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.413 ' HB2' ' OH ' ' A' ' 70' ' ' TYR . 4.0 mm? -100.84 122.69 43.86 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.441 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -103.95 119.05 38.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.883 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 45' ' ' VAL . 12.1 p -97.14 119.07 44.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.972 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.4 m -122.41 -178.2 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.001 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' A' ' 83' ' ' MET . . . 133.68 -91.04 0.25 Allowed Glycine 0 CA--C 1.518 0.281 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER 160.81 129.25 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.814 0.446 . . . . 0.0 110.129 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 83' ' ' MET . 6.8 m-85 -137.62 27.58 2.75 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 51' ' ' ASP . . . 51.95 92.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.838 0.351 . . . . 0.0 111.186 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 50' ' ' ALA . 17.8 t70 87.44 21.87 0.06 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.238 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.96 43.72 0.1 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.646 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 m -67.43 87.67 0.2 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.918 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.529 ' CD1' ' N ' ' A' ' 54' ' ' TRP . 1.3 m0 73.07 61.13 0.1 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.684 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -107.46 116.1 31.34 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.472 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -153.15 94.78 1.88 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.578 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.409 ' CG ' ' HG2' ' A' ' 60' ' ' ARG . 5.5 ptmt -74.02 135.93 76.68 Favored Pre-proline 0 C--O 1.233 0.187 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.727 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 52.3 Cg_exo -55.09 -26.6 51.19 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.897 2.398 . . . . 0.0 112.95 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -28.26 69.35 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.495 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.409 ' HG2' ' CG ' ' A' ' 57' ' ' LYS . 0.6 OUTLIER -130.97 22.53 4.92 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.79 0.329 . . . . 0.0 110.916 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . . . -63.35 -16.89 61.8 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.119 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -162.69 128.18 3.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.711 0.291 . . . . 0.0 111.164 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 mtm105 -116.85 130.86 56.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.663 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.479 ' CZ ' HD11 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -76.6 118.64 19.45 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.458 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.925 ' HA ' HG22 ' A' ' 32' ' ' THR . 1.8 t -107.77 105.55 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.758 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -55.51 88.62 0.01 OUTLIER Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.595 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.441 ' CB ' ' O ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER 158.93 27.2 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.188 0.581 . . . . 0.0 112.485 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 61.83 21.47 12.27 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.884 0.373 . . . . 0.0 110.199 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.748 HG23 ' HG3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -111.58 155.88 22.64 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.074 -179.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.413 ' OH ' ' HB2' ' A' ' 43' ' ' LEU . 47.9 t80 -114.62 134.97 54.65 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.772 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.47 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . 2.8 tp-100 -126.56 136.46 52.59 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.741 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.67 110.35 4.04 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.419 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.568 HG22 HG12 ' A' ' 129' ' ' VAL . 39.7 t -76.85 132.36 33.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.272 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.566 ' HB ' ' CE1' ' A' ' 128' ' ' TYR . 14.1 t -130.69 136.54 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.743 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -96.92 131.12 44.01 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.518 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -138.57 161.5 36.93 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.864 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.15 172.74 10.97 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.697 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.798 ' HB2' ' HB2' ' A' ' 125' ' ' ALA . . . -82.01 129.53 34.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.399 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.88 140.05 0.67 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.247 -0.501 . . . . 0.0 113.117 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.07 104.04 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.861 0.363 . . . . 0.0 111.499 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 122' ' ' LEU . 19.5 m-85 -132.21 138.69 48.05 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.733 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 -159.35 127.64 5.05 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.186 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -151.97 174.0 14.17 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.135 0.493 . . . . 0.0 112.074 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -168.29 142.75 3.4 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.26 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.548 ' O ' ' HB2' ' A' ' 93' ' ' GLN . 4.0 m-85 -99.09 142.94 29.93 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 111.35 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.97 125.1 3.48 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.75 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.13 169.49 14.94 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.261 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -78.91 -34.75 44.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.319 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.5 31.14 2.63 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.299 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 53.41 40.57 31.54 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.968 0.414 . . . . 0.0 111.249 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.404 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 1.0 OUTLIER -86.58 178.55 2.21 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.567 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 91' ' ' SER . 99.1 Cg_exo -43.62 121.72 2.85 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.726 2.284 . . . . 0.0 112.895 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.548 ' HB2' ' O ' ' A' ' 85' ' ' TYR . 11.8 pt20 -118.36 -175.22 2.82 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.616 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.446 ' HB3' ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -123.0 121.32 35.8 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.084 0.468 . . . . 0.0 110.428 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.82 112.81 3.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.191 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 99' ' ' LEU . . . -107.86 130.02 55.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.464 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.67 118.93 24.19 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.904 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.11 42.27 80.97 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.196 -0.525 . . . . 0.0 112.367 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.529 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 4.7 tp -84.61 -56.65 3.5 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.547 0.202 . . . . 0.0 111.547 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 60.74 85.2 0.12 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.328 0.585 . . . . 0.0 110.02 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.727 ' CG ' HG11 ' A' ' 145' ' ' VAL . 7.1 tt -69.94 144.48 52.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.546 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.453 HG23 ' HD2' ' A' ' 103' ' ' PRO . 87.9 m -135.35 142.93 43.32 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.129 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.454 ' HG3' HD11 ' A' ' 122' ' ' LEU . 85.2 Cg_exo -46.52 111.05 0.32 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.669 2.246 . . . . 0.0 112.479 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.39 34.43 16.92 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.553 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.743 ' O ' HG12 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -128.38 150.83 49.94 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.995 0.426 . . . . 0.0 110.864 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.526 HG22 ' HG2' ' A' ' 144' ' ' MET . 28.4 p -80.39 142.53 34.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.024 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.831 ' HB3' ' HB ' ' A' ' 143' ' ' ILE . . . -103.88 140.21 38.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.234 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.2 m -76.49 126.99 31.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.224 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.836 ' HG ' HD11 ' A' ' 143' ' ' ILE . 0.6 OUTLIER -116.28 96.59 5.62 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.644 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.93 -48.26 0.37 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.316 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.75 131.14 34.21 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.695 0.283 . . . . 0.0 110.798 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -133.75 61.73 0.64 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.571 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.84 90.49 0.08 OUTLIER Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.562 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 64.74 98.92 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 111.298 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -145.01 -134.84 2.8 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.281 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.82 131.36 55.06 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.621 0.248 . . . . 0.0 110.708 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.08 132.49 48.65 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.69 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 101' ' ' LEU . 4.2 m -80.82 114.32 19.62 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.594 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.41 144.96 26.07 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.439 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 81' ' ' PHE . 2.5 t -127.43 138.76 53.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.995 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.3 m -106.7 100.72 10.21 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.414 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.583 ' HB2' ' CE1' ' A' ' 81' ' ' PHE . 0.9 OUTLIER -130.87 117.5 17.31 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.051 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.32 8.24 4.5 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.796 2.331 . . . . 0.0 113.303 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -129.38 143.07 50.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.675 0.274 . . . . 0.0 110.942 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.798 ' HB2' ' HB2' ' A' ' 78' ' ' ALA . . . -86.72 140.08 30.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.041 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 166.92 177.11 38.46 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.776 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -101.75 135.73 42.8 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 111.085 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.566 ' CE1' ' HB ' ' A' ' 74' ' ' VAL . 14.1 p90 -108.73 163.24 13.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.811 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.65 HG21 ' O ' ' A' ' 28' ' ' CYS . 12.1 m -111.76 130.7 64.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.433 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.474 ' HE1' ' HH ' ' A' ' 128' ' ' TYR . 1.7 m95 -92.37 112.44 24.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.536 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.477 ' C ' HD12 ' A' ' 132' ' ' LEU . 0.9 OUTLIER -109.32 125.94 52.85 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.979 0.418 . . . . 0.0 110.584 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.622 ' HG ' HG23 ' A' ' 143' ' ' ILE . 7.0 mp -134.33 135.76 42.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.493 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.748 ' HG3' HG23 ' A' ' 69' ' ' THR . 14.8 tttm -127.91 132.15 49.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.972 0.415 . . . . 0.0 111.688 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -128.92 145.3 51.26 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.62 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.94 HG21 ' HD2' ' A' ' 140' ' ' PRO . 10.3 t -78.45 178.91 7.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.287 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.22 -35.21 16.32 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.312 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 t -68.97 -26.82 65.23 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.503 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.727 ' H ' HG23 ' A' ' 135' ' ' THR . . . 88.83 26.49 26.7 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.248 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.582 ' CB ' ' CD ' ' A' ' 140' ' ' PRO . 0.9 OUTLIER -106.6 -76.49 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 117.122 0.461 . . . . 0.0 110.948 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.94 ' HD2' HG21 ' A' ' 135' ' ' THR . 37.1 Cg_endo -65.7 136.33 45.38 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.247 1.964 . . . . 0.0 112.264 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.783 ' HG2' HD13 ' A' ' 109' ' ' LEU . 5.8 tt0 -149.54 117.36 6.26 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.829 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.72 158.25 44.6 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.343 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.836 HD11 ' HG ' ' A' ' 109' ' ' LEU . 24.2 mt -124.99 154.8 33.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.254 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.526 ' HG2' HG22 ' A' ' 106' ' ' THR . 0.0 OUTLIER -143.21 134.27 25.67 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.964 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 105' ' ' LYS . 14.0 p -122.73 140.29 46.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.849 0.357 . . . . 0.0 111.028 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 51.8 p -138.17 155.29 48.84 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.88 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.06 136.68 52.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 69.6 m -94.38 149.67 37.03 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.034 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 C--O 1.249 1.043 0 C-N-CA 122.741 2.294 . . . . 0.0 112.841 179.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.47 ' HB ' ' HD3' ' A' ' 2' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.47 ' HD3' ' HB ' ' A' ' 1' ' ' THR . 73.0 Cg_endo -77.8 -44.72 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.187 1.925 . . . . 0.0 113.146 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.32 30.66 12.91 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.651 0.262 . . . . 0.0 111.278 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.91 36.21 4.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.037 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 m -67.52 -42.26 83.06 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.109 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.17 72.02 0.03 OUTLIER Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.407 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.6 mt -62.52 119.83 9.93 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.748 0.309 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.33 87.13 2.47 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.934 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.75 ' O ' HG12 ' A' ' 10' ' ' VAL . 8.4 tttt -91.69 121.13 33.06 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.706 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 9' ' ' LYS . 9.9 p 56.75 153.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.882 0.739 . . . . 0.0 112.359 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.03 113.53 14.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.921 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.2 t -108.19 117.79 35.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.896 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 t 65.51 130.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.653 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.5 t -111.24 143.8 41.42 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.51 137.27 21.54 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.186 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.8 120.38 11.16 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.201 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 m -83.13 135.64 34.74 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.17 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.57 103.27 10.85 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.606 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 mp 57.37 26.29 12.3 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.397 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.9 tt -135.62 138.7 47.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.829 0.347 . . . . 0.0 110.987 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.66 143.24 15.63 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.466 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -128.67 138.35 52.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.641 0.258 . . . . 0.0 110.703 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.78 -18.1 41.07 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.779 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -53.15 -37.85 62.2 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.83 0.315 . . . . 0.0 111.457 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -60.49 -30.08 69.48 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.408 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -105.25 11.32 33.11 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.428 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -92.05 -30.67 15.91 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.406 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 p 178.97 -35.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.38 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.44 85.27 0.17 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.1 0.476 . . . . 0.0 110.494 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 3.4 m-80 -75.49 113.91 30.86 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.105 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 30' ' ' ASN . 1.2 Cg_endo -82.03 100.55 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.491 2.127 . . . . 0.0 112.154 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -116.93 97.26 5.86 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.34 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.591 HD13 ' N ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -129.74 102.79 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.294 0.569 . . . . 0.0 111.982 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 67' ' ' GLU . 8.8 mm-40 -146.27 106.9 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.049 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.83 -130.05 6.58 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.371 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -157.94 93.13 1.23 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 111.242 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.82 158.68 32.68 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.848 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.73 104.18 1.44 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.664 2.243 . . . . 0.0 112.938 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.436 ' HA ' ' CE2' ' A' ' 64' ' ' TYR . 3.7 mt -77.11 154.06 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.84 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 74.65 25.69 69.3 Favored Glycine 0 C--N 1.337 0.583 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.822 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.54 131.85 45.28 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.969 0.414 . . . . 0.0 111.535 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.934 HG23 ' HB1' ' A' ' 61' ' ' ALA . 61.6 m -115.71 141.65 47.8 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.575 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 43' ' ' LEU . 9.9 mt -112.65 124.1 51.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.626 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.86 118.36 36.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.399 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 85' ' ' TYR . 13.8 p -111.78 136.06 49.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.18 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.571 HG12 HE22 ' A' ' 56' ' ' GLN . 7.9 m -122.39 120.35 60.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.247 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.71 110.27 1.45 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.372 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.21 82.74 0.35 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.097 0.475 . . . . 0.0 110.322 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.449 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 13.6 m-85 -83.52 -171.81 3.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.086 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.23 -61.07 2.0 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.711 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -109.24 44.82 1.11 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.884 0.373 . . . . 0.0 111.35 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 49' ' ' PHE . . . -154.61 -56.5 0.1 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.958 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.6 m 53.54 98.48 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.373 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 19.2 m0 66.55 62.57 0.53 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.689 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HG3' ' HB1' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -94.69 125.17 39.17 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.29 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.571 HE22 HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -146.43 143.36 28.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.761 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -123.98 147.58 54.51 Favored Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.919 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.12 -30.8 46.53 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.603 2.202 . . . . 0.0 112.349 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.16 2.4 35.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.561 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -128.6 19.82 6.17 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.37 0.128 . . . . 0.0 111.055 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.934 ' HB1' HG23 ' A' ' 42' ' ' THR . . . -47.38 -50.97 21.15 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.926 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.422 ' CE1' ' CE1' ' A' ' 64' ' ' TYR . 0.0 OUTLIER 176.33 123.89 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.62 179.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 33.8 ttp180 -83.9 135.41 34.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.931 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.436 ' CE2' ' HA ' ' A' ' 39' ' ' ILE . 7.6 m-85 -81.57 118.92 23.16 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.121 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -128.9 103.99 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 67' ' ' GLU . . . -41.45 163.6 0.02 OUTLIER Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.794 -0.639 . . . . 0.0 114.513 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.446 ' HB3' HG23 ' A' ' 69' ' ' THR . 1.1 tm-20 84.49 28.98 0.07 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.148 0.579 . . . . 0.0 111.922 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 62.6 19.83 11.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.445 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.81 HG22 ' HG2' ' A' ' 133' ' ' LYS . 3.0 p -97.82 152.63 18.97 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -128.28 142.89 51.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.734 0.302 . . . . 0.0 110.888 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -143.77 136.62 27.38 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.844 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.17 130.76 13.96 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.696 0.284 . . . . 0.0 111.416 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.4 t -81.98 131.82 32.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.761 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.7 t -125.27 145.68 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.92 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -116.47 118.76 33.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.411 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -127.13 163.9 22.79 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.348 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.32 174.51 5.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.505 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.67 ' HB1' ' O ' ' A' ' 123' ' ' PRO . . . -68.32 123.33 20.44 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.443 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 127.55 148.69 6.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.298 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.14 131.74 45.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.782 0.325 . . . . 0.0 111.391 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.03 147.53 37.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.004 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.0 mtp-105 -104.49 154.42 19.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.91 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -152.98 162.91 40.75 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.077 0.465 . . . . 0.0 111.955 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.52 156.73 32.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.674 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.524 ' HB2' ' HB3' ' A' ' 94' ' ' PHE . 2.9 m-85 -113.39 146.24 39.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.922 0.391 . . . . 0.0 111.175 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.73 123.38 1.5 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.073 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.01 147.39 45.16 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.943 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -60.73 -30.0 69.72 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.45 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.59 28.26 4.32 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.619 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 1.7 m95 54.4 38.82 30.29 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.988 0.423 . . . . 0.0 111.098 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.423 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -86.88 178.71 2.1 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.047 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 91' ' ' SER . 93.3 Cg_exo -43.28 118.53 1.38 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.857 2.371 . . . . 0.0 112.683 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.478 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 41.8 mt-30 -105.03 -175.01 2.67 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.203 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.524 ' HB3' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -127.09 133.17 50.47 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.755 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.12 111.71 1.97 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.543 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.688 ' HB3' ' CG2' ' A' ' 118' ' ' THR . . . -92.08 100.18 12.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.854 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.07 107.65 0.57 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.038 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 54.45 77.67 0.14 Allowed Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.607 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.739 HD21 ' CB ' ' A' ' 107' ' ' ALA . 6.0 tp -138.72 -34.51 0.61 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 47.66 79.67 0.06 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.577 0.703 . . . . 0.0 110.782 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.812 HD21 HG21 ' A' ' 145' ' ' VAL . 1.2 tp -47.35 139.77 6.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.011 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.9 m -128.43 141.38 41.27 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.607 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.651 ' CG ' HD13 ' A' ' 122' ' ' LEU . 75.6 Cg_exo -51.2 127.61 22.57 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.99 2.46 . . . . 0.0 112.857 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.17 34.76 85.57 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.535 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 145.9 50.95 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.049 0.452 . . . . 0.0 111.298 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.9 m -71.13 144.08 50.36 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.889 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.739 ' CB ' HD21 ' A' ' 99' ' ' LEU . . . -127.97 150.28 49.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.523 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.19 139.01 32.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.035 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.632 HD22 ' CE2' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -114.72 96.99 6.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.399 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -73.45 0.28 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.324 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.38 -177.72 5.78 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.719 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.18 141.02 12.32 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.598 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.59 -90.04 0.21 Allowed Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.485 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -126.51 90.88 3.25 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.879 0.371 . . . . 0.0 110.721 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -136.67 -139.59 3.97 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.047 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -111.05 124.16 51.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.696 0.284 . . . . 0.0 110.849 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.69 151.11 48.05 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.688 ' CG2' ' HB3' ' A' ' 96' ' ' ALA . 40.2 p -93.95 114.33 26.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.057 0.456 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.13 126.35 40.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.646 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.449 HG23 ' HD3' ' A' ' 103' ' ' PRO . 9.9 p -117.21 124.96 73.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.958 0.408 . . . . 0.0 110.984 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.2 m -94.06 94.78 8.6 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.75 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.651 HD13 ' CG ' ' A' ' 103' ' ' PRO . 13.7 tp -130.8 100.69 17.38 Favored Pre-proline 0 N--CA 1.456 -0.169 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.254 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.67 ' O ' ' HB1' ' A' ' 78' ' ' ALA . 10.6 Cg_exo -71.44 8.91 1.04 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.371 2.714 . . . . 0.0 113.499 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -114.29 141.76 47.18 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.72 0.295 . . . . 0.0 110.923 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -100.41 140.04 35.23 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 170.38 -175.35 44.31 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.113 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -77.96 139.95 39.2 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 110.879 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.64 ' HE1' HG22 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -126.37 147.05 49.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.04 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 17.3 m -123.53 122.17 64.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.941 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -90.09 115.56 27.44 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.42 ' C ' HD12 ' A' ' 132' ' ' LEU . 5.2 t -109.11 126.16 52.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.531 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 132' ' ' LEU . 3.4 mp -140.84 136.32 32.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.81 ' HG2' HG22 ' A' ' 69' ' ' THR . 0.0 OUTLIER -133.0 120.12 20.96 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.906 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.632 ' CE2' HD22 ' A' ' 109' ' ' LEU . 3.2 m-85 -126.43 145.06 50.62 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.366 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 81.1 p -113.42 176.55 4.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.427 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -87.03 -18.91 29.48 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.747 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.8 m -65.87 -26.91 67.85 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.64 -17.47 54.48 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.385 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.465 ' CB ' ' HD3' ' A' ' 140' ' ' PRO . 0.5 OUTLIER -92.63 -54.52 0.25 Allowed Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 117.004 0.402 . . . . 0.0 110.976 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.465 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 13.5 Cg_exo -68.22 75.97 0.7 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.59 2.193 . . . . 0.0 112.122 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -130.67 103.46 6.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.631 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.18 152.91 41.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.65 HG13 ' HB3' ' A' ' 107' ' ' ALA . 5.2 pt -124.16 162.44 25.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.322 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -142.58 156.87 45.15 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.924 0.392 . . . . 0.0 111.013 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.812 HG21 HD21 ' A' ' 101' ' ' LEU . 13.4 p -135.9 134.25 50.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.2 m -145.01 153.02 41.05 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.97 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.557 ' HE3' HD11 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -111.71 155.76 22.96 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.368 -179.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 14.1 m -87.33 109.19 23.71 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.334 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 C--O 1.249 1.072 0 C-N-CA 122.893 2.395 . . . . 0.0 112.825 -179.635 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.398 0.142 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -51.77 96.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.977 2.451 . . . . 0.0 112.663 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.48 -51.04 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.8 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.42 85.98 2.5 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.392 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.23 104.17 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.507 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.29 43.6 2.52 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.631 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.21 149.68 48.88 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.726 0.298 . . . . 0.0 110.73 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.6 m -110.31 86.71 2.36 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.006 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.66 120.36 27.02 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.837 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.47 152.06 21.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.411 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.32 118.48 20.55 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.207 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 t -91.76 123.98 35.56 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.104 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 15' ' ' ALA . 21.6 t 67.97 131.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.585 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.9 p -79.9 -28.36 39.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.206 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' H ' HG12 ' A' ' 13' ' ' VAL . . . 65.82 91.31 0.08 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.012 0.434 . . . . 0.0 111.423 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -168.44 135.68 2.04 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.11 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.1 p -102.32 98.04 8.22 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.513 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.3 m -121.81 128.71 51.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.271 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.477 ' N ' HD22 ' A' ' 19' ' ' LEU . 3.4 mm? -92.23 -30.1 16.08 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.104 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 tt -73.56 137.32 23.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.704 0.287 . . . . 0.0 111.299 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -128.98 142.69 13.78 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.527 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -143.81 138.61 28.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.752 0.31 . . . . 0.0 111.218 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.17 33.48 5.58 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.857 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -63.91 -34.97 79.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.702 0.287 . . . . 0.0 111.025 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 15.4 mtm -62.65 -26.15 68.49 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.237 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.88 -16.79 64.25 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -85.97 11.64 11.07 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.564 ' O ' HG11 ' A' ' 129' ' ' VAL . 31.9 m 64.82 22.45 12.53 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.676 0.274 . . . . 0.0 111.367 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.44 91.56 5.87 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.88 0.371 . . . . 0.0 110.36 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -88.94 113.35 55.67 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.011 -179.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 30' ' ' ASN . 1.8 Cg_endo -82.78 99.41 0.92 Allowed 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.323 2.015 . . . . 0.0 111.508 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.474 ' O ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -116.98 97.19 5.81 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.467 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -135.88 102.16 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.32 0.581 . . . . 0.0 111.886 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 67' ' ' GLU . 20.7 mt-10 -146.77 106.65 3.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.683 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.77 -144.92 16.01 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.052 -1.07 . . . . 0.0 112.232 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -137.84 107.33 6.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.72 0.295 . . . . 0.0 111.016 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.71 -165.16 8.4 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.214 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.34 107.37 2.43 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.511 2.141 . . . . 0.0 112.315 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.508 HG12 ' CE2' ' A' ' 64' ' ' TYR . 18.6 mt -90.14 153.88 3.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.442 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.474 ' N ' HG22 ' A' ' 39' ' ' ILE . . . 59.62 19.4 48.45 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.067 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -130.62 131.54 44.99 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.887 0.375 . . . . 0.0 111.465 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.4 ' HB ' ' CD2' ' A' ' 62' ' ' TYR . 4.5 t -116.01 141.06 48.62 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.95 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.45 HD12 ' CD1' ' A' ' 70' ' ' TYR . 63.2 mt -100.33 146.39 27.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.643 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -125.16 118.96 27.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.041 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.443 ' HB ' ' CE1' ' A' ' 85' ' ' TYR . 12.1 p -110.64 131.3 62.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.338 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.4 m -143.51 -179.2 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.362 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 83' ' ' MET . . . 150.32 -101.79 0.22 Allowed Glycine 0 N--CA 1.453 -0.205 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 81' ' ' PHE . 6.4 p-10 -171.54 117.17 0.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 111.06 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 83' ' ' MET . 1.1 m-85 -126.29 44.17 2.93 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.318 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 49' ' ' PHE . . . 72.97 -68.34 0.23 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -178.28 50.56 0.01 OUTLIER 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.165 0.507 . . . . 0.0 110.269 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.22 30.86 0.54 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.779 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.514 ' HG ' ' HD1' ' A' ' 49' ' ' PHE . 82.8 p -142.15 -142.33 0.14 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.948 -0.115 . . . . 0.0 110.795 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 10.3 m0 53.12 34.15 16.68 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -136.47 125.44 24.29 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.005 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.76 75.58 1.48 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.973 0.416 . . . . 0.0 110.89 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -71.58 162.3 73.75 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.073 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.52 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 21.0 Cg_endo -60.67 -33.15 93.66 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.725 2.283 . . . . 0.0 112.651 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -59.92 -27.38 66.71 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.384 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -129.77 21.94 5.45 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.798 0.332 . . . . 0.0 110.726 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . . . -58.42 -39.89 81.0 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.449 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.401 ' HB2' ' CE2' ' A' ' 70' ' ' TYR . 13.0 p90 -171.58 140.45 1.36 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.53 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -111.51 120.34 41.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.215 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.508 ' CE2' HG12 ' A' ' 39' ' ' ILE . 23.6 t80 -73.89 118.13 16.49 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.875 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -134.41 113.19 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.482 -0.781 . . . . 0.0 108.978 178.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -41.76 166.67 0.01 OUTLIER Glycine 0 C--N 1.338 0.65 0 N-CA-C 114.921 0.729 . . . . 0.0 114.921 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER 76.88 26.93 0.75 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.836 0.454 . . . . 0.0 112.073 178.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 61.95 19.79 11.01 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.666 0.27 . . . . 0.0 111.384 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.687 ' O ' HG23 ' A' ' 65' ' ' VAL . 21.7 p -92.02 150.91 20.72 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.515 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.45 ' CD1' HD12 ' A' ' 43' ' ' LEU . 9.9 t80 -128.17 134.09 49.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.518 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 130' ' ' TRP . 0.7 OUTLIER -132.85 137.46 46.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.786 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.44 132.04 14.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.419 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.84 131.0 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.6 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.85 142.23 44.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 111.855 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -95.74 124.39 39.74 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.598 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.543 ' HG3' ' CD2' ' A' ' 128' ' ' TYR . 1.7 mm-40 -116.94 163.32 16.39 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.964 0.411 . . . . 0.0 111.815 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -117.92 167.44 11.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.061 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.9 115.52 7.52 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.181 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 122' ' ' LEU . . . 129.43 147.79 6.39 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.321 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.93 137.34 58.23 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.767 0.318 . . . . 0.0 111.329 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.431 ' CE2' ' CG1' ' A' ' 120' ' ' VAL . 4.1 p90 -140.97 146.51 37.42 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.509 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.0 139.63 43.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.588 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.554 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -153.51 176.08 12.45 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.018 0.437 . . . . 0.0 111.948 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.46 142.09 13.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.46 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.508 ' O ' ' HB2' ' A' ' 93' ' ' GLN . 0.1 OUTLIER -97.68 143.14 28.64 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.717 0.294 . . . . 0.0 110.996 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.481 ' HA ' ' HB3' ' A' ' 93' ' ' GLN . . . -162.35 124.54 2.78 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.356 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.449 ' HB3' ' H ' ' A' ' 91' ' ' SER . 0.2 OUTLIER -71.86 179.15 3.3 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.963 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -84.54 -48.01 10.0 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.212 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -94.09 46.48 1.17 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.328 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 45.66 41.17 6.91 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.558 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.501 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.4 OUTLIER -86.41 170.21 13.15 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.83 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' A' ' 91' ' ' SER . 2.3 Cg_endo -41.45 117.82 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.344 2.696 . . . . 0.0 112.598 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.508 ' HB2' ' O ' ' A' ' 85' ' ' TYR . 4.5 pt20 -124.74 -175.51 3.3 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.53 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.604 ' HA ' HD11 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -123.4 133.65 54.06 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.981 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.447 HG21 ' HA2' ' A' ' 112' ' ' GLY . 0.3 OUTLIER -163.08 112.58 1.34 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.45 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.01 112.76 25.52 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.311 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -78.52 122.84 26.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.375 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.43 49.75 8.32 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.734 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.608 ' C ' HD13 ' A' ' 99' ' ' LEU . 3.0 tm? -108.02 -53.86 2.57 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.425 ' C ' HD13 ' A' ' 99' ' ' LEU . 0.3 OUTLIER 61.76 82.03 0.18 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.388 0.613 . . . . 0.0 109.63 -178.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.5 HD12 ' HB2' ' A' ' 107' ' ' ALA . 9.6 tt -69.12 147.34 51.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.134 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.564 HG23 ' HD2' ' A' ' 103' ' ' PRO . 95.1 m -117.32 144.54 34.1 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.847 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.564 ' HD2' HG23 ' A' ' 102' ' ' THR . 78.2 Cg_exo -40.76 110.7 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.727 2.284 . . . . 0.0 112.935 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.78 34.77 23.9 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.504 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.17 155.81 46.38 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.056 0.455 . . . . 0.0 111.202 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.671 HG23 ' HB3' ' A' ' 144' ' ' MET . 1.5 m -91.31 145.07 24.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.454 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.5 ' HB2' HD12 ' A' ' 101' ' ' LEU . . . -124.1 146.68 48.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.492 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.2 m -68.86 145.14 53.96 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.095 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.674 HD22 ' HG2' ' A' ' 141' ' ' GLU . 2.4 tt -129.95 133.19 46.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.805 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.2 -65.7 0.85 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.261 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -172.01 142.89 1.5 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.762 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.447 ' HA2' HG21 ' A' ' 95' ' ' THR . . . -72.01 -119.46 0.06 OUTLIER Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.126 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 58.7 45.5 94.69 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.207 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 62.09 87.03 0.1 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.85 0.357 . . . . 0.0 111.252 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -115.35 -139.79 6.92 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.264 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.85 122.88 33.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.585 0.231 . . . . 0.0 110.56 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.76 122.76 18.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.839 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -76.87 114.31 15.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.613 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.88 123.51 38.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.991 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.431 ' CG1' ' CE2' ' A' ' 81' ' ' PHE . 10.2 p -117.27 131.96 68.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.3 m -80.97 112.37 18.3 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.231 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.644 HD21 ' HE2' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -125.92 108.17 25.22 Favored Pre-proline 0 CA--C 1.529 0.164 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.301 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -84.72 8.35 4.68 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.641 2.227 . . . . 0.0 113.31 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.436 ' O ' HD12 ' A' ' 122' ' ' LEU . 16.3 tt0 -166.68 150.59 7.15 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.988 0.423 . . . . 0.0 111.504 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.87 142.25 40.26 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.998 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -178.13 163.8 32.18 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.871 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -65.3 137.57 57.62 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.748 0.309 . . . . 0.0 111.084 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.644 ' HE2' HD21 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -125.33 149.9 47.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.005 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.564 HG11 ' O ' ' A' ' 28' ' ' CYS . 26.4 m -124.61 127.76 73.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.34 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.628 ' CE2' HG11 ' A' ' 145' ' ' VAL . 0.9 OUTLIER -103.34 113.52 27.07 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.74 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.446 ' C ' HD13 ' A' ' 132' ' ' LEU . 78.6 p -134.97 126.25 28.22 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.147 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -148.48 149.01 30.91 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.118 0.485 . . . . 0.0 111.244 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.494 ' HG3' HG22 ' A' ' 69' ' ' THR . 12.3 tttm -109.81 134.7 51.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.817 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.443 ' HE1' HD13 ' A' ' 109' ' ' LEU . 22.8 m-85 -114.72 144.83 42.84 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.379 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.49 HG21 ' N ' ' A' ' 139' ' ' ASP . 9.9 t -82.38 163.8 21.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.8 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -91.48 -43.06 9.92 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.203 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 p -68.77 -26.85 65.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.765 0.317 . . . . 0.0 111.524 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.21 30.58 7.31 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.223 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.554 ' CB ' ' HD3' ' A' ' 140' ' ' PRO . 0.6 OUTLIER -111.31 -73.95 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 117.036 0.418 . . . . 0.0 111.654 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 82.1 Cg_endo -78.19 124.6 6.69 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.424 2.083 . . . . 0.0 113.507 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.674 ' HG2' HD22 ' A' ' 109' ' ' LEU . 1.1 tt0 -142.72 113.17 7.29 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.817 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.61 150.0 44.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.503 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.535 HG21 HD12 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -146.86 136.64 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.874 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.671 ' HB3' HG23 ' A' ' 106' ' ' THR . 4.1 ppp? -145.27 150.98 37.63 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.86 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.628 HG11 ' CE2' ' A' ' 130' ' ' TRP . 35.1 m -136.61 146.0 29.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 120.756 0.312 . . . . 0.0 111.378 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 52.1 p -133.37 155.41 49.52 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.31 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.47 ' HB3' ' CE2' ' A' ' 128' ' ' TYR . 9.6 pttp -109.77 153.66 24.04 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.044 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 60.9 m -84.06 148.28 53.16 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.876 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 122.614 2.209 . . . . 0.0 112.415 -179.74 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.642 0.258 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.35 115.29 3.96 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.749 2.3 . . . . 0.0 112.576 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.51 167.81 11.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 60.11 74.92 0.43 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.437 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 t 63.88 95.35 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.381 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.79 -56.64 0.11 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.971 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 8' ' ' THR . 6.6 tt 69.58 -73.52 0.09 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.353 0.261 . . . . 0.0 110.769 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.561 ' O ' HD23 ' A' ' 7' ' ' LEU . 10.9 t 47.27 -173.06 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.85 119.15 35.6 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-O 120.798 0.333 . . . . 0.0 111.476 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 m -142.35 38.05 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.6 137.01 57.07 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.328 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.51 HG22 HG23 ' A' ' 13' ' ' VAL . 4.0 m -95.46 132.98 39.96 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.51 HG23 HG22 ' A' ' 12' ' ' THR . 25.8 t 63.85 90.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.198 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.3 p -109.47 149.59 29.36 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.173 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.37 124.25 47.61 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.144 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.55 114.17 10.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.004 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 p -116.52 137.16 52.39 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.04 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.2 m -164.94 91.15 0.54 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.995 0.426 . . . . 0.0 111.18 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mp -110.82 -19.48 12.81 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.662 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.615 ' H ' HD13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -120.23 141.33 41.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.726 0.298 . . . . 0.0 111.089 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.7 143.69 14.85 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.786 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.35 148.41 45.09 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.008 0.432 . . . . 0.0 111.084 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.26 34.05 3.71 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.707 -0.679 . . . . 0.0 113.111 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -68.07 -41.35 82.07 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.732 0.266 . . . . 0.0 110.832 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -63.09 -29.91 71.18 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.004 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.96 9.46 27.72 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.768 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.04 14.45 26.36 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.427 0.156 . . . . 0.0 111.417 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.473 ' HA ' HG21 ' A' ' 129' ' ' VAL . 3.8 m 59.3 55.92 4.05 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.565 0.222 . . . . 0.0 111.137 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -158.56 31.1 0.23 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -78.85 113.13 32.72 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.894 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -90.84 99.99 0.25 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.926 2.417 . . . . 0.0 113.03 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.512 ' O ' HG12 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -117.64 96.72 5.51 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.872 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -132.91 102.38 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.423 0.63 . . . . 0.0 112.322 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -147.1 106.42 3.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.292 177.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.39 -140.99 15.55 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.013 -1.089 . . . . 0.0 112.785 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.505 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 0.6 OUTLIER 59.04 -86.44 0.02 OUTLIER 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.224 0.61 . . . . 0.0 110.977 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.14 -69.54 0.21 Allowed Glycine 0 CA--C 1.521 0.428 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.894 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.85 89.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.122 2.548 . . . . 0.0 113.486 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.899 HG23 ' CE1' ' A' ' 64' ' ' TYR . 1.3 mp -69.7 153.33 8.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.781 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.16 39.34 27.41 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.704 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.83 132.28 35.17 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.67 0.272 . . . . 0.0 110.75 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.0 m -114.91 147.92 39.33 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.606 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.74 HD11 ' HD2' ' A' ' 70' ' ' TYR . 15.5 mt -136.21 170.6 15.76 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.696 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -125.19 118.81 26.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.906 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.473 ' HB ' ' CZ ' ' A' ' 85' ' ' TYR . 13.7 p -111.36 134.77 52.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.0 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.466 ' HB ' ' CD1' ' A' ' 54' ' ' TRP . 32.5 m -131.82 128.03 59.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.292 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 54' ' ' TRP . . . -101.49 173.37 23.87 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.243 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -160.86 89.17 0.79 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.235 0.54 . . . . 0.0 111.09 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 165.14 -82.15 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.043 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.918 ' HB1' ' HG2' ' A' ' 77' ' ' LYS . . . -89.11 -43.25 11.19 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -118.8 68.47 0.79 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.719 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.82 -7.52 59.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.886 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.1 m -50.81 -24.91 3.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.037 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.466 ' CD1' ' HB ' ' A' ' 46' ' ' VAL . 16.2 m0 65.83 62.35 0.63 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.899 0.381 . . . . 0.0 110.97 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -95.62 123.67 39.28 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.078 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -117.59 63.37 0.74 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.699 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 142.89 94.08 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.882 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.42 -51.69 1.85 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.419 2.079 . . . . 0.0 112.118 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -10.33 33.74 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 73' ' ' VAL . 5.2 mmt85 -94.21 -23.12 18.02 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.383 0.135 . . . . 0.0 110.955 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.51 64.73 1.45 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.75 0.31 . . . . 0.0 111.531 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -138.53 21.33 2.73 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.913 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 mmm-85 -106.05 114.44 28.59 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.821 0.343 . . . . 0.0 111.295 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.899 ' CE1' HG23 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -101.28 120.04 39.66 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.041 179.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -111.55 122.29 65.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.0 0.429 . . . . 0.0 110.349 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' A' ' 36' ' ' ASP . . . -51.77 169.58 0.48 Allowed Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.901 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER 78.69 30.89 0.35 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.644 0.377 . . . . 0.0 111.234 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 62.27 21.06 12.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.461 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.801 HG22 ' HA ' ' A' ' 133' ' ' LYS . 60.2 p -95.91 155.06 16.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.752 0.311 . . . . 0.0 110.75 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.74 ' HD2' HD11 ' A' ' 43' ' ' LEU . 6.8 m-85 -127.74 133.6 49.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.392 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.46 129.5 43.04 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.084 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.5 131.4 14.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.473 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.462 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 29.4 t -82.55 125.3 39.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.403 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.2 t -125.97 140.21 49.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.772 0.32 . . . . 0.0 111.082 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -115.83 124.26 50.25 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.37 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -137.67 166.29 24.3 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.092 0.472 . . . . 0.0 111.673 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.918 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -85.96 173.42 9.95 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.412 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.52 133.41 52.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.813 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.82 147.22 7.54 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.52 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.0 136.68 57.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.679 0.276 . . . . 0.0 110.738 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.558 ' CZ ' HD13 ' A' ' 122' ' ' LEU . 7.3 p90 -142.19 147.07 35.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.587 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.733 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 2.8 mtt85 -103.29 131.62 50.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.498 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.462 ' CE ' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -136.21 164.96 26.86 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.029 0.442 . . . . 0.0 111.748 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -142.12 152.67 43.47 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.806 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.473 ' CZ ' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -117.8 142.01 47.78 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.345 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.401 ' HA ' ' HG2' ' A' ' 93' ' ' GLN . . . -161.54 134.35 6.13 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.115 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 91' ' ' SER . 0.4 OUTLIER -82.4 153.78 25.54 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.126 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -66.71 -30.15 70.31 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.504 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -95.72 30.09 2.45 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.352 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 10.9 m0 53.39 41.24 32.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 111.382 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.461 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.4 OUTLIER -86.05 169.58 15.12 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.388 179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 91' ' ' SER . 3.3 Cg_exo -40.11 126.6 1.95 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.185 2.59 . . . . 0.0 112.56 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.401 ' HG2' ' HA ' ' A' ' 86' ' ' ALA . 1.5 mt-30 -104.77 -178.03 3.54 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.504 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -128.53 122.94 32.27 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.656 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.78 129.3 11.43 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.86 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.04 108.17 19.16 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.6 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.11 95.03 0.08 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.624 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 53.88 82.45 0.05 OUTLIER Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.148 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.654 HD12 HD12 ' A' ' 101' ' ' LEU . 3.2 tm? -129.4 -77.94 0.55 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.806 0.303 . . . . 0.0 111.451 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 119' ' ' ALA . 34.9 mt-10 64.41 113.17 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.116 0.26 . . . . 0.0 110.969 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.836 HD21 HG12 ' A' ' 145' ' ' VAL . 0.0 OUTLIER -144.35 149.71 36.61 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.613 HG23 ' HD2' ' A' ' 103' ' ' PRO . 97.6 m -77.5 145.95 72.68 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.806 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.725 ' HD3' HG12 ' A' ' 120' ' ' VAL . 97.5 Cg_exo -43.56 130.39 7.08 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.678 2.252 . . . . 0.0 112.443 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.39 26.2 33.98 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.043 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.564 ' HB3' HD23 ' A' ' 101' ' ' LEU . 12.0 tttm -132.06 151.96 51.46 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.026 0.441 . . . . 0.0 111.119 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.7 m -77.98 145.58 35.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.49 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.82 132.99 46.68 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.246 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 m -69.19 127.92 34.8 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.68 HD13 HG12 ' A' ' 143' ' ' ILE . 16.1 tp -107.74 138.65 43.59 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.644 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.9 -61.18 1.77 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -167.8 -175.85 2.88 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.995 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -123.82 113.75 2.15 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.464 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -174.67 -108.49 0.22 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.515 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -127.38 48.46 2.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.923 0.392 . . . . 0.0 110.998 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.22 -135.2 5.47 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.466 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -100.4 136.78 39.76 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.667 0.27 . . . . 0.0 110.907 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.36 131.05 41.43 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.9 m -76.1 141.37 41.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.707 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.733 ' HB2' ' CG ' ' A' ' 82' ' ' ARG . . . -125.04 143.69 50.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.053 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.725 HG12 ' HD3' ' A' ' 103' ' ' PRO . 15.7 t -116.74 124.77 73.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.404 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.4 m -74.95 93.21 2.66 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.686 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.558 HD13 ' CZ ' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -105.74 113.16 64.25 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.94 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.64 8.28 4.71 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.695 2.263 . . . . 0.0 112.609 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -166.99 151.03 6.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.779 0.324 . . . . 0.0 110.948 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.29 136.02 49.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.854 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -178.69 169.76 41.4 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.161 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -85.31 132.24 34.28 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 111.199 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -134.75 148.68 50.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.66 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 28' ' ' CYS . 3.5 m -114.8 130.92 68.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.89 0.376 . . . . 0.0 111.459 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.41 ' CZ3' ' HB ' ' A' ' 145' ' ' VAL . 0.7 OUTLIER -88.92 115.54 26.55 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.559 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 28.1 t -114.58 134.85 54.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.152 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.609 ' HA ' HG22 ' A' ' 143' ' ' ILE . 4.0 mp -134.09 135.1 43.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.807 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.801 ' HA ' HG22 ' A' ' 69' ' ' THR . 6.8 tttm -148.8 121.83 8.83 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.909 0.385 . . . . 0.0 111.973 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -141.32 145.79 35.89 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.891 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.0 p -75.71 169.25 18.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.083 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.25 -1.82 50.55 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.801 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.65 -27.1 68.13 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.383 0.142 . . . . 0.0 111.383 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.57 -16.89 58.35 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.049 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.508 ' CB ' ' HD3' ' A' ' 140' ' ' PRO . 0.2 OUTLIER -102.01 -58.64 0.1 Allowed Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 117.005 0.403 . . . . 0.0 111.567 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 47.5 Cg_exo -57.81 94.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.562 2.175 . . . . 0.0 112.598 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -130.76 104.69 7.32 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.575 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.49 138.39 47.54 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.749 0.309 . . . . 0.0 111.268 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.68 HG12 HD13 ' A' ' 109' ' ' LEU . 1.7 pp -137.86 141.83 37.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -139.82 156.26 46.83 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.03 0.443 . . . . 0.0 111.47 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.836 HG12 HD21 ' A' ' 101' ' ' LEU . 10.8 p -122.73 139.79 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.666 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 67.7 m -129.03 135.48 49.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.129 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -112.88 135.76 53.28 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.771 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 2.1 p -117.73 109.35 41.63 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.787 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--O 1.251 1.143 0 C-N-CA 122.539 2.159 . . . . 0.0 112.55 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.548 0.213 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.04 165.02 33.04 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.808 2.338 . . . . 0.0 112.416 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 t -116.15 123.34 47.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.62 135.59 51.67 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 p -127.21 37.61 4.23 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.972 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.51 28.62 69.92 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.841 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.16 82.23 1.13 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.927 0.394 . . . . 0.0 110.588 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.6 p -129.06 -65.55 0.86 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.783 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -115.78 109.78 18.16 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.614 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.7 t -148.63 -65.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.4 115.37 20.71 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.117 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.7 m -92.62 122.12 34.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.713 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.9 m -124.86 122.53 63.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.172 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -152.65 118.65 5.46 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.963 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.19 96.38 5.77 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.003 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.46 97.56 1.62 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.216 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.7 p -146.99 131.62 17.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.154 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.75 123.58 37.77 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.985 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.6 tp 61.47 89.87 0.07 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.956 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.623 ' H ' HD13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -135.22 139.81 46.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.367 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.36 144.22 15.97 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.6 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.41 138.96 44.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.639 0.257 . . . . 0.0 110.905 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.91 152.68 20.61 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.061 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -65.42 -39.25 91.91 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.486 0.184 . . . . 0.0 111.247 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -26.41 68.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.121 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.88 -11.82 59.43 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.13 -30.42 39.04 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.529 0.204 . . . . 0.0 110.725 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.496 ' O ' HG11 ' A' ' 129' ' ' VAL . 35.2 t -63.03 -37.46 87.29 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.691 0.282 . . . . 0.0 110.306 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -145.11 103.18 3.84 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.541 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -71.0 137.56 84.9 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.556 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -53.48 117.03 3.38 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.683 2.255 . . . . 0.0 112.126 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.928 HG22 ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -108.12 97.6 7.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.342 0.592 . . . . 0.0 111.119 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 tt -92.83 160.51 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.271 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -64.11 107.26 1.23 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.772 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.658 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -107.46 -119.49 4.43 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.894 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -113.44 29.53 7.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.648 0.261 . . . . 0.0 110.805 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.11 117.39 10.7 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.312 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.4 112.65 1.11 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.742 2.295 . . . . 0.0 112.246 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.499 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.7 mp -70.24 153.63 8.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.98 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.95 22.82 76.2 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.485 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.493 ' HA ' ' HG2' ' A' ' 88' ' ' LYS . 1.7 mttp -127.94 132.23 49.27 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.855 0.359 . . . . 0.0 111.296 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.412 HG23 ' CD2' ' A' ' 62' ' ' TYR . 20.9 m -115.32 140.18 49.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.718 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.6 123.19 47.5 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.416 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.464 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -93.99 130.82 39.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.908 0.385 . . . . 0.0 111.162 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.777 HG12 ' CE2' ' A' ' 85' ' ' TYR . 8.0 m -112.34 132.83 59.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.307 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 84' ' ' GLN . 8.1 t -137.76 161.06 33.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.869 0.366 . . . . 0.0 110.76 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.43 ' N ' HG12 ' A' ' 46' ' ' VAL . . . -125.34 -159.07 10.2 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.916 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER 172.19 135.66 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.05 0.453 . . . . 0.0 111.259 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 48' ' ' ASP . 1.8 m-85 72.16 130.24 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.549 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 63.53 10.2 4.75 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.535 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 t0 40.25 64.85 0.84 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.935 0.398 . . . . 0.0 111.192 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.88 -37.73 12.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.658 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.428 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 13.4 t -122.99 -101.42 0.4 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.224 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 15.8 m95 49.35 30.99 3.52 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.873 0.368 . . . . 0.0 110.949 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -132.81 117.07 17.32 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.367 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.464 ' HG3' ' CE1' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -114.29 103.79 11.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.887 -179.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -98.28 116.23 65.58 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.923 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.95 -33.48 72.53 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.846 2.364 . . . . 0.0 112.871 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -59.35 -27.68 66.16 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.444 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.426 ' HD3' ' HB ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -130.62 20.65 5.12 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.151 179.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.45 -30.62 71.71 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.366 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.488 ' HB2' ' CE2' ' A' ' 70' ' ' TYR . 2.3 p90 -151.76 120.91 6.72 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.833 0.349 . . . . 0.0 111.311 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.45 120.41 38.05 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.187 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -62.44 118.36 7.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.317 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.928 ' HA ' HG22 ' A' ' 32' ' ' THR . 3.4 t -105.09 122.7 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.658 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -66.4 76.11 0.13 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.411 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' CG ' ' O ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER 167.83 29.24 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 O-C-N 123.849 0.382 . . . . 0.0 111.965 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 t30 61.91 24.95 14.93 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.891 0.376 . . . . 0.0 110.529 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.772 HG22 ' HA ' ' A' ' 133' ' ' LYS . 0.7 OUTLIER -113.75 156.02 24.57 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.398 -179.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.488 ' CE2' ' HB2' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -127.43 133.91 49.92 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.088 179.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -143.25 157.7 44.27 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 111.828 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.5 132.13 14.88 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.209 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.426 ' HB ' ' HD3' ' A' ' 60' ' ' ARG . 15.0 t -74.63 127.08 36.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.555 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.9 t -130.52 143.88 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.083 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -101.88 136.83 41.04 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.174 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -131.22 166.6 20.8 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.036 0.446 . . . . 0.0 112.05 -179.339 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -99.8 171.39 7.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.357 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.09 120.57 21.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.406 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 122' ' ' LEU . . . 129.61 152.79 7.67 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.505 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.36 126.14 27.28 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.754 0.311 . . . . 0.0 111.494 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 9.5 p90 -141.27 152.8 44.82 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.068 0.461 . . . . 0.0 111.497 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.851 ' HG3' ' HB2' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -103.59 149.55 24.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.794 178.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.7 137.86 37.19 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.504 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.493 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 1.2 tt0 -111.97 148.33 34.0 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.415 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.777 ' CE2' HG12 ' A' ' 45' ' ' VAL . 6.2 m-85 -128.07 159.77 34.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.394 0.616 . . . . 0.0 112.3 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.514 ' CB ' ' HA ' ' A' ' 92' ' ' PRO . . . -121.27 153.62 37.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.069 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.52 173.6 6.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.051 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.493 ' HG2' ' HA ' ' A' ' 41' ' ' LYS . 39.1 tptt -76.92 -9.58 58.79 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.79 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.04 31.91 0.77 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.724 0.297 . . . . 0.0 111.051 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 10.6 m0 60.32 17.35 7.01 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.1 t -97.6 117.56 65.22 Favored Pre-proline 0 C--O 1.231 0.086 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.514 ' HA ' ' CB ' ' A' ' 86' ' ' ALA . 57.3 Cg_endo -97.75 61.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.158 2.572 . . . . 0.0 113.429 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -157.78 124.44 4.91 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.648 ' CG ' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -141.71 126.15 17.71 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.544 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 94' ' ' PHE . 11.6 p -157.2 164.13 38.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.921 0.391 . . . . 0.0 111.666 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 108' ' ' SER . . . -133.24 97.54 4.01 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.679 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.02 110.4 0.39 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.379 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.01 78.06 0.14 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.215 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.811 HD21 ' HB1' ' A' ' 107' ' ' ALA . 19.1 tp -135.62 -66.96 0.55 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 69.94 83.44 0.15 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.324 0.583 . . . . 0.0 110.003 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.714 HD11 HG21 ' A' ' 145' ' ' VAL . 1.5 tt -60.41 144.96 49.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.421 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.808 HG22 ' HD2' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -135.5 151.2 74.18 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.979 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.808 ' HD2' HG22 ' A' ' 102' ' ' THR . 69.9 Cg_exo -52.07 118.63 4.73 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.799 2.333 . . . . 0.0 112.451 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.84 34.47 65.93 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.415 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.82 144.58 51.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.841 0.353 . . . . 0.0 111.111 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.498 HG22 ' HG2' ' A' ' 144' ' ' MET . 71.8 p -72.63 143.04 48.32 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.112 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.811 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -119.65 137.18 54.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.3 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -72.95 138.12 45.93 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.859 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.947 ' HG ' HD11 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -116.69 101.71 8.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.661 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.78 -70.62 0.54 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -179.55 -64.82 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.979 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 149.62 -131.67 3.74 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.303 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.89 48.4 66.6 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.516 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 59.74 65.82 1.08 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.89 0.376 . . . . 0.0 111.091 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.2 -137.12 9.12 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.216 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -102.92 113.41 26.83 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.822 0.311 . . . . 0.0 111.079 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -64.64 145.27 56.42 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.154 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.579 ' CG2' HD23 ' A' ' 99' ' ' LEU . 0.7 OUTLIER -86.65 119.55 27.02 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.351 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.851 ' HB2' ' HG3' ' A' ' 82' ' ' ARG . . . -110.34 138.32 46.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.66 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.512 ' HB ' HD23 ' A' ' 101' ' ' LEU . 14.7 p -116.54 126.07 73.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 120.898 0.38 . . . . 0.0 110.998 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.5 m -80.47 95.42 6.45 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.032 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 122' ' ' LEU . 10.0 mt -124.91 114.04 26.66 Favored Pre-proline 0 C--O 1.225 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.437 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.92 8.9 4.19 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.87 2.38 . . . . 0.0 113.292 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -155.02 151.81 28.88 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.016 0.436 . . . . 0.0 111.376 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -86.11 143.38 28.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.419 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -178.11 172.26 44.77 Favored Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.611 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -66.67 139.24 57.84 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.784 0.326 . . . . 0.0 111.076 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.88 142.39 50.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.055 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.496 HG11 ' O ' ' A' ' 28' ' ' CYS . 12.5 m -116.2 121.18 66.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 120.957 0.408 . . . . 0.0 110.639 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -98.51 117.04 32.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.536 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.677 ' C ' HD12 ' A' ' 132' ' ' LEU . 18.1 t -126.41 142.55 51.49 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.186 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.716 ' HG ' HG23 ' A' ' 143' ' ' ILE . 10.3 mp -133.86 142.76 47.94 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.758 0.313 . . . . 0.0 111.021 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.772 ' HA ' HG22 ' A' ' 69' ' ' THR . 0.0 OUTLIER -111.82 120.23 41.25 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.11 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.4 ' HE2' HD13 ' A' ' 109' ' ' LEU . 67.4 m-85 -114.12 144.96 42.29 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.795 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.891 HG21 ' HD2' ' A' ' 140' ' ' PRO . 9.4 t -86.86 -178.57 6.35 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.123 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -92.41 -41.05 10.54 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.333 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 p -66.41 -22.84 66.24 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.685 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.751 ' H ' HG23 ' A' ' 135' ' ' THR . . . 86.4 17.0 61.28 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.039 -0.6 . . . . 0.0 113.01 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.535 ' CB ' ' CD ' ' A' ' 140' ' ' PRO . 0.5 OUTLIER -102.97 -73.32 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.999 0.4 . . . . 0.0 111.033 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.891 ' HD2' HG21 ' A' ' 135' ' ' THR . 54.3 Cg_endo -69.12 127.47 15.15 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.304 2.003 . . . . 0.0 112.509 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 109' ' ' LEU . 6.7 mm-40 -138.99 116.97 11.64 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.139 0.495 . . . . 0.0 110.618 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.88 158.01 31.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.988 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.947 HD11 ' HG ' ' A' ' 109' ' ' LEU . 2.7 mt -123.47 153.42 29.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.171 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.498 ' HG2' HG22 ' A' ' 106' ' ' THR . 0.0 OUTLIER -137.81 116.84 12.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.611 179.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.714 HG21 HD11 ' A' ' 101' ' ' LEU . 30.1 m -122.88 148.68 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.818 0.342 . . . . 0.0 111.406 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 60.1 p -154.11 157.79 39.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.906 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.24 147.24 41.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.76 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 49.1 m -70.34 138.52 86.68 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.886 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.658 2.239 . . . . 0.0 112.814 -179.885 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 120.475 0.178 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.82 -33.9 42.79 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.523 2.149 . . . . 0.0 112.395 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.3 m -141.66 131.55 24.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.942 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.4 149.34 20.6 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.637 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 m -143.35 110.93 5.87 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.084 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.26 -145.05 11.11 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.73 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.63 34.27 22.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.751 0.31 . . . . 0.0 111.211 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.9 p -128.68 107.37 9.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.03 112.27 4.92 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.276 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.79 161.51 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.496 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.48 115.35 4.16 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.321 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.9 m -101.05 131.03 47.14 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.3 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.3 m -145.85 132.71 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.179 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.8 78.13 1.52 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.296 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 68.2 115.13 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.69 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -116.32 122.3 44.49 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.319 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.59 137.31 42.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.577 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.4 m -128.12 118.17 22.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.818 0.342 . . . . 0.0 111.182 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.08 32.39 5.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.229 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.637 ' H ' HD13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -138.48 140.71 39.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.215 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.12 146.55 13.87 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.572 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -128.8 145.18 51.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.794 0.331 . . . . 0.0 111.028 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -120.3 -156.94 10.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.174 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -54.47 -34.32 61.34 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.3 mtm -55.89 -30.48 61.64 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -109.55 10.02 25.17 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.96 -30.56 14.68 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.7 t -171.0 64.16 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.874 0.368 . . . . 0.0 110.833 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -155.23 23.38 0.42 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.818 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -97.46 114.41 64.81 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.805 -0.18 . . . . 0.0 111.385 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -70.24 142.33 45.56 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.025 2.484 . . . . 0.0 112.441 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.884 HG22 ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -108.38 117.02 33.08 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.398 0.618 . . . . 0.0 111.874 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.407 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 5.7 tt -131.56 164.15 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.177 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.08 107.45 0.64 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.547 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.745 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -116.95 -134.96 5.41 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.314 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -105.71 36.72 2.44 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.632 0.253 . . . . 0.0 111.173 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.1 129.32 23.51 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.599 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HB2' ' HG2' ' A' ' 41' ' ' LYS . 48.9 Cg_exo -56.23 116.85 3.48 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.943 2.429 . . . . 0.0 112.523 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 mp -80.36 154.82 4.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.552 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.18 14.71 81.96 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.706 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.473 ' HG2' ' HB2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -131.0 132.31 44.92 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.018 0.409 . . . . 0.0 111.169 179.539 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.64 144.05 44.47 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.08 122.81 31.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.322 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -105.0 118.7 37.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.617 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.429 HG23 ' CZ ' ' A' ' 85' ' ' TYR . 8.0 p -115.46 135.24 56.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.28 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.566 HG12 ' NE2' ' A' ' 56' ' ' GLN . 33.2 m -131.77 120.89 46.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.591 ' HA3' ' HB1' ' A' ' 52' ' ' ALA . . . -77.79 115.67 4.3 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.759 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.73 88.35 7.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.079 0.466 . . . . 0.0 111.149 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.417 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER 73.2 -176.85 0.17 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.552 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' CB ' ' HB3' ' A' ' 81' ' ' PHE . . . 72.55 49.9 0.19 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.322 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 56.97 31.98 20.79 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.572 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.591 ' HB1' ' HA3' ' A' ' 47' ' ' GLY . . . -97.93 -40.78 8.31 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.966 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.2 t 57.28 25.28 10.93 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.731 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 49.35 62.64 2.52 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.927 0.394 . . . . 0.0 111.151 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.3 mtmm -94.75 137.86 33.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.137 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.566 ' NE2' HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -141.99 90.59 2.27 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.132 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -77.78 130.21 74.08 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.134 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.64 -26.5 46.69 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.972 2.448 . . . . 0.0 112.852 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -70.67 -7.51 45.1 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.906 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.447 ' HG2' ' HB ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -127.8 20.64 6.51 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.51 0.195 . . . . 0.0 111.032 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.8 -86.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.04 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.461 ' CE1' ' HE3' ' A' ' 41' ' ' LYS . 8.9 t80 -129.36 137.12 50.78 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.833 0.349 . . . . 0.0 111.046 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.68 121.68 41.52 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.136 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -62.61 118.35 7.5 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.832 0.349 . . . . 0.0 111.623 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.884 ' HA ' HG22 ' A' ' 32' ' ' THR . 1.8 t -107.28 107.12 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.745 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -54.32 87.72 0.01 OUTLIER Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.558 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 66' ' ' GLY . 0.4 OUTLIER 160.12 25.84 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 t30 61.74 23.21 13.58 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.935 0.398 . . . . 0.0 110.358 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.808 HG22 ' HA ' ' A' ' 133' ' ' LYS . 19.7 p -116.68 155.82 28.17 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.23 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.439 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -112.37 148.82 33.47 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.986 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.494 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -146.7 140.2 25.76 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.091 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.4 130.64 13.65 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.182 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.447 ' HB ' ' HG2' ' A' ' 60' ' ' ARG . 23.2 t -81.15 136.31 23.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.856 0.36 . . . . 0.0 110.691 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.469 HG21 ' OH ' ' A' ' 85' ' ' TYR . 12.1 t -129.94 146.05 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.25 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.64 131.63 54.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.124 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.26 165.72 23.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.841 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.55 168.22 9.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.39 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 123' ' ' PRO . . . -63.43 124.74 22.07 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.718 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.67 149.19 8.6 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.133 -0.555 . . . . 0.0 112.605 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.66 128.55 20.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.742 0.306 . . . . 0.0 111.516 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.474 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 22.3 p90 -142.87 148.33 36.83 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.825 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.458 ' HG3' ' HB2' ' A' ' 119' ' ' ALA . 0.4 OUTLIER -110.99 156.36 21.36 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.58 179.154 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -144.22 150.44 37.98 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.424 ' HB3' ' CG2' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -118.7 144.72 46.04 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.573 178.179 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.473 ' HB2' ' CG ' ' A' ' 94' ' ' PHE . 16.0 m-85 -128.22 160.09 33.18 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.589 0.709 . . . . 0.0 112.574 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.59 ' CB ' ' HA ' ' A' ' 92' ' ' PRO . . . -111.2 123.81 50.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.489 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.03 -178.03 0.72 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.101 0.476 . . . . 0.0 111.904 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -80.98 -14.95 57.48 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.012 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -87.94 42.21 1.04 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.486 0.184 . . . . 0.0 111.363 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 51.95 23.28 2.09 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.651 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 t -101.42 118.11 60.63 Favored Pre-proline 0 CA--C 1.522 -0.098 0 CA-C-O 120.499 0.19 . . . . 0.0 110.67 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.59 ' HA ' ' CB ' ' A' ' 86' ' ' ALA . 70.4 Cg_endo -89.13 53.47 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.739 2.293 . . . . 0.0 112.582 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 92' ' ' PRO . 13.2 mt-30 -152.43 124.59 8.1 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.473 ' CG ' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -141.92 120.63 12.62 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.404 ' HB ' ' N ' ' A' ' 116' ' ' GLN . 69.2 p -152.36 125.97 8.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.676 0.274 . . . . 0.0 111.248 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.62 99.59 11.2 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.766 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.79 114.31 2.02 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.665 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.06 85.54 0.04 OUTLIER Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.494 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.747 HD21 ' HB1' ' A' ' 107' ' ' ALA . 12.8 tp -152.5 -57.1 0.14 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 64.45 79.85 0.25 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.44 0.638 . . . . 0.0 109.426 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.03 HD21 HG11 ' A' ' 145' ' ' VAL . 0.5 OUTLIER -53.03 143.85 16.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.149 -178.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.842 HG22 ' HD2' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -131.6 151.47 78.73 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.452 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.842 ' HD2' HG22 ' A' ' 102' ' ' THR . 50.3 Cg_exo -56.15 118.75 5.6 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.875 2.383 . . . . 0.0 112.267 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.0 34.77 89.39 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.025 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.89 147.57 48.75 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.91 0.386 . . . . 0.0 111.542 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.5 t -71.56 145.48 49.04 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.305 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.747 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -128.9 144.23 51.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.671 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.8 m -82.09 129.38 34.79 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.915 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.679 HD12 HD13 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -95.53 95.72 8.58 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.601 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -73.89 -65.37 0.84 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -176.54 -66.25 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.563 0.22 . . . . 0.0 111.45 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 116.68 114.73 2.8 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.467 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.86 75.97 0.03 OUTLIER Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.237 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 58.92 34.76 23.83 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.739 0.304 . . . . 0.0 111.169 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.58 -128.89 4.78 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.303 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.404 ' N ' ' HB ' ' A' ' 95' ' ' THR . 14.7 tt0 -109.38 111.71 23.42 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.731 0.3 . . . . 0.0 110.993 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.67 150.37 47.29 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.586 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.52 ' CG2' HD23 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -83.44 113.96 21.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.765 0.317 . . . . 0.0 110.756 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.458 ' HB2' ' HG3' ' A' ' 82' ' ' ARG . . . -102.12 126.46 49.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.061 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.88 ' HB ' HD23 ' A' ' 101' ' ' LEU . 11.3 p -116.68 124.99 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.452 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 m -85.65 92.74 8.65 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.272 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.9 tp -131.5 101.15 16.04 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.341 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.55 ' O ' ' HB1' ' A' ' 78' ' ' ALA . 15.5 Cg_exo -68.91 8.62 0.56 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.467 2.778 . . . . 0.0 113.816 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -123.08 142.97 50.29 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.659 0.266 . . . . 0.0 111.038 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -98.57 142.33 30.3 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.34 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.03 175.27 40.73 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.248 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -67.26 140.35 57.36 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.761 0.315 . . . . 0.0 111.012 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.543 ' CE1' HG22 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -130.33 148.48 52.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.268 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.42 129.44 73.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.848 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.565 ' HE3' HD11 ' A' ' 132' ' ' LEU . 4.9 m95 -106.48 112.3 25.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.039 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.802 ' O ' HD13 ' A' ' 132' ' ' LEU . 66.3 p -109.33 134.38 51.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.294 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 131' ' ' SER . 0.4 OUTLIER -132.84 135.66 45.77 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.679 0.276 . . . . 0.0 110.643 -179.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.808 ' HA ' HG22 ' A' ' 69' ' ' THR . 11.2 tptm -106.63 130.57 54.35 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.644 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 132' ' ' LEU . 21.8 m-85 -139.84 145.05 37.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.918 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.4 p -110.65 -179.63 3.81 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.365 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -89.57 -20.84 23.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.582 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.2 m -65.61 -27.14 68.19 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.78 -17.26 55.71 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.256 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.513 ' CB ' ' HD3' ' A' ' 140' ' ' PRO . 0.3 OUTLIER -86.1 -56.85 0.36 Allowed Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 117.154 0.477 . . . . 0.0 110.897 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 139' ' ' ASP . 22.6 Cg_exo -63.77 98.59 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.613 2.209 . . . . 0.0 112.0 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.652 ' HG2' HD22 ' A' ' 109' ' ' LEU . 1.3 tt0 -134.2 106.78 7.33 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.63 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.95 144.97 51.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.256 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.739 ' HB ' HD12 ' A' ' 132' ' ' LEU . 21.3 pt -134.91 139.18 47.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.006 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -147.93 161.23 41.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.973 0.416 . . . . 0.0 111.487 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 1.03 HG11 HD21 ' A' ' 101' ' ' LEU . 8.3 p -125.29 145.77 32.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.6 m -144.43 151.52 39.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -105.67 141.18 37.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.063 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 149' ' ' PRO . 62.0 m -121.32 131.35 24.48 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.696 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 148' ' ' CYS . 50.9 Cg_exo . . . . . 0 C--O 1.252 1.18 0 C-N-CA 122.697 2.265 . . . . 0.0 112.313 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.488 0.185 . . . . 0.0 111.308 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 1' ' ' THR . 43.0 Cg_exo -56.73 154.37 31.88 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.109 2.539 . . . . 0.0 113.127 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.2 m -150.61 144.01 24.98 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.218 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.14 128.54 33.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.854 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.4 101.38 14.06 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.116 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.67 -56.87 5.24 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.536 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.12 90.01 2.22 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.88 0.371 . . . . 0.0 111.076 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.21 -49.4 0.08 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.075 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -62.9 136.85 58.07 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.368 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.2 p -93.77 150.21 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.207 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.97 115.83 4.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.134 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -107.72 126.3 52.44 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.335 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 t 67.43 109.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.688 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 m 66.78 95.53 0.06 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.513 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.92 98.07 1.18 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.654 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -172.24 122.75 0.47 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.317 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.04 90.89 1.08 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.34 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 m 64.5 104.74 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.825 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.2 -44.1 69.36 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.154 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.442 HD13 ' N ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -73.55 141.33 16.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.877 0.37 . . . . 0.0 111.251 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.442 ' N ' HD13 ' A' ' 20' ' ' ILE . . . 168.81 141.28 3.16 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.683 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -121.16 138.44 54.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.642 0.258 . . . . 0.0 110.9 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.04 -26.66 58.7 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.881 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.4 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -61.58 -50.0 74.39 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.71 0.255 . . . . 0.0 111.11 179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.405 ' CE ' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -82.19 -19.42 39.87 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.085 179.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.405 ' HB2' ' CE ' ' A' ' 25' ' ' MET . . . -86.29 11.51 12.01 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -91.01 -30.34 16.86 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 122.283 -0.261 . . . . 0.0 111.018 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.3 p -116.35 -32.83 5.15 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -117.06 99.04 6.79 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.942 0.401 . . . . 0.0 111.5 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -97.24 152.76 38.45 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.644 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.24 119.93 7.26 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.311 2.007 . . . . 0.0 112.456 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.19 141.44 31.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.123 0.487 . . . . 0.0 110.623 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.604 HG23 ' HA3' ' A' ' 66' ' ' GLY . 15.5 tt -148.75 164.65 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.714 -178.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -61.55 108.05 0.9 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.804 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.772 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -147.65 -159.57 8.45 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.978 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 61.12 -73.92 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.235 0.214 . . . . 0.0 111.558 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 35' ' ' GLY . . . 96.8 -114.51 4.98 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.37 -19.19 33.54 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.471 2.114 . . . . 0.0 112.998 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.521 HG22 ' H ' ' A' ' 40' ' ' GLY . 3.8 mt -89.02 167.68 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.662 0.268 . . . . 0.0 111.11 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.521 ' H ' HG22 ' A' ' 39' ' ' ILE . . . 78.54 51.15 5.71 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.614 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.29 157.92 21.38 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.035 0.445 . . . . 0.0 111.155 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.543 ' HB ' ' CD1' ' A' ' 62' ' ' TYR . 1.5 t -54.47 120.79 7.13 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.432 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.775 HD23 ' HB2' ' A' ' 87' ' ' SER . 1.0 OUTLIER -119.31 177.02 5.06 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.982 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -130.77 118.89 21.5 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.094 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.648 HG12 ' OE1' ' A' ' 56' ' ' GLN . 12.1 p -97.4 130.87 45.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.522 ' HB ' ' CG ' ' A' ' 54' ' ' TRP . 1.3 m -141.5 -179.1 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.29 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.08 -18.25 12.42 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.912 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.807 ' HB3' ' HB3' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -43.0 -80.64 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 68.41 4.49 4.27 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.44 60.77 0.6 Allowed 'General case' 0 C--O 1.231 0.091 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.6 t70 71.7 20.66 4.57 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.009 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.807 ' HB3' ' HB3' ' A' ' 48' ' ' ASP . . . -100.99 -44.21 5.8 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.52 0.2 . . . . 0.0 110.875 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.9 m 71.56 25.42 3.36 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.576 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.522 ' CG ' ' HB ' ' A' ' 46' ' ' VAL . 23.1 m0 48.88 62.19 2.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 111.558 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -95.26 136.88 35.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.283 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.648 ' OE1' HG12 ' A' ' 45' ' ' VAL . 40.9 tp60 -136.15 96.01 3.31 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.725 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.8 116.32 17.93 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.714 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 51.8 Cg_exo -54.66 -32.52 75.77 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.765 2.31 . . . . 0.0 112.538 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -58.34 -24.58 60.18 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.581 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.406 ' HD3' ' HB ' ' A' ' 73' ' ' VAL . 92.4 mtt180 -130.62 22.86 5.06 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.748 0.309 . . . . 0.0 110.917 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . . . -53.06 -30.11 34.03 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.759 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.543 ' CD1' ' HB ' ' A' ' 42' ' ' THR . 1.9 p90 -163.95 131.71 3.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.777 0.322 . . . . 0.0 111.241 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.74 115.4 23.83 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.992 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -60.96 118.18 6.4 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.915 0.388 . . . . 0.0 111.367 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.515 ' CG2' ' HB2' ' A' ' 71' ' ' GLN . 2.4 t -101.46 96.42 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.772 ' HA2' ' HA3' ' A' ' 35' ' ' GLY . . . -45.23 87.9 0.01 OUTLIER Glycine 0 C--N 1.337 0.618 0 O-C-N 123.89 0.744 . . . . 0.0 112.726 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER 156.52 26.05 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.377 0.692 . . . . 0.0 112.451 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t30 62.27 25.18 15.04 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 122.071 -0.393 . . . . 0.0 111.052 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.563 HG22 ' O ' ' A' ' 132' ' ' LEU . 0.6 OUTLIER -112.8 154.75 25.75 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.497 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.487 ' HB2' HD21 ' A' ' 132' ' ' LEU . 1.2 m-85 -117.35 133.56 55.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.833 0.349 . . . . 0.0 111.115 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.515 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -141.49 133.71 27.9 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.972 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.7 120.24 7.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.718 HG22 HG12 ' A' ' 129' ' ' VAL . 28.7 t -76.71 130.43 36.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.495 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.444 HG11 HG11 ' A' ' 45' ' ' VAL . 6.6 m -127.26 134.02 66.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -104.72 99.86 9.52 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.343 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -126.37 166.76 16.57 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.427 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 169.57 3.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.243 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.771 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -119.39 143.92 47.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.158 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.52 97.28 1.95 Allowed Glycine 0 C--N 1.335 0.485 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.387 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.97 72.33 0.49 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.679 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -134.34 139.04 45.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.706 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -120.55 155.84 32.83 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.929 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.5 ptm -154.58 155.06 34.07 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.939 0.4 . . . . 0.0 111.992 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.13 140.7 17.91 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.302 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.42 ' CE1' ' HB ' ' A' ' 45' ' ' VAL . 7.5 m-85 -97.09 142.37 29.1 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 111.725 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.513 ' HA ' ' CB ' ' A' ' 93' ' ' GLN . . . -163.76 122.98 2.02 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.123 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.775 ' HB2' HD23 ' A' ' 43' ' ' LEU . 8.8 t -74.6 165.08 25.8 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.842 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.2 mtmm -69.97 -50.2 44.14 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.332 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.93 35.66 0.85 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.924 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 1.3 t90 52.31 40.84 29.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.004 0.43 . . . . 0.0 111.452 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.67 177.14 2.98 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.895 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.419 ' O ' HD21 ' A' ' 43' ' ' LEU . 81.4 Cg_exo -45.62 111.49 0.33 Allowed 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.905 2.403 . . . . 0.0 112.849 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.513 ' CB ' ' HA ' ' A' ' 86' ' ' ALA . 10.3 pt20 -128.09 -174.76 3.3 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.948 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.608 ' HA ' HD11 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -122.87 120.0 32.18 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.956 0.408 . . . . 0.0 110.3 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.542 HG22 ' HA3' ' A' ' 115' ' ' GLY . 9.9 p -129.07 134.48 48.11 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.019 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.532 ' HB1' ' CD2' ' A' ' 99' ' ' LEU . . . -125.75 140.65 52.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.129 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 116' ' ' GLN . 0.1 OUTLIER -128.15 104.79 7.96 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.879 0.371 . . . . 0.0 111.854 -179.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.57 102.55 0.01 OUTLIER Glycine 0 C--N 1.337 0.585 0 CA-C-N 116.019 -0.537 . . . . 0.0 113.213 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.532 ' CD2' ' HB1' ' A' ' 96' ' ' ALA . 1.1 pt? -169.74 -38.86 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 60.1 76.36 0.37 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.757 0.789 . . . . 0.0 109.534 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.784 HD21 HG11 ' A' ' 145' ' ' VAL . 9.6 tt -55.65 143.67 29.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.078 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.513 HG22 ' HD2' ' A' ' 103' ' ' PRO . 1.9 m -130.02 143.1 47.74 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.13 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.77 ' HG3' HD23 ' A' ' 122' ' ' LEU . 82.9 Cg_exo -46.55 118.36 2.54 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.899 2.399 . . . . 0.0 112.448 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.07 34.52 29.87 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.537 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.792 ' O ' HG12 ' A' ' 145' ' ' VAL . 0.0 OUTLIER -130.29 144.65 51.5 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.798 0.333 . . . . 0.0 111.15 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.2 t -78.65 137.27 37.74 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 143' ' ' ILE . . . -108.83 145.57 35.05 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.18 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.6 m -81.62 134.25 35.47 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.888 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.608 HD11 ' HA ' ' A' ' 94' ' ' PHE . 49.5 tp -104.05 142.59 34.19 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.812 0.339 . . . . 0.0 110.798 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -102.74 -70.91 0.74 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.178 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 179.99 -66.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.723 0.297 . . . . 0.0 111.035 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 155.58 146.79 4.53 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.502 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.79 -33.23 6.02 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.442 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -147.16 97.11 2.83 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.718 0.294 . . . . 0.0 110.369 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.542 ' HA3' HG22 ' A' ' 95' ' ' THR . . . -127.49 102.12 0.59 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.206 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.414 ' HB2' ' HA ' ' A' ' 97' ' ' ASP . 0.4 OUTLIER -50.93 143.77 9.67 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.82 0.343 . . . . 0.0 110.772 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 82' ' ' ARG . 13.5 m-20 -64.09 122.44 16.57 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.082 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 82' ' ' ARG . 94.3 m -93.82 113.98 26.13 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.918 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.55 137.77 32.02 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.017 0.437 . . . . 0.0 111.78 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.507 ' CG2' HD22 ' A' ' 101' ' ' LEU . 16.0 t -125.23 133.76 68.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.581 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.1 m -92.5 93.23 8.45 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.747 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.771 ' O ' ' HB1' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -131.5 107.31 14.46 Favored Pre-proline 0 C--O 1.226 -0.184 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.611 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -76.76 8.55 3.03 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.723 2.282 . . . . 0.0 113.785 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.406 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.8 tt0 -122.43 117.02 24.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.741 0.305 . . . . 0.0 111.181 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . . . -79.94 140.9 36.47 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.286 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 171.11 -165.34 38.47 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.84 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -95.8 121.61 37.71 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 110.822 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.452 ' CD1' ' HG3' ' A' ' 147' ' ' LYS . 0.9 OUTLIER -105.91 154.53 20.43 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.544 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.718 HG12 HG22 ' A' ' 73' ' ' VAL . 32.4 m -110.56 120.54 61.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.048 0.452 . . . . 0.0 111.623 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.409 ' CZ3' HG23 ' A' ' 145' ' ' VAL . 0.9 OUTLIER -101.31 112.09 24.5 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.336 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.68 ' C ' HD13 ' A' ' 132' ' ' LEU . 79.7 p -123.24 133.55 54.19 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.218 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.68 HD13 ' C ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -135.82 136.66 40.83 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.729 0.3 . . . . 0.0 110.853 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.519 ' HA ' HG22 ' A' ' 69' ' ' THR . 13.3 tptm -124.23 119.75 30.25 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.066 0.46 . . . . 0.0 110.735 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 141' ' ' GLU . 1.9 p90 -142.85 152.52 42.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.395 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.52 HG21 ' HB3' ' A' ' 139' ' ' ASP . 6.2 p -72.12 157.2 38.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.057 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -93.96 -12.01 29.67 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.782 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.1 t -93.07 15.35 15.33 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.1 -8.38 79.91 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.674 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.643 ' HB3' ' HD2' ' A' ' 140' ' ' PRO . 1.2 m-20 -61.68 -178.07 0.17 Allowed Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 117.012 0.406 . . . . 0.0 111.441 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.643 ' HD2' ' HB3' ' A' ' 139' ' ' ASP . 68.3 Cg_exo -41.16 154.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.397 2.731 . . . . 0.0 113.851 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.581 ' HB3' ' HB2' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -140.2 115.27 9.74 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.085 -178.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.42 154.03 38.29 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.012 0.434 . . . . 0.0 111.77 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.622 HG23 ' HB3' ' A' ' 132' ' ' LEU . 10.4 mt -123.63 155.95 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.97 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.72 132.81 39.27 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.793 0.33 . . . . 0.0 111.146 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.792 HG12 ' O ' ' A' ' 105' ' ' LYS . 13.0 p -125.42 129.21 72.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.817 0.341 . . . . 0.0 111.105 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 95.1 p -143.8 144.99 32.04 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.967 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.452 ' HG3' ' CD1' ' A' ' 128' ' ' TYR . 8.8 ttpp -117.06 104.01 10.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.893 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -114.97 141.52 27.05 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.753 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.251 1.149 0 C-N-CA 122.438 2.092 . . . . 0.0 112.494 -179.775 . . . . . . . . 0 0 . 1 stop_ save_